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Abstract 
Vertebrate DNA is globally modified by the incorporation of 5-methylcytosine 
(m5C) exclusively within CpG dinucleotides. In mammals DNA methylation is 
negatively correlated with the transcriptional activity of genes. A family of proteins 
have been identified that are targeted to methylated DNA by a methyl-CpG binding 
domain (MBD) and serve to mediate the transcriptional silencing and potentially 
other biological consequences of cytosine methylation. In contrast to vertebrates the 
genomes of the invertebrates Drosophila melanogaster and Caenorhabditis elegans 
lack detectable methylation. The recently sequenced genome of the model organism 
C. elegans was found to contain a gene that potentially encoded a protein containing 
a methyl-CpG binding domain and intriguingly, two motifs present in chromatin-
associated transcriptional regulators - the PHD-zinc finger and bromodomain. The 
gene was given the standard name pbm-1 for PHD-zinc finger, bromodomain and 
MBD gene-1. The MBD of pbm-1 was found to be highly homologous to a human 
EST suggesting evolutionary and functional conservation of this domain. A mouse 
cDNA, mPBM1 was identified that encoded a protein with the same modular 
organisation of motifs as the C. elegans PBM-1 protein. The aim of this project was 
the characterisation of this gene family using a cross-species approach that exploited 
the advantages particular to the nematode and mammalian systems. 
The MBDs of PBM-1 and mPBM1 did not associate with methylated sequences in a 
series of in vitro binding studies. These findings do not rule out the possibility that 
the MBDs mediate binding to other covalent modifications of DNA or specific 
sequence targets. In support of the in vitro findings, the mPBM1 protein did not 
associate with the heavily methylated mouse major satellite when fused to GFP and 
was found to localise in a diffuse, granular pattern in the nucleus. Furthermore, the 
MBD of mPBM 1 was dispensable for the spatial localisation of the protein. Deletion 
of a C-tenninal element encompassing the PHD-zinc finger and bromodomain regions 
abolished the wild type localisation in mouse nuclei. 
The PHD-zinc finger has been identified in a number of chromosomal translocations 
involved in acute leukaemias suggesting that deregulation of normal expression 
contributes to the transformation phenotype. The hPBM1 gene was physically 
mapped to chromosome 2q23 in a region found deleted and rearranged in leukaemias. 
Interestingly, mPBM1 fused to a heterologous DNA-binding domain was found to 
modestly repress the transcription of a reporter gene in mouse cells. 
The field of DNA methylation has been unable to utilise the expertise present in the 
nematode, C. elegans because this organism appears to lack m 5C. An EMS-induced 
deletion within the pbm-1 gene was identified and a C. elegans strain, pbm-1 
(qal 700) was established that was homozygous mutant for this deletion. The pbm-1 
(qal 700) strain was viable and the phenotype was indistinguishable from wildtype. 
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CHAPTER ONE: INTRODUCTION 
1.1 Introduction 
The base 5-methylcyto sine (m 5C) represents about 1% of the nucleotides in the 
vertebrate genome. The covalent modification of DNA by methylation represents an 
epigenetic mechanism to modulate the informational content present within the 
primary sequence of nucleotide bases. The predominant methylated sequence in all 
animals is the self complementary dinucleotide CpG and the vertebrate genome is 
characterised by a bimodal pattern of DNA methylation where most (60-90%) of the 
CpGs are methylated with the remaining CpU residues conspicuously unmethylated 
(Gruenbaum et al., 1981a; Cooper et al., 1983). This small fraction of unmethylated 
CpG dinucleotides are present in discrete clusters, termed CpG islands that are found 
primarily at the 5' end of genes (Bird, 1986). In somatic tissues, CpG islands are 
constitutively unmethylated with certain exceptions such as the island-containing 
genes on the inactive X chromosome and parentally imprinted genes (Riggs and 
Pfeifer, 1992; Ferguson-Smith et al., 1993). Direct evidence exists that in vitro 
methylation of DNA and transfection into mammalian cells is correlated with 
transcriptional suppression (Busslinger et al., 1983; Yisraeli et al., 1988). However, 
methylation per se does not inhibit transcription as in certain cases silencing precedes 
methylation (Lock et al., 1987). Furthermore, methylated reporters are not 
immediately silenced when introduced to cells (Buscbhausen et al., 1987) and loss of 
transcriptional activity coincides with the formation of chromatin (Kass et al., 1997). 
As vertebrates are characterised by genome-wide methylation this has suggested that 
DNA methylation might be involved in long term transcriptional silencing. 
tj 
1.1.1 DNA methylation in early embryogenesis 
The methylation of DNA in gametes is comparable to that found in adult tissues, 
however studies of embryonic methylation in the mouse have suggested the process 
is dynamic with a demethylation event occurring during pre-implantation 
development (Monk et al., 1987; Howlett and Reik, 1991). A wave of de novo 
methylation at around the time of implantation is thought to establish the adult 
modification pattern comprising genome wide methylation and constitutively 
unmethylated CpG islands (Shemer et al., 1991; Kafri et al., 1992). CpG islands were 
found to be resistant to this de novo methylation activity in transgenic mice studies 
and in cultured embryonic cells (Kolsto et al., 1986; Szyf et al., 1990; Frank et al., 
1991). A passive mechanism of demethylation has been proposed where prevention 
of methyltransferase binding to a transcriptionally active CpG island results in 
demethylation (Matsuo et al., 1998). This is a replication-based model where two 
rounds of replication of symmetrically methylated DNA can result in a passive 
demethylation in the absence of maintenance methylation. Evidence does exist 
suggesting CpG islands in embryonic cells are transcriptionally active (Macleod et al., 
1998) and asymmetric Spi elements within the CpG island of the aprt gene are also 
required to maintain the immunity of this region from the embryonic de novo 
methylation event (Macleod et al., 1994; Brandeis et al., 1994). 
1.1.2 Maintenance and de novo DNA (cytosine-5) methyltransferases 
The incorporation of a methyl group at position-5 of the cytosine ring is carried out 
by a conserved family of DNA (cytosine-5) methyltransferases. DNA methylation 
patterns are maintained by the action of Dnmtl, that preferentially methylates hemi-
methylated DNA (Gruenbaum et al., 1982; Bestor and Ingram, 1983). The Dnmtl 
enzyme is termed the maintenance DNA (cytosine-5) methyltransferase although the 
enzyme can also methylate unmethylated DNA in vitro (de novo methylation) 
suggesting a single enzymatic activity might mediate both maintenance and de novo 
functions. However, no de novo methyltransferase activity has been reported for 
Dnmtl in vivo and ES cells homozygous for a null mutation in the Dnmtl gene were 
able to de novo methylate a provirus introduced into these cells (Lei et al., 1996). 
This suggested that additional activities independent of the Dnmtl enzyme exist in 
mouse and these enzymes represent strong candidates for mediating the de novo 
methylation of genomic DNA occuring at the time of implantation during mouse 
development. 
The Dnmtl methyltransferase contains a C-terminal region of 500 amino acids that 
is related to bacterial type II cytosine-5 methyltransferases (Lauster et al., 1989; 
Posfai et al., 1989). A reverse genetics approach has identified a family of mammalian 
DNA (cytosine-5) methyltransferases by using the type II bacterial enzymes to 
search the expressed sequence tag (EST) databases (Okano et al., 1998a). These 
proteins, Dnmt2 and Dnmt3 contain the highly conserved cytosine-5 
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methyltransferase motifs however the Dnmt2 enzyme did not methylate DNA in 
vitro or in vivo (Okano et al., 1998b). Furthermore, targeted deletion of Dnmt2 in ES 
cells did not affect growth or morphology suggesting Dnmt2 is not essential in 
contrast to Dnmtl (see section 1.3.1). Dnmt2 is homologous to the fission yeast 
pmtl (pombe methyltransferasel) which does not possess any detectable 
methyltransferase activity (Wilkinson et al., 1995). The Dnmt3 protein showed only 
a modest ability to enzymatically modify unmethylated and hemi-methylated DNAs. 
Targeted deletion by homologous recombination will clarify the role of Dnmt3 in 
mouse development and de novo methylation. 
1.1.3 Intrinsic mutability of 5-methylcytosine 
The methyl group present in m 5C can directly affect protein-DNA interactions 
(Iguchi-Ariga and Schaffer, 1989; Bednarik et al., 1991), increase the thermal stability 
of C-G base pairs by several degrees (Collins and Myers, 1987) and alter the 
energetics of structural transitions from the B to Z forms of DNA (Behe and 
Felsenfeld., 1981). The base m 5C also possesses an intrinsic mutability. Cytosine 
moieties in DNA can spontaneously deaminate to uracil and dedicated uracil DNA 
glycosylases repair mismatches arising from C to U transitions. Deamination of m 5 C 
however generates thymine which cannot be repaired by the uracil DNA gylcosylase 
pathway. Hydrolytic deamination of m 5C allows a single-step conversion between 
nucleotides that is not possible for the other bases within DNA (Lindahi and Nyberg, 
1974). Human cells contain an activity that recognises T/G (T DNA glycosylase, 
Wi 
TDG) in m5CpG/TpG mismatches and preferentially removes the T (Nedderman and 
Jiricny, 1993). However, m5CpG to TpG mutations account for almost 50% of 
mutations in colon cancer (Holistein et al., 1996) and approximately one-third of 
single base pair mutations causing human genetic disease occur in m 5CpG 
dinucleotides (Cooper and Youssoufian, 1988). As a result, the dinucleotide CpG is 
depleted in the vertebrate genome and this is likely the result of the loss of m 5CpG to 
its deamination products, TpG and CpA (Bird, 1980). Lieb and Rehmat (1997) have 
reported a markedly reduced rate of spontaneous deamination of m 5C in non-dividing 
bacteria which was similar to m 5C in solution. The authors suggest that the mutation 
hot spots at m5C in rapidly dividing cells is the result of insufficient time for T/G 
mismatch repair pathways to operate before the next round of replication. 
Interestingly, the mutation frequency of p53 in tissues that are growing rapidly is 
increased relative to the mutation rate observed in slowly growing tissues (Hollstein 
et al., 1996). 
1.2 DNA methylation outside the vertebrate lineage 
1.2.1 Plant DNA methylation 
The genomic DNA of plants contains m5C at the symmetric sites, CpG and CNG 
and as much as 30% of total cytosine residues are modified to m 5C (Gruenbaum et 
al., 1981b). Plants also contain a constitutively non-methylated CpG-rich fraction 
that co-localises with the 5' ends of genes and are analogous to vertebrate CpG 
islands (Antequera and Bird, 1988). Transcriptional silencing of transgenes in plants 
correlates with their hypermethylation (Ye and Singer, 1996) and gene silencing in 
2. 
plants usually arises following sequence duplication events occurring either in cis or 
in trans in a phenomenon termed homology dependent gene silencing. In active 
transgenes there is a low basal level of methylation ('-10% of cytosines) and this 
increases to 80-90% upon inactivation. DNA (cytosine-5) methyltransferases in 
plants act preferentially on hemi-methylated DNA and have a high specificity for 
CpG or CAG and CTG (Finnegan and Dennis, 1993; Pradhan and Adams, 1995). In a 
forward genetic screen in Arabidopsis, two genes DDM1 and DDM2 (Decrease in 
DNA Methylation) were identified that are required to maintain normal levels of m 5 C 
(Vongs et al., 1993). In DDMJ mutants a 70% reduction in genomic m 5C levels was 
observed, with hypomethylation of repeated sequences occurring initially. 
Interestingly, DDMJ encodes a protein with a high degree of similarity to the 
SWI2/SNF2 suggesting that the DDM1 protein alters genomic methylation patterns 
by influencing chromatin structure (Jeddeloh et al., 1999). DDM1 may simply 
operate as a co-activator for the expression of a methyltransferase or alternatively a 
more interesting hypothesis is that DDM1 may operate to remodel nucleosomes that 
then increases the accessibility of DNA methyltransferases to hemi-methylated 
targets in nascent chromatin. 
1.2.2 Fungal DNA methylation 
DNA methylation has not been detected in the model yeasts Saccharomyces 
cervisiae (Proffitt et al., 1984) and Schizosaccharomyces pombe (Antequera et al., 
1984). In Ascobolus however, DNA repeats are densely methylated and inactivated 
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(Goyon and Faugeron, 1989). This silencing phenomenon is similar to homology 
dependent gene silencing in plants where duplicated elements are de novo methylated 
and inactivated. This process is termed "methylation induced premeiotically" (MIP) 
(Goyon et al., 1994). The inactivation process occurs after fertilisation in dikaryotic 
tissue and the methylation is subsequently maintained. Masci (Mtase  from 
Ascobolus B is required for this de novo methylation and is homologous to bacterial 
type II and eukaryotic maintenance type DNA (cytosine-5) methyltransferases 
however Masc 1 does not have demonstrable de novo methyltransferase activity in 
vitro (Malagnac et al., 1997). Disruption of masci in homokaryons has no 
phenotype and the gene is thus not essential for vegetative growth. Furthermore, 
homokaryons were able to perform maintanance methylation of a previously 
inactivated transgene however crossing of masci mutants results in sterility in 
dikaryons and progeny are arrested at an early stage of sexual reproduction. No 
vertebrate homologs of masci have been identified to date. 
1.2.3 Invertebrate DNA methylation 
Vertebrate genomes are characterised by a global low density of methylation as are 
the earliest examples of vertebrates, the jawless fishes. In contrast, the genomes of 
certain chordates such as Ciona and Amphioxus have intermediate levels of 
methylation that are present in discrete compartments or appear to lack detectable 
methylation genome as is the case for the fruitfly, Drosophila melanogaster (Rae and 
Steele, 1979). Initially it was thought these methylated domains were present 
6., 
exclusively at repetitive sequences with genes located in the non-methylated 
compartments (Bird et al., 1979) however subsequent findings suggest that significant 
numbers of genes in Ciona and Amphioxus are located within both the methylated and 
unmethylated regions (Tweedie et al., 1997; Simmen et al., 1999). It is unclear what 
directs certain regions for modification in the fractionally methylated genomes of 
these organisms but the establishment of the methylation pattern clearly does not 
operate in a analogous manner to that seen with the de novo methylation of 
transgenes in homology dependent gene silencing in plants or the siniiliar MIP 
phenomenon in Ascobolus, as genes and repetitive elements are found in both 
fractions (Tweedie et al., 1997). In contrast the genome of the invertebrate Physarum 
is methylated and the retrotranspo son-like element, Tp 1 is located predominantly 
within the methylated fraction (Rothnie et al., 1991). 
Simpson etal., (1986) were unable to detect m 5C in the genome of C. elegans at any 
stage of development. A qualitative analysis using the methylation-sensitive and 
methylation-insensitive isoschizomers, HpaII and MspI did not detect any 
differences in the restriction pattern following digestion with these enzymes and no 
methylation of a repeated element (Tcl) was detectable by Southern analysis. The 
use of the HpaII and MspI isoschizomers to detect DNA methylation in this study 
biased the search for genomic methylation as modification outwith their symmetric 
target sequence (CCGG) would not have been detected. The sensitive and 
quantitative technique of high performance liquid chromatography was also applied 
to C. elegans genomic DNA and the authors concluded that fewer than 1:10000 
cytosines (<0.01 mole percent) were methylated in any sequence context. Therefore, 
the possibilities for m5C in the regulation of transcription and mediating other 
biological effects are limited in C. elegans. In eukaryotic organisms, there are three 
other covalently modified nucleotide bases identified in DNA in addition to m 5C: N6-
methyladenine, hydroxymethyluracil and 3-D-g1ucosyl-hydroxymethyluracil. Many 
restriction enzymes are inhibited by the presence of modified bases within their 
recognition sequences (Berkner et al., 1979; Huang et al., 1982) and covalent 
modifications of DNA are often inferred from unusual digestion patterns of genomic 
DNA when compared with the same cloned DNA sequence (Bernards et al., 1984; 
Pays et al., 1984). Despite the fact that there are no reported cases of anomalous 
resistance of genomic DNA to restriction endonucleases in the nematode worm, novel 
forms of covalent modification in C. elegans cannot be excluded. 
1.3 DNA methylation and development 
The genomes of the model genetic organisms Caenorhabditis elegans and Drosophila 
melanogaster lack detectable DNA methylation (Simpson et al., 1986; Rae and 
Steele, 1979) and this has lead to questions being raised as to the functional 
consequences and the relevance of this modification in higher metazoans. DNA 
methylation has long been correlated with transcriptional silencing and this has been 
demonstrated on numerous occasions in vitro by methylation of gene constructs and 
transfection into cell-lines (Vardimon et al., 1982; Stein et al., 1982). In addition, the 
nucleoside analogue 5-aza-2'-deoxycytidine (5-azaC) which alters genomic 
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methylation patterns by covalently trapping the maintenance methyltransferase, 
Dnn-itl (Juttermann et al., 1994), was found to promote aberrant gene expression 
(Jones and Taylor, 1980). 
1.3.1 Reduced genomic methylation and developmental abnormalities 
Gene targeting experiments that introduced mutations at the murine DNA (cytosine-
5) methyltransferase (MTase) locus (Dnmt]) were found to have an embryonic lethal 
phenotype with the mice dying early in development (Li et al., 1992; Lei et al., 
1996). Assuming that the lethality arises as a result of reduced genomic methylation 
and not some unknown function of the Dnmtl protein, these findings suggest that the 
completion of embryonic development in higher vertebrates requires normal patterns 
of methylation. Embryonic stem (ES) cells homozygous for this mutation in Dnmtl 
grown in the presence of differentiation-inhibitory activity were found to be viable in 
culture but died rapidly following differentiation (Li et al., 1992). This has lead to the 
suggestion that DNA methylation is dispensable for pluripotent embryonic stem 
cells and is only required for differentiated somatic cells (Jaenisch, 1997). 
Subsequently, wild type genomic methylation patterns have been found to be a 
necessary prerequisite for development in a more diverse group of organisms 
following the finding that mutations that reduce levels of m 5C in the DNA of a 
vascular plant (Vongs et al., 1993) and fungi (Foss et al., 1993; Malagnac et al., 1997) 
cause defects in chromosome stability and segregation. Furthermore, a partial 
demethylation phenotype has been generated by inhibition of the Arabidopsis 
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methyltransferase and this was found to result in developmental abnormalities 
following expression of the antisense RNA (Ronemus et al., 1996). Taken together, 
these findings suggest an important role for DNA methylation in the development of 
both higher plants and mammals. 
1.3.2 Phenotype of the Dnmtl knockout mouse 
Why do organisms so diverse require normal genomic methylation patterns for the 
completion of development? A potential explanation may lie in the genome defence 
model (Bestor, 1990; Yoder et al., 1997) which posits that the main role of DNA 
methylation in animals is to restrain the spread of endogenous elements, proviruses 
and other selfish sequences in germ cells. The developmental abnormalities seen in 
these organisms might thus arise through perturbation of gene expression as a result 
of increased transposition into active areas of chromatin. However, determining 
whether methylation is targeted preferentially to selfish elements as opposed to 
genes within a mammalian genome is difficult because of the low-level genome-wide 
methylation seen in higher vertebrates. Simmen et al., (1999) have sought to test this 
prediction of the genome defence model - a co-linearity between DNA methylation 
and known selfish elements - by analysing the specificity of methylation patterns in 
the genome of the invertebrate urochordate, Ciona intestinalis. In contrast to the 
global modification by methylation evident in vertebrate DNA, Ciona possesses a 
fractionally methylated genome (Tweedie et al., 1997). Thus any bias in predicted 
gene or transposon location would be informative in this organism. Strikingly, 
multiple copies of transposons were found to reside within unmethylated regions 
12 
whereas genes were located predominantly in methylated domains, a result not easy 
to reconcile with the genome defence model. A caveat of these findings however is 
that it is unknown whether methylation regulates gene activity in invertebrates and 
methylation may simply operate in a mechanistically different manner than in 
vertebrates. An alternative explanation for the phenotype of the Dnmtl knockout 
mouse and the developmental abnormalities seen in a range of organisms with reduced 
levels of genomic m5C is that DNA methylation is responsible for developmental 
gene control. Walsh and Bestor (1999) were unable to find ectopic expression of 
genes reported to be regulated in a methylation-dependent manner in the Dnmt1 
mutant embryos. However, Li et al., (1993) found a failure in Dnmti' ES cells to 
regulate expression of imprinted genes. In the mutant embryos, the three imprinted 
genes H19, Igf-2 and Igf-2r were abnormally expressed. The normally repressed 
paternal allele of H19 was active whereas in contrast the normally active paternal Igf-
2 and maternal Igf-2r were repressed. In addition, ectopic expression of the Xist 
transcript in differentiated Dnmtl ES cells was observed from the normally silenced 
inactive X-chromosome which correlated with a dramatic increase in apoptosis 
(Panning and Jaenisch , 1996). These findings suggest the embryonic lethality 
observed in the Dnmtl knockout mice might arise because of aberrant gene dosage of 
X-linked and imprinted loci as a result of a failure in methylation-mediated 
repression. 
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1.4 Molecular mechanisms for methylation-mediated repression 
1.4.1 Direct inhibition of transcription factor binding 
How might the reduction in levels of genomic methylation in the DnmtF' alter 
transcriptional regulation of imprinted and sex-linked genes? The simplest 
conceivable model for methylation-mediated transcriptional repression is by direct 
interference of transcription factor binding. Indeed, several well understood 
transactivators are unable to bind their target sites when methylated. Examples 
include the cyclic AMP response element binding protein (CREB; Iguchi-Ariga and 
Schaffer, 1989) as well as the ubiquitous transcription factor, NF-KB (Bednarik et al., 
1991). This model cannot however explain silencing, attributed to methylation, from 
promoters where no identified methylation-sensitive transcription factors are 
present. Indeed, some factors such as Spi are known to be capable of binding 
irrespective of the methylation status of their recognition sequence and relatively few 
transcription factors contain the dinucleotide CpG within their cognate sites. These 
findings argue against a widespread role for direct inhibition of transcription factor 
binding in mediating the repression associated with DNA methylation. 
1.4.2 Indirect inhibition of transcription factor binding 
An indirect model for transcriptional inhibition posits that nuclear proteins with 
affinity for methyl-CpG sites bind within promoter regions and thereby preclude the 
assembly of the transcriptional machinery. Evidence for an indirect mechanism of 
methylation-mediated transcriptional repression comes from a number of reports. 
Murray and Grosveld (1987) demonstrated that the transcriptional inhibition of the 
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y-globin gene was not dependent on specific sites within the promoter, since the 
presence of methyl-CpGs in different locations within the promoter was sufficient to 
repress transcription. The authors concluded that a minimal methylation free zone 
was required for expression, and hypothesised that proteins with affinity for methyl-
CpGs were responsible for repression. Involvement of chromatin in mediating the 
effects of DNA methylation was suggested by experiments from Buschhausen et al. 
(1985, 1987). Buschhausen et al., (1987) observed that methylation of the herpes 
simplex thymidine kinase (HSV-tk) gene and subsequent microinjection into mouse 
L929 cell nuclei did not lead to immediate transcriptional inhibition. Indeed, the HSV-
tk gene remained transcriptionally active for -8 hours following injection into cells 
before being repressed. This observation is incompatible with a model where 
methylation of CpG would directly interfere with assembly of the initiation complex 
and implied that time was required for interactions with nuclear components to 
abrogate transcription. In addition, Keshet et al. (1986) found that M13 gene 
constructs when methylated to completion and transfected into mouse L929 cells 
were preferentially assembled into nuclease resistant chromatin. This was in contrast 
to unmethylated sequences which integrated in a potentially active DNaseI-sensitive 
conformation. These results suggested that methylation may exert its effects on gene 
transcription by altering both specific and non-specific interactions between DNA 
and nuclear proteins. Furthermore, it is known that methyl-CpG sites are protected 
from cleavage by non-specific nucleases (Solage and Cedar, 1978) and against 
restriction enzymes that specifically recognise CpGs (Antequera et al., 1989). A 
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major advance in the understanding of DNA methylation was the establishment of a 
link between this phenomenon and that of the other major epigenetic modification of 
chromatin - histone acetylation. 
1.5 Histone acetylation and deacetylation in gene control 
1.5.1 Introduction 
Eukaryotic DNA is packaged into chromatin which thus affects every cellular 
process that requires access to the DNA template. The nucleosome is the primary 
unit of chromatin organisation and is composed of two molecules each of the core 
histones H2A, H2B, H3 and H4 with approximately two turns of DNA wrapped 
around this octamer of proteins. The assembly of DNA into nucleosomal chromatin 
represses transcription in vivo and in vitro and the structure of chromatin and the 
regulation of gene expression are as a result intimately linked processes. DNA in 
chromatin thus serves a dual role in both the packaging of DNA and globally 
repressing gene transcription. The amino termini of the core histones extend from the 
nucleosome core and are subject to post-translational modifications by ADP-
ribosylation, methylation, phosphorylation and acetylation. Since the identification 
of core histone acetylation (Allfrey et al., 1964) a general correlation has been found 
to exist between the acetylation status of a chromosomal domain and transcriptional 
activity. 
16 
1.5.2 Histone acetylation and gene activation 
Hyperacetylated histones are found preferentially within active, euchromatic 
domains (Hebbes et al., 1994) whereas hypoacetylated histones are found to reside 
within areas that are silent and heterochromatic (Braunstein et al., 1993). 
Euchromatin decondenses during the interphase of the cell cycle and is gene-rich 
whereas conversely heterochromatin condenses during interphase and is gene-poor. 
The amount of histone acetylation is the result of an equilibrium between opposing 
histone acetyltransferase and histone deacetylase activites. Acetylation of the 
nucleosomal core histones occurs on the highly conserved N-terminal lysine residues 
that lie outside the nucleosome. The N-terminal tails are known to play a key role in 
denying transcription factors access to the nucleosomal DNA templates (Lee et al., 
1993) as well as interacting with regulatory proteins (Johnson et al., 1990). The 
hyperacetylation of histone tails is thought to direct an allosteric destabilisation of 
the nucleosome by neutralising the electrostatic interaction between the positively 
charged lysine residues and the negatively charged phosphodiester backbone of the 
DNA template. Given that histone acetylation is conserved throughout eukaryotes, it 
is an attractive central point to regulate gene activity and the enzymatic activities that 
establish these dynamic patterns on histones have been intensively studied. 
17 
1.5.3 Histone acetyltransferases 
Following the purification and sequencing of the gene that encodes the Tetrahymena 
p55 nuclear histone acetyltransferase, a suprising homology was identified to a 
previously isolated yeast transcriptional regulator GCN5. Brownell et al., (1996) 
subsequently demonstrated that GCN5 possessed acetyltransferase activity and a 
central region of GCN5 showed homology to previously identified histone 
acetyltransferases (Kieff et al., 1995). The S. cereviseae heterotrimeric 
GCN5/ADA2/ADA3 activator complex was identified by Guarente and colleagues 
screening for mutations in genes that confer resistance to the potent and toxic 
chimaeric activator GAL4-VP16 (Berger et al., 1992). The genes identified from the 
screen were reasoned to encode proteins necessary for VP16 activation of 
transcription. Subsequently, ADA2 was proposed to serve as an adaptor linking 
activation domains and the basal transcriptional machinery and ADA2 has been 
shown to interact with the TATA-binding protein (TBP) of TFIID as well as with 
generic acidic activation domains (Barley et al., 1995; Silverman et al., 1994). This 
suggested that GCN5 might be targeted to promoters to activate gene transcription 
by ADA2 associating with sequence-specific DNA binding proteins. Mutations in 
GCN5 diminished the ability of the DNA-binding transcription factor GCN4 to 
activate transcription (Georgakopoulos and Thireos, 1992) suggesting the potential 
for GCN5 to be recruited to a gene through interactions with transcription factor(s) 
to modulate transcription. GCN5 was found to be non-essential for yeast viability 
which raised the possibility that multiple redundant and overlapping genes might 
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exist encoding acetyltransferases (Georgakopoulos and Thireos, 1992). This 
suggestion was confirmed by the identification of the p300/CBP-associated factor 
(PCAF) that was capable of acetylating the nucleosomal core histones (Yang et al., 
1996a). The p300/CBP (CREB-binding protein) itself was found to also possess 
histone acetyltransferase potential (Ogryzko et al., 1996) and is known to mediate 
gene regulation by a diverse array of DNA-binding transcription factors (Kamei et al., 
1996). TFIID, the transcription factor complex of the TATA-binding protein (TBP) 
and the TBP-associated factors (TAFs) contains histone acetyltransferase activity 
and TAF 11250 was found to possess intrinsic histone acetyltransferase potential 
(Mizzen et al., 1996). This suggests that the basal transcriptional machinery might 
destabilise nucleosomes over promoters to activate gene transcription. PCAF and 
GCN5 are related proteins but no significant sequence similarity or structural 
homology is thought to exist between these proteins and the other identified histone 
acetyltransferases. PCAF is able to acetylate histone H3 in a nucleosome while 
human GCN5 can acetylate both free and nucleosomal histones H3 and H4 (Xu et al., 
1998). In contrast, recombinant p300/CBP can acetylate all core histones in a 
nucleosomal context and acetylation occurs on histone H4 at K5, 8, 12 and 16 which 
are the same positions modified in vivo (Yang et al., 1996). A number of major 
questions remain as to whether histone hyperacetylation is a cause or effect of the 
chromatin disruption process at activated gene promoters and how the targeting of 
chromosomal regions for accumulation of hypo- or hyperacetylated histones (or 
other non-histone targets) occurs. 
II, 
The bromodomain motif is widely conserved during evolution and is commonly 
found in transcription factors implicated in transcriptional regulation at the level of 
the chromatin template (Haynes et al., 1992; Jeanmougin et al., 1997). The 
bromodomain is present in the vast majority of identified histone acetyltransferases 
including the yeast and human GCN5s (Brownell et al., 1996; Georgakopoulos and 
Thireos, 1992), PCAF (Yang et al., 1996), CBP/p300 (Bannister and Kouzarides, 
1996) and human TAF 11250 and Drosophila TAF11 230 (Mizzen et al., 1996; Ruppert 
et al., 1993) proteins. The bromodomain is not required for histone acetyltransferase 
activity (Candau et al., 1997) and this suggests it might serve some ancillary function 
for regulating these enzymatic activities or targeting to chromatin sites. Secondary 
structure predictions suggest that the bromodomain is composed of four hydrophobic 
a-helices (Jeanmougin et al., 1997) that might constitute a protein-protein interaction 
motif. Bromodomains are frequently found in association with other conserved 
motifs that are known to serve a catalytic function. In addition to its presence in 
histone acetyltransferases, the bromodomain is interestingly also found in the yeast 
transcriptional regulator SWI2/SNF2, a component of the large SWJISNF complex 
(Peterson et al., 1994; Cairns et al., 1994). Genetic suppressors of SWI2/SNF2 
encode both histone and non-histone proteins, suggesting the SWIJSWF complex 
counteracts histone-mediated and non-histone based transcriptional repression 
(Kruger et al., 1995). SWI2/SNF2 also shares homology including a bromodomain 
with brahma (brm) an activator of the homeotic gene clusters in Drosophila. 
1.5.4 Histone deacetylases 
The recruitment by sequence-specific DNA-binding factors of transcriptional 
regulators with intrinsic enzymatic ability to modulate the architecture of chromatin 
to control gene regulation has become an attractive way to model how the structural 
core histones interact with the transcriptional machinery. This model while first 
supported by studies on transcriptional activators/co-activators was subsequently 
widened to include transcriptional repressors/co-repressors as it became clear that the 
repression of gene transcription utilised similar yet opposing mechanisms to that 
used to activate gene transcription. 
Employing an affinity matrix with the ligand trapoxin, a high affinity irreversible 
hi stone deacetylase inhibitor, the HDAC 1 protein was identified in complex with the 
WD40 repeat protein RbAp48 (Taunton et al., 1996). The HDAC1 protein showed 
60% sequence identity to S. cereviseae RPD3 that was previously found to be 
required for full repression and activation of a subset of genes (Vidal and Gaber, 
1991). In Drosophila mutation of an RPD3 homolog resulted in an increase in 
position effect variegation suggesting an increase in silencing (De Rubertis et al., 
1996). Deletions in RPD3 in yeast resulted in the predicted hyperacetylation of 
histones H3 and H4 however somewhat paradoxically resulted in an increase in 
repression at telomeres (Rundlett et al., 1996). 
The bifunctional transcriptional regulator YY1 is a zinc-finger transcription factor 
that is thought to be involved in the regulation of cell proliferation and differentiation 
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(Shi et al., 1991; Shrivastava and Calame, 1994). Yang et al., (1996b) demonstrated 
interaction between YY1 and the mammalian RPD3 co-repressor. Fusion of RPD3 to 
a heterologous DNA binding domain could direct a dose dependent transcriptional 
inhibition of a cis-linked reporter gene. Furthermore site direct mutagenesis of a 
glycine rich motif in YY1, necessary for interaction with RPD3 abrogated the ability 
of YY1 to repress transcription. This suggested that the tethering of RPD3 to YY1 
bound on DNA could negatively regulate gene transcription by removal of acetyl 
moieties on the N-termianl lysine residues of the nucleosomal core histones. 
A number of transcriptional repressors have now been shown to associate with 
histone deacetylases and one of the best characterised is the transcriptional repressor, 
Mad. Mad can form heterocomplexes with the DNA targeting protein, Max which 
binds E-boxes on promoters (Ayer et al., 1995; Alland et al., 1997). The Mad-Max 
heterodimer can influence cell growth and differentiation in mammalian cells (Ayer et 
al., 1995). The DNA-binding Max protein can heterodimerise with the Myc family of 
bHLH-ZIP proteins that include Myc, Mad and Mxi-1 (Ayer et al., 1993) in order to 
influence the activity of downstream target genes. The Myc-Max complex bound at 
E-boxes is an activator of transcription and is the complex found in proliferating cells 
whereas the Mad-Max transcriptional repressor complex is the form found in 
differentiated cells and acts in a manner antagonistic to the Myc-Max complex. Two 
mammalian proteins, mSin3A and mSin3B have been identified that interact with the 
Mad repressor and are homologous to yeast Sin3. Mutation of the second of four 
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paired amphipathic helix (PAH) domains of mSin3A abolishes binding to the Mad-
Max complex and prevents the complex from repressing transcription (Ayer et al., 
1995). Three different histone deacetylases (HDACs), HDAC1-3 have been 
identified in mammalian cells (Grunstein et al., 1997) and appear to possess 
overlapping activities. Co-immunoprecipitation revealed the Mad, Sin3 proteins and 
the histone deacetylases to reside in a complex together (Alland et al., 1997). In 
experiments employing the histone deacetylase inhibitor trichostatin A (TSA) 
(Yoshida et al., 1990), the ability of the Mad-Max complex to repress transcription 
was attenuated demonstrating a clear role for deacetylation in gene control. The 
mechanism by which unliganded nuclear hormone receptors represses transcription 
also utilises the mSin3/HDAC pathway (Alland et al., 1997; Heinzel et al., 1997). 
Unliganded thyroid hormone and retinoic acid receptors bind the transcriptional co-
repressor, NCoR (Horlein et al., 1995) which interacts with the mSin3/HDACs 
(Alland et al., 1997; Heinzel et al., 1997) to repress transcription and this repression 
is alleviated entirely by inhibtion of histone deacetylases using TSA (Wolfe et al., 
1997). Furthermore, repression of meiotic genes by the yeast Ume6 also involves 
association with a Sin3fRpd3 complex. These findings taken together suggest that the 
modification of the nucleosomal core histones by acetyltransferases and deacetylases 
is a widely conserved mechanism to modulate eukaryotic gene transcription. 
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1.6 Methyl-CpG binding Proteins (MeCPs) 
Methylation of mammalian DNA can lead to repression of transcription and 
alteration of chromatin structures. Both effects are potentially the result of 
interactions between methylated sites in the genome and proteins with affinity for 
methylated DNA. A number of activities have been identified in mammalian nuclei 
which associate with methylated DNA irrespective of sequences flanking the methyl-
CpG site and represent strong candidates for mediating the global consequences of 
methylation. This relaxed sequence specificity distinguishes these activities from 
human methylated DNA-binding protein 1 (MDBP 1; Wang et al., 1986) and chicken 
methylated DNA-binding protein 2 (MDBP2; Pawlak et al., 1991) each of which 
require specific nucleotide sequence contexts to bind to methylated sites. 
Methyl-CpG binding protein 1 (MeCP1) was identified originally as an activity 
present in mouse nuclear extracts that bound to methylated DNA containing a high 
density of methyl-CpGs in a variety of sequence contexts (Meehan et al., 1989). 
MeCP 1 has been implicated as a mediator of methylation-associated transcriptional 
silencing (Boyes and Bird, 1991, 1992). The activity was detectable in a range of 
somatic tissues but was conspicuously absent from cell lines derived from embryonic 
lineages suggesting that the protein was dispensable for growth in undifferentiated 
cells. MeCP2 was first detected during attempts to obtain MeCPs by expression 
cloning (Lewis et al., 1992). MeCP2 is an abundant nuclear protein that can bind a 
single methyl-CpG pair in contrast to MeCP1. Immunofluorescence using an anti- 
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MeCP2 antibody showed a preferential localisation to the pericentromeric 
heterochromatin in the mouse genome which closely matched the mouse major 
satellite DNA. The consensus sequence of the mouse major satellite is a 234bp AT-
rich unit which contains eight CpGs and at least seven have been shown to be 
methylated (Horz and Altenburger, 1981; Manuelidis, 1981). This satellite therefore 
contains >40% of all the methyl-CpGs in the mouse nucleus. Miller et al., (1974) 
directly visualised this non-random distribution in the m 5C distribution by anti-m5 C 
antibody and the staining pattern closely matches that with the anti-MeCP2 
antibody. 
MeCP2, by virtue of is ability to bind to a single methyl-CpG pair, could explain 
transcriptional repression of weak promoters brought about by the presence of a 
small number of methyl-CpG moieties. The high abundance of MeCP2 (10 6 
molecules per nucleus) may explain the genome-wide protection of CpG sites from 
nuclease digestion (Solage and Cedar, 1978; Antequera et al., 1989). MeCP2 is known 
to be abundant in brain tissue where methyl-CpG sites are found to be particularly 
resistant to the action of exogenous nucleases. In contrast, embryonic PC13 cells 
which lack both MeCPs, exhibit markedly reduced levels of protection (Antequera et 
al., 1989). 
1.6.1 The methyl CpG-binding domain (MBD) 
Deletion analysis determined that binding to methylated DNA required a minimal 
region between amino acids 89 and 162 at the N-terminus of MeCP2 (Nan et al., 
1993). This peptide was named the methyl CpG-binding domain (MBD) and this 
region is known to be invariant in rat, mouse, chicken and human MeCP2s. DNA 
methylation has been causally implicated in the localisation of MeCP2 in chromatin 
(Nan et al., 1996). The preferential localisation of MeCP2 in heterochromatic regions 
suggested by immunofluorescence was addressed by transfecting expression 
constructs for MeCP2-l3geo fusions into a mouse ES cell line that show a reduced 
level of genomic m5C (Li et al., 1992). The observed disruption in the ability of 
localise MeCP2 to heterochromatin in DnmtF" cells compared to wild type ES cells 
indicates that DNA methylation is a major determinant of the sub-cellular localisation 
of MeCP2 in vivo. 
1.6.2 MeCP2 is a transcriptional repressor and is essential for mouse 
development 
Nan et al., (1997) found that native and recombinant MeCP2 were able to repress 
transcription from a reporter template in a methylation-specific fashion. An internal 
deletion of the N-terminal MBD of MeCP2 abrogated the ability to silence 
transcription in vitro in primer extension assays from a methylated template. A 
GAL4-MeCP2 fusion was also found to be capable of repressing transcription of a 
reporter gene in vivo. This silencing effect was mapped to a highly basic central 
region of the protein, the transcriptional repression (TR) domain. Earlier experiments 
by Hug et al., (1995) had suggested that promoter methylation per se was not always 
required for transcriptional inhibition but that distally situated sites of high density 
methylation could operate in cis to silence linked reporters. MeCP2 was found to be 
capable of repressing transcription at a distance in vitro and in vivo. MeCP2 can 
interact with methylated sites in the context of chromatin and intriguingly was 
capable of displacing histone Hi. This replacement of histone Hi by MeCP2 may 
explain the distinct chromatin structure that occurs within methylated domains of 
chromatin. Histone Hi has been shown to be an abundant component of 
heterochromatin (Weintraub, 1984) and to be associated with nucleosomes containing 
m5C (Ball et al.,1983). In contrast, Hi is absent from CpG island chromatin (Tazi 
and Bird, 1990) which is characteristic of active, autosomal housekeeping genes, and is 
depleted in chromatin which contains active genes (Bresnick et al., 1991). Histone Hi 
is known to known to bind the internucleosomai linker, to play a role in higher-order 
stabilisation of chromatin structure (Thoma et al., 1979) and to be capable of 
transcriptional silencing in vitro (Wolfe, 1989; Croston et al., 1991). Previous 
reports describing interactions between Hi and methylated DNA demonstrating 
transcriptional repression have been done with naked DNA (Levine et al., 1993; 
Johnson et al., 1995; McArthur and Thomas, 1996) and it is assumed that the effects 
observed reflect in vivo interactions of Hi and chromatin. This assumption is made in 
the light of the fact that the interaction of Hi in chromatin is primarily with DNA 
rather than with the core histones (Thoma et al., 1979). Campoy et al. (1995), 
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however found no affinity of Hi for methylated DNA with chromatin assembled on 
plasmids in a Xenopus oocyte extract in the presence of added rat hi stone Hi. 
MeCP2 has been mapped to the X-chromosome (Quaderi et al., 1994). To assess the 
functional significance of the protein in vivo, hemizygotes were generated by targeted 
disruption of the locus in ES cells employing a promoterless lacZ construct (Tate et 
al., 1996). The mutant ES cells lacking MeCP2 grew normally during in vitro passage 
and were capable of considerable differentiation. Chimaeric embryos however 
exhibited developmental defects proportional to the contribution of mutant ES cells. 
Embryos with the highest levels of chimaerism failed to gastrulate leading to 
embryonic death at mid-gestation. Similarities exist between the MeCP2 and the 
Dnmtl mutants. Both genes apparently are superfluous to survival of 
undifferentiated cells yet are absolutely required during development. 
1.7 The MBD protein family 
1.7.1 Comparative genomics and expressed sequence tags (EST5) 
The development of large scale sequencing projects has lead to an exponential 
increase in the amount of sequence information available to investigators, resulting in 
the rapid identification of new genes and their corresponding cDNAs from a diverse 
array of organisms. In particular, the development of expressed sequence tag (EST) 
based libraries, such as dbEST (Boguski et al., 1993) and XREFdb (Bassett et al., 
1997), for the model organisms Drosophila melanogaster, Caenorhabditis elegans 
and the laboratory mouse, Mus musculus has proven to be invaluable tools for the 
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isolation of novel cDNAs related to conserved functional domains of interest. In 
parallel with the growth of these large scale sequencing projects, the fields of 
comparative and functional genomics have developed and represent a new multi-
organismal approach to biology that have lead to major advances in genetic analysis. 
However, with these vast amounts of information to hand, a requirement for a 
matching scale-up and new approaches to functional studies is required in order to 
assign function to these new sequences. To this end, a consortium has been formed to 
disrupt all C. elegans genes and strategies are being developed in the mouse to rapidly 
generate mutants to analyse gene function (Zambrowicz et al., 1998). ESTs are 
random, single-pass unedited cDNAs and have become powerful molecular tools for 
novel gene identification (Cross et al., 1997), candidate disease gene identification 
(Scharf et al., 1998), genomic sequence interpretation (Jiang and Jacob, 1998), the 
development of microarrays for functional genomics (Schena et al., 1998), 
comparative genomics (Makalowski et al., 1996) and the development of gene based 
maps of entire genomes (Schuler et al., 1996). The EST based libraries of sequence 
information have gradually began to usurp the more traditional approaches of novel 
gene identification such as degenerate RT-PCR based applications and low stringency 
library screening with functional domains of interest. These reverse genetic 
approaches, where defined motifs are employed to isolate additional proteins through 
database screens has been employed successfully to identify the protein mediators of 
the biological consequences of the methylation of DNA in higher vertebrates. 
1.7.2 Employing ESTs to identify novel MBD-containing proteins 
Methylation can inhibit transcription factor binding directly (Watt and Molloy, 
1988; Iguchi-Ariga and Schaffer, 1989), but methylated sequences are not efficiently 
silenced in cell lines where MeCP1 and MeCP2 are undetectable (Boyes and Bird, 
1991; Levine et al., 1991) suggesting indirect mechanisms are more important. It is 
plausible that the transcriptional suppression, chromatin alterations, late replication 
and inhibition of recombination known to correlate with DNA methylation are the 
biological consequences of association between MeCPs and methyl-CpG sites in the 
genome. Thus the identification of novel MeCPs is an area of intense interest, as 
these proteins may well serve as the molecular integrators of diverse biological 
phenomena. MeCP2 like many transcription factors exhibits a modular organisation, 
containing an N-terminal methyl-CpG binding domain (MBD) (Nan et al., 1993; Nan 
et al., 1996) and a centrally located transcriptional repression domain (TRD) (Nan et 
al., 1997). An N-terminal region of 80 amino acids of MeCP2 has been delineated as 
the minimal region necessary to confer specific association with methylated DNA 
(Nan et al., 1993) and an intact MBD is absolutely required for the association of 
MeCP2 and chromatin (Nan et al., 1996). Whilst no TRD-containing proteins, apart 
from MeCP2 homologs, have been identified within the EST databases, the MBD of 
MeCP2 has been found to be widely conserved through many lineages. 
In order to identify new sequences with homology to the MBD, Cross et al., (1997) 
searched the EST databases with the 80 amino acid MBD of MeCP2 reasoning that 
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this motif would be conserved in other methyl-CpG binding proteins. This 
hypothesis was substantiated by the identification of a number of ESTs that 
exhibited strong similarity to the MBD of MeCP2. A human retinal cDNA library 
was found to contain two ESTs that exhibited 43.6% identity and 52.7% similarity 
over 55 amino acids comprising the MBD. This protein is termed MBD1 (Hendrich 
and Bird, 1998). Recombinant MBD1 was found to bind symmetrically methylated 
DNA specifically and this property was dependent on an intact MBD. Moreover, 
MBD 1 was demonstrated to be capable of repressing transcription, as addition of 
recombinant protein to a series of in vitro primer extension reactions repressed 
transcription in a methylation-dependent manner. Hendrich and Bird, (1998) have 
extended this EST based approach to identify further MBD-containing cDNAs and 
have characterised three additional proteins (MBD2, MBD3 and MBD4) expressed 
widely in mouse and human tissues. Using a combination of both in vitro and in vivo 
assays, MBD1, MBD2 and MBD4 were demonstrated to complex specifically with 
symmetrically methylated DNA irrespective of sequence context. Thus, with 
MeCP2 these methylated DNA-binding proteins represent strong candidates for 
operating as the protein mediators for the biological influence of DNA methylation. 
1.8 DNA methylation and histone deacetylation 
The recent advances in the characterisation of the repressor/co-repressor complexes 
that mediate transcriptional inhibition by recruitment of complexes that deacetylate 
the core histones 113 and H4 have aided in the elucidation of the molecular mechanism 
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by which DNA methylation silences gene transcription. Hsieh (1994) reported that 
following transfection of a methylated reporter construct and treatment with the 
histone deacetylase inhibitor sodium butyrate, derepression of the normally silenced 
state was observed suggesting the involvement of histone deacetylation in mediating 
the transcriptional silencing by CpG methylation. Selker (1998) also observed a 
derepression of previously silenced and methylated genes in the Neurospora system 
following treatment with trichostatin A, implicating DNA methylation in the control 
histone acetylation. Similar observations were made by Chen and Pikaard (1997) 
studying the phenomenon of nucleolar dominance in plants, where nucleoli form 
around rRNA genes inherited from one parent only in one of the earliest descibed 
examples of epigenetic phenomena (Navashin, 1934). Chen and Pikaard (1997) found 
that growth in the presence of demethylating drug, 5-azaC resulted in a derepression 
of the previously silenced plant rRNA genes. This activation was also observed 
following treatment with the histone deacetylase inhibitors, trichostatin A and 
sodium butyrate. These results taken together suggest that DNA methylation and 
histone deacetylation are linked phenomena in transcriptional silencing. 
1.8.1 DNA methylation recruits histone deacetylation 
Compelling support now exists that m 5CpG-mediated silencing arises through 
recruitment of a repressor that directs the formation of a multiprotein repression 
complex containing chromatin-remodeling activities (Nan et al., 1998; Jones et al., 
1998). Using deletions of GST-MeCP2 fusions, a region co-linear with the 
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transcriptional repression domain (TRD) associates with the co-repressor mSin3A 
and recruits histone deacetylases HDAC1 and HDAC2. Association between native 
MeCP2 and the mSin3 co-repressor complex was demonstrated by using anti-
MeCP2 and anti-mSin3 antibodies to co-immunoprecipitate proteins from rat brain 
nuclear extracts. The proposed association between MeCP2 and mSin3A was further 
substantiated by immunoprecipitating histone deacetylase activity with anti-MeCP2 
antibodies. The mSin3A interacting region of MeCP2 encompassing the TRD 
represses transcription in mouse L929 cells (Nan et al., 1997). This silencing was 
found to be partially derepressed following addition of TSA suggesting that at least 
part of the mechanism of gene inhibition was mediated by recruitment of the HDACs 
to deacetylate nucleosomal core histones (or other protein targets). Jones et al., 
(1998) tested directly whether the chromatin alterations and silencing observed on 
methylated hsp70 templates injected into Xenopus oocytes could be alleviated by 
treatment with TSA. DNaseI hypersensitivity was restored and the methylation-
directed silencing could be abolished following inhibition of histone deacetylase 
activity. Antibodies to Xenopus MeCP2 and mSin3A showed these activities to exist 
in high molecular weight complexes that co-fractionated with each other further 
suggesting these proteins physically interacted. These findings by Nan et al., (1998) 
and Jones et al., (1998) establish a causal link between methylation-dependent gene 
inhibition, histone deacetylation and chromatin modification. Eden et al., (1998) have 
demonstrated that DNA methylation operates to induce histone hypoacetylation. 
Using cell lines containing stably integrated copies of methylated or unmethylated 
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HSV-tk, immunoprecipitation was carried out to distinguish between 
transcriptionally competent hyperacetylated mononucleosome fractions and bulk 
chromatin. This revealed that hyperacetylated regions preferentially contain the 
unmethylated and active construct whereas the methylated and inert gene was not 
found to be enriched in the highly acetylated nucleosomal fractions. These results 
suggested that the covalent modification by methylation of the reporter genes 
directed histone deacetylation because identical DNA sequences were used in the 
initial transfections. To assess whether the deacetylated histories preferentially 
associating with the methylated and silenced tk gene were responsible for the 
repression, the cells were treated with and without TSA. Treatment of the cells with 
TSA resulted in an increase in acetylation, increase in DNaseI sensitivity and 
importantly an elevation of transcription by the methylated tk construct. These three 
studies (Nan et al., 1998; Jones et al., Eden et al., 1998) strongly support the idea 
that DNA methylation directs the formation of an inactive chromatin structure by 
recruitment of histone deacetylase activities resulting in alteration of the acetylation 
status of the core histones H3 and 114 (Pazina and Kadonaga, 1997) or other non-
histone proteins leading to transcriptional silencing. 
1.8.2 Chromatin remodeling complexes and DNA methylation 
A growing number of distinct nucleo some remodeling complexes have been identified 
in eukaryotes (Travers, 1999). The RSC (remodeling the structure of chromatin) was 
identified in yeast on the basis of homology to the SWIISNF complex (Cairns et al., 
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1996). RSC possesses DNA-dependent ATPase activity and can remodel 
nucleosome structure in vitro however how the energy in ATP is used by RSC, 
SWI/SNF and the other nucleosome-remodeling activities is unclear at present. It has 
been suggested that an ATP-mediated translocation of these complexes on 
nucleosomal DNA would remodel local chromatin (Pazin et al., 1997). In Drosophila, 
the ATP-dependent nucleosome remodeling factor (NURF) is required for GAGA-
mediated transcriptional activation (Tsukiyama et al., 1994; Tsukiyama and Wu, 
1995). Interestingly, a subunit of the NURF complex, ISWI is homologous to the 
ATPase domain of the product of the brahma (brm) gene. The brm gene was 
identified as a dominant suppressor of mutations in Polycomb that exert positive and 
negative effects respectively on Drosophila homeotic gene expression during 
development. The ISWI subunit of NURF is also present in the CFIRAC (comatin 
accessibility complex; Varga-Weisz et al., 1997) and ACF (ATP-utilising chromatin 
assembly and remodeling factor; Ito et al., 1997) complexes which suggests that ATP 
hydrolysis by ISWI may lead to specific nucleosome remodeling within each distinct 
complex. ATP-dependent nucleosome remodeling was thought to be exclusively 
involved in transcriptional activation however the NuRD complex (cleosome 
remodeling and histone deacetylase complex; Zhang et al., 1998) contains both ATP-
dependent nucleosome remodeling activities and histone deacetylases. The purified 
NuRD complex has seven subunits, the SWI2/SNF2 helicase/ATPase domain-
containing protein Mi2, the histone deacetylases HDAC1 and HDAC2, the histone-
binding proteins RbAp46 and RbAp48, the metastasis-asociated protein MTA2 and 
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the methyl CpG-binding domain family member, MBD3 (Zhang et al., 1999). The 
MIBD3 protein is highly related to MBD2 which binds to methylated DNA in vitro 
and in vivo (Hendrich and Bird, 1998). However, mouse MBD3 does not bind 
methylated DNA with high affinity (Hendrich and Bird, 1998; Wade et al., 1999) and 
does not localise with the heavily methylated mouse major satellite when 
overexpressed (Hendrich and Bird, 1998). MBD2 was found to associate with the 
NuRD activity and target the complex to methylated DNA whereas the highly related 
MBD3 protein could not direct association of the NuRD complex to methyl-CpG 
specifically (Zhang et al., 1999). MBD2 is able to function as a transcriptional 
repressor when tethered to a cis-linked reporter gene and this silencing is derepressed 
completely in certain cases following addition of trichostatin A demonstrating that 
the mechanism of inhibition is deacetylase dependent (Ng et al., 1999). Dramatically, 
Anti-MBD2 and anti-HDAC1 antibodies were found to retard the electrophoretic 
mobility of the MeCP1 complex. Furthermore, anti-HDAC1 antibodies can 
immunodeplete the MeCP1 and MBD2 activities from HeLa cells strongly suggesting 
that MBD2 is a component of the MeCP1 methylation-specific repressor complex. 
MBD2 has been reported to demethylate DNA in vitro which would result in gene 
activation (Bhattacharya et al., 1999) and reverse the histone deacetylase-mediated 
gene silencing, however the MBD2 demethylase activity has not been independently 
verified (Zhang et al., 1999; Ng et al., 1999; Wade et al., 1999). These findings 
establish a second methylation-dependent, deacetylase-mediated transcriptional 
repression complex in mammalian cells in addition to the MeCP2-Sin3 histone 
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deacetylase complex. MeCP1 binds multiple symmetrically methylated sites 
(Meehan et al., 1989) whereas MeCP2 can bind a single methyl-CpG pair (Nan et al., 
1993). These differences in methyl CpG-binding specificities between MeCP1 and 
MeCP2 may serve to mediate distinct transcriptional silencing requirements. 
Given the absence of the Sin3 co-repressor that serves to nucleate HDAC 1/2-
containing complexes on DNA-binding proteins (Alland et a!, 1997; Hassig et al., 
1997; Heinzel et al., 1997; Kadosh and Struhl, 1997; Nagy et al., 1997; Zhang et al., 
1997) within the NuRD complex, the Mi2-HDAC 1 interaction was analysed by pull 
down assays and found to require the PHD-zinc fingers of Mi2 but was not itself 
sufficient for association between Mi2 and the HDACs (Zhang et al., 1998) 
suggesting that PHD-zinc finger proteins interact indirectly with the histone 
deacetylase machinery. 
1.8.3 Conservation of the NuRD complex during evolution 
The NuRD complex is evolutionarily conserved and represents the most abundant 
form of deacetylase activity in Xenopus oocytes (Wade et al., 1998) as well as in 
cultured mammalian cells (Zhang et al., 1998). Both Drosophila and C. elegans 
encode proteins homologous to the metastasis-associated protein 1, (Wade et al., 
1999; Solari et al., 1999). Furthermore an MBD2/3 homolog has been identified in 
Drosophila (Wade et al., 1999) however no MBD2/3-related sequences have been 
characterised in the C. elegans genome to date. Drosophila Mi2 (dMi2) was 
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identified in a screen for proteins that interact with Hunchback (Hb) (Kehle et al., 
1998). Gap proteins, like Hb are required to delimit the expression boundaries of the 
homeotic genes however they are transient and require Polycomb-group gene 
products to maintain the epigenetic gene silencing. This interaction between dMi2 
and Hb suggests importantly that the silencing of homeotic genes by the Polycomb 
group requires histone deacetylation and furthermore that proteins with restricted 
DNA-binding specificities, compared to MBD2, are also capable of targeting the 
NuRD-deacetylase complex. 
The C. elegans egl-27 and egr-1 genes are functionally redundant to one another and 
are homologous to MTA1 (Solari et al., 1999). Inhibition of egl-27 resulted in a 
defect in pattering in certain regions during development whereas egr-1 inhibition has 
a weak posterior defect. Strikingly, the double mutant contains global defects in 
tissue organisation however differentiation is unaffected. Interestingly, the sequence 
of EGL-27 shares a domain (ELM 1: EGL-27 and MTA1 homology) present in the 
Dnmtl maintenance methyltransferase and the origin recognition complex (ORC-1) 
protein which has lead to the suggestion that this motif might be involved in linking 
DNA methylation and replication (Callebut et al., 1999). 
1.8.4 Reversal of methylation-mediated silencing 
At a methylated, hypoacetylated and silenced gene locus there are a number of 
possibilities as to how this inhibition might be reversed : active demethylation would 
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result in MeCP displacement and attenuation of histone deacetylase activity, 
allowing histone acetyltransferase access to modify histones H3 and H4 to render the 
chromatin template accessible to transcription factors. Alternatively, as methylation 
by itself does not decrease transcription, it is conceivable that the histone 
acetyltransferases are capable of over-riding the methylation-directed deacetylase-
associated repression. In support of this hypothesis, the tat transactivator is able to 
circumvent the methylation-mediated silencing at HIV promoter sequences (Bednarik 
et al., 1990) and TSA-mediated inhibition of histone deacetylase activity can allow 
transcriptional activation with methylation in place (Sheridan et al., 1997). This 
model where methyl-CpG binding proteins recruit co-repressors to silence gene 
activity at methylated promoters by alterations in chromatin structure obviously 
does not exclude the existence of additional methyl-CpG binding proteins that serve 
to mediate similar effects. The possibility that additional mechanisms whereby CpG 
methylation could reduce transcription also remains open. In mouse L cells and 
Xenopus oocytes, TSA did not lead to a complete restoration of transcriptional 
competence of the reporter repressed by MeCP2 and as MeCP2 is undetectable in 
HeLa cells (Ng and Bird, 1999) which are known to efficiently repress methylated 
templates this suggests the existence of additional mediators of the global effects of 
DNA methylation on chromatin and gene expression. 
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1.9 MeCPs and expression inheritance 
In the mammalian genome the majority of CpG sites, occurring every 1 OObp or so, in 
bulk intergenic DNA are methylated whereas the remaining fraction reside within 
CpG islands that are constitutively unmethylated (Bird, 1986). CpG islands in 
housekeeping genes remain free from methylation, whereas genes exhibiting a tissue-
restricted pattern of expression are generally methylated in every cell with the 
exception of tissues that express the gene. Pollack et al., (1980) first demonstrated 
that this methylation pattern was clonally inherited and the Dnmtl maintenance 
methyltransferase is the proposed enzymatic activity that maintains the methyl-CpG 
content on nascent hemimethylated daughter strands following DNA replication 
(Holliday, 1987). Dnmtl possesses an N-terminal domain that is involved in targeting 
to replication foci and the re-establishment of the symmetric methylation at CpG 
sites occurs rapidly following de novo DNA synthesis (Leonhardt et al., 1992; 
Gruenbaum et al., 1983) whereas the assembly of chromatin takes place later (Cusick 
et al., 1983). Little is known how cell-specific expression patterns based on 
nucleosome positioning and chromatin structure occurs and how they are inherited 
following chromatin disruption at the replication fork after DNA synthesis. However 
an attractive possibility is that the stably, inherited methylation pattern directs the 
formation of inert chromatin structures that are transcriptionally opaque through 
binding of MeCP 1 and MeCP2 plus additional methylation-specific silencers that 
recruit histone deacetylase co-repressors. Evidence suggests that the default state of 
nascent chromatin is hyperacetylated as newly synthesised histones are acetylated 
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and deposited onto newly replicated DNA (Sobel et al., 1995). The potent activator 
GAL4-VP16 can transcribe methylated templates if bound prior to assembly into 
chromatin (Kass et al., 1997). Macleod et al., (1994) and Brandeis et al., (1994) 
provided support for a model where binding sites for the transactivator Spi and 
presumably active gene transcription generally (Macleod et al., 1998) is necessary to 
maintain an unmethylated CpG island. DNA demethylation may then conceivably 
occur by a passive mechanism through the steric exclusion of the maintenance 
methyltransferase, Dnmtl at CpG islands that are transcriptionally active (Matsuo et 
al., 1998). Thus the propagation of DNA methylation on newly synthesised DNA 
could help establish the acetylation profile to control gene accessibility where active 
genes would remain methylation free and contain hyperacetylated histones H3 and 
H4 (Tazi and Bird, 1990) whereas methylated sequences would direct via methyl-
CpG binding proteins a hypoacetylated state (Nan et al., 1998; Jones et al., 1998; 
Eden et al., 1998) present throughout the cell cycle. The resistance of methylated 
domains to nuclease treatment is known to increase appreciably following DNA 
replication, consistent with this idea and high-densities of DNA methylation can 
prevent V(D)J recombination in lymphocytes after replication has occurred (Hsieh 
and Lieber, 1992). The ability to maintain epigenetic expression states may well be 
dependent on this ability of DNA methylation to pattern histone acetylation in the 
genomes of higher vertebrates. 
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CHAPTER TWO: MATERIALS AND METHODS 
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2.1 Bacterial Cell Culture 
2.1.1 Media and solutions 
All media were sterilised by autoclaving or by filtration through a 0.22m membrane 
before use. 
L-broth (LB) agar and top agarose 
lOg Bacto-tryptone (Difco), 5g yeast extract (Difco), lOg NaCl and 2.46g MgSO4 
were added per litre of dH20. L-broth agar contained in addition 15g/L agar (Oxoid) 
and top agarose 7gfL agarose (Boehringer Mannheim). 
')V VT 1.-+1, 
lOg yeast extract, 5g NaCl and 16g Na2HPO4 per litre dH20. 
Soc broth 
20g tryptone, 5g yeast extract, 0.59g NaCl, 1.86g KC1, 10mM M902, 10mM 
MgSO4 and 20mM glucose per litre dH20. 
Media additives 
Ampicillin was used at 50j.tg/ml and tetracycline at 12.5jg/ml where selection was 
appropriate. X-gal and IPTG were added to molten L-agar to facilitate identification 
of recombinant bacteria by a-complementation. To prepare plating cells for 
adsorption of ? phage, cells were grown in 0.2% maltose and 10mM MgSO4 to 
increase competency. Bacteria were grown typically at 37 0C with good aeration. 
Bacterial stocks were maintained at -80 0C in LB media containing 20% glycerol. 
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2.1.2 Bacterial strains 
Bacterial hosts for transformation and propagation of plasmid episomes were either 
E. coli strain: 
XL1 Blue - supE44, hsdR17, recAl, endAl, gyrA96, thi, relAllac, F' : pro AB, 
laclq, lacZM15, TnlO(tet') or 
DH5a - supE44, hsdR17, recAl, endAl, ghrA46, this-i relAl 
For protein expression the bacterial host was E. coli strain: 
BL21(DE3)pLysS - F': dcm ompT hsdS(r b mb)  gal X (DE3) [pLysS Cam'] 
2.1.3 Preparation of competent cells for electroporation 
1 litre of L broth was inoculated with lml of a fresh overnight culture (either XL1- 
Blue or DH5a) and grown with vigorous shaking at 37 0C to an OD595um of 
approximately 0.7 - 0.8. The cells were harvested by chilling on ice and pelleting at 
3000g for 10 minutes at 4 0C. The cells were resuspended in 500mls of ice cold dH20 
(or other low ionic strength buffer) and repelleted by centrifugation. The cells were 
then subsequently washed twice in lOOml of ice cold dH20, lOml of 10% glycerol 
and repelleted by centrifugation. The cells were then resuspended in a final volume of 
2-3m1 of 10% glycerol, aliquoted as 40j.tl stocks and stored at -80 0C at a cell 
concentration of approximately 3 X 1010 cells/mi. 
2.1.4 Electroporation of competent cells 
An aliquot of competent cells were thawed on ice and plasmid DNA or ligation 
reaction were added, mixed and left on ice for 1 minute. This mixture was then 
transferred to a chilled, sterile electroporation cuvette and subjected to a pulse of 
2.5kV in a Gene Pulser (BioRad). The time constant for the pulse should be between 
4.5 and 5.0 msec. imi of Soc was immediately added to the cells and resuscitated at 
370c with constant shaking at 250 RPM for lhr before plating on L-agar plates 
containing antibiotic selection where appropriate and incubated overnight at 370c. 
2.2 Cell and Tissue Culture 
2.2.1 Media and reagents 
DMEM (Gibco BRL) 
Dulbecco's Modified Eagle Medium supplemented with 10% Bovine calf serum 
(GIB CO BRL) and penicillin/streptomycin at 100 units/ml and lOOg/ml respectively. 
MEM Alpha (Gibco BRL) 
MEM Alpha medium supplemented with 10% Bovine calf serum (GIBCO BRL) and 
penicillin/streptomycin at 100 units/ml and 1 OOgIml respectively. 
TrypsinIEDTA solution (TIE) 
2.5% trypsin and 0.02% EDTA in phosphate buffered saline (PBS). 
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2.2.2 Mammalian cell lines 
EFS2 cells were derived from an murine ES cell line containing a randomly integrated 
3-geo transgene (Hendrich and Bird, 1998). 
HeLa cells are derived from a cervical carcinoma expressing the human papiloma virus 
16 E6 tumour antigen. 
L929 (L) cells are a mouse fibroblast cell line. 
2.2.3 Thawing of cells stored in liquid nitrogen 
All cell lines utilised in this work were stored in liquid nitrogen, in lml of culture 
medium and 10% DMSO. Cells were recovered by rapidly thawing in a 37 °C water 
bath, then resuspending in 9mls of the appropriate medium and spinning at 1200 
RPM for 2 minutes. The supernatant was then aspirated and the pellet resupended 
gently in lOmls of fresh medium in a T-25 flask at 37 0C under 5% CO2 atmosphere. 
The culture medium was changed 24 hrs after plating out the cells to wash out 
residual DMSO. 
2.2.4 Maintenance of cell lines 
Cell culture work was carried out in a laminar flow hood. 
L929 cells and HeLa lines were cultured in DMEM, supplemented with 10% BCS 
and penicillin/streptomycin at 100 units/ml. and 100g/ml respectively. These lines 
were grown as a monolayer in sterile T-75 flasks in a 37 0C incubator under 5% CO2 
atmosphere. These lines were passaged once a week by washing the cells twice in 
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PBS, adding 2mls of TIE for 2 min to dislodge the cells, pelleting gently at 1200RPM 
X 3 min and then re-seeding at 1:10 dilution to maintain the line. 
EFS2 fibroblasts were cultured as a monolayer in MEM alpha medium supplemented 
with 10% BCS and penicillin/streptomycin at lOOunits/ml and 100g/ml respectively 
and this line was passaged twice weekly. 
2.2.5 Transfection of mammalian cell lines 
In order to establish transient cell lines, cells were grown in either 3mm dishes or six 
well culture dishes until 30-50% confluent then transfected with constructs by either 
of the following methods. 
DNA-liposome transfection: 1 Op.l of either Lipefectin or Lipofectamine (Life 
Technologies) were diluted in lOOj.tl of MEM Alpha medium without serum and 
allowed to incubate at room temperature for 45 min. Various concentrations of DNA 
(500ng - 10pg) were resuspended in lOOj.tl of MEM Alpha medium and the two 
solutions were gently mixed and complex formation allowed to proceed for 15 min. 
Subsequently 0.8ml of serum-free and antibiotic-free MEM Alpha medium was 
added to the DNA-lipofectin mix and overlaid onto cells that had been washed with 
serum-free medium. Cells were incubated for 5 hr at 37 0C incubator under 5% CO2 
atmosphere and the DNA containing medium was removed and replaced with 
complete growth medium and incubated for a further 48 hr. Cells were then either 
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fixed in 4% paraformaldehyde in phosphate-buffered saline for 20 min at 37 0C and 
then washed twice in phosphate-buffered saline prior to counterstaining or assayed 
as in 2.2.6. 
DEAE-dextran transfection: Approximately 5 X 1 05  mouse L cells (1:10 split) were 
grown in culture until 30-50% confluent. Prior to transfection, DNA (5-10pJ) in TE 
was added to 3OpJ of TB  and subsequently added to 80tl of 10mg/mi DEAE-dextran 
in TBS while constantly shaking the tube. The media was aspirated from the L929 
cells and the plate washed with PBS and overlaid with lml of DMEM-1%FCS. The 
DNAj'DEAE-dextran mixture was then added dropwise to each plate equally over the 
surface of the cells and incubated for 4 hr in a 37 0C incubator under 5% CO2 
atmosphere. This DNA/DEAE-dextran mixture was then aspirated from the plates 
and the cells were shocked by adding 5ml of 10% DMSO in PBS for 1 mm. The 
DMSO was aspirated, washed with PBS twice and imi of complete medium was 
added to each plate. Cells were incubated for 48 hr and then assayed as in 2.2.6. 
2.2.6 -gaIactosidase assay 
Cells were grown to confluence following transfection of reporter constructs, washed 
twice in phosphate-buffered saline and overlaid with 500pJ of lx lysis buffer 
(Promega) and incubated for 15 min at room temperature. Cells were carefully 
scraped down using rubber policemen and the suspension was transferred to a sterile 
microfuge tube and put on ice. Samples were subsequently centrifuged at 14000 
RPM for 2 min at 40C and 150jil of the supernatant was assayed directly by adding 
an equal volume of 2X Assay Buffer (120mM Na2HPO4, 80mM NaH2PO4, 2mM 
MgCl2, 100mM -mercaptoethanol, 1.3 mg/ml ONPG) and incubated at 37 0C for 30 
mm. The reaction was then terminated by addition of 1 M sodium carbonate and the 
spectrophotometric absorbance at 420 nm determined. 
2.3 Preparation of Nucleic Acids 
2.3.1 Isolation of plasmid DNA 
1 Omis of LB media containing 50.tg/ml ampicillin (Sigma) were inoculated with a 
single bacterial transformant and incubated with shaking overnight at 37 0C. Cells were 
harvested by centrifugation at 2000 RPM for 10 mm. Cells were resuspended in 
250p1 50mM Tris-HC1, 10mM EDTA, RNase A 10.ig/m1, then lysed in 250pJ 0.2M 
NaOH, 1% SDS and the suspension was mixed thoroughly by inversion before 
adding 300il of a neutralising solution containing 3M potassium acetate, 2M acetic 
acid. Bacterial debris was then pelleted at 14000 RPM for 10 min and the 
supernatant was applied to a column containing a selectively absorptive silica based 
resin (Qiagen). Plasmid DNA was bound by centrifugation for 14000 RPM for 1 mm 
and washed in 7501.d 55% ethanol, 8.0mM Tris-HC1 (pH 8.0) and 40mM EDTA, 
then spun twice in a microcentrifuge at 14000 RPM for 1 min to remove residual 
ethanol. The bound plasmid DNA was eluted in either dH20 or TE (10 mM Tris-
HC1, pH 7.5, 1mM EDTA). 
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2.3.2 Isolation of total RNA from cultured cells and tissues 
This protocol is based on the single step method for total RNA isolation 
(Chomczynski and Sacchi, 1987). Typically 100mg of tissue (frozen in liquid 
nitrogen after dissection) or cells harvested from a near confluent 25cm 3 tissue culture 
flask were homogenised in SOOjil of Solution D (4M guanidinium isothiocyanate, 
25mM sodium citrate pH 7.0, 0.5% L-lauryl sarcosine, 0.1 M -mercaptoethanol). 
20p.l of DEPC-treated 2M sodium acetate, 500j.d of water-saturated phenol and 100i1 
of chloroform were added and the mixture was vigorously shaken and placed on ice 
for 20 mm. After centrifugation at 14000 RPM for 20 min at 4 0C the RNA-
containing supernatant was precipitated with one volume of isopropanol at -20 0C for 
at least one hour. RNA was pelleted by centrifugation again at 14000 RPM for 20 
min at 40C and the pellet was resuspended in 300 jii of solution D and reprecipitated 
with one volume of isopropanol at -20 0C. The precipitated RNA was washed in 75% 
ethanol, repelleted, dried and either resuspended in DEPC-treated dH20 or stored as 
ethanol precipitates at -70 0C. Yield and relative purity were assessed by measuring 
the absorbance of a diluted aliquot of this total RNA at wavelengths of 260nm and 
280nm. 
2.3.3 Synthesis of cDNA for RT-PCR 
5j.ig of total RNA was adjusted to a 1 2jd volume containing 250ng of random 
hexanucleotide primers (Boehringer Mannheim) with DEPC-treated dH20. This 
sample was heated to 70 0C for 10 min and cooled on ice. To this solution was added 
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2l of lox PCR buffer, 21.d of M902  ltl of 10 mM dNTPs and 2j11 0.1M DTT per 
reaction. The sampled was mixed gently and incubated at 250C for 10 min followed 
by incubation at 42 0C for 2 mm. lJ.tl (200 units) of Superscript II reverse 
transcriptase (GIBCO BRL) was added to the reaction and incubated at 42 0C for a 
minimum of 50 mm. The reaction was stopped by heat inactivation at 70 for 15 mm. 
The cDNA was now used directly in RT-PCR experiments (2j.tl per reaction). 
2.4 Gel Electrophoresis 
2.4.1 Electrophoresis of DNA 
For both preparative and analytical purposes 0.8% to 1.5% (w/v) agarose gels in 1X 
TAE (40mM Tris-acetate, 1mM EDTA) containing 1il of ethidium bromide 
(lOmg/ml) per 5Omls melted agarose were used to separate DNA fragments ranging in 
size from 300bp to 15kb. Samples were prepared by addition of 0.1V of loading 
buffer (15% Ficoll type 400, 10mM EDTA and 0.25% orange G) and following 
electrophoresis in 1X TAE buffer, DNA was visualised on a UV transilluminator. 
2.4.2 Electrophoresis of RNA 
For Northern blots or in order to assess total RNA quality prior to cDNA synthesis, 
RNA samples were run on horizontal 1.2% agarose gels in 1X MOPS (1M MOPS 
pH 7.0, 3M sodium acetate pH 7.0, 0.5M EDTA) containing 1.1% formaldehyde. To 
10ig of total RNA in 61.d of DEPC-treated dH20, 12.5p1 of deionised formaniide, 
2.5j.tl of lOX MOPS, 4xl of formaldehyde and 1il ethidium bromide. Samples were 
heated to 650C for 10 min,O.1V of RNA loading buffer (15% Ficoll, and 0.25% 
I ' 
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bromophenol blue and 0.25% xylene cyanol FF) added, and following electrophoresis 
in 1X MOPS buffer, RNA was visualised on a UV transilluminator. 
2.5 Radioisotopic labelling of DNA fragments 
2.5.1 Random Primed Labelling of DNA probes 
DNA probes for blot hybridisation were labelled with [a- 32P]-dCTP by random 
hexanucleotide primers using the Kienow fragment of E. coli DNA polymerase I 
(Feinberg and Vogeistein, 1983). 50ng of DNA probe was resuspended in 12g1 
dH20, denatured by boiling for 5 min and chilled on ice. To this 4R'  of 5X 
oligolabelling buffer (0.25M Tris-HC1, 50mM MgC12, 0.5mM dithioerythritol, 
1mg/mi BSA, 312 A260 units/ml hexanucleotides, 250j.tM each of dATP, dTTP, 
dGTP pH 7.2), 30iCi [a- 32P]-dCTP (lOp.Ci/pi) (Amersham) and finally 1i1 Klenow 
enzyme (2 units) was added and incubated at 37 0C for 30 min. Unincorporated 
nucleotides were removed by centrifugation through a imi Sephadex G-50 column 
(Pharmacia). Prior to hybridisation the probe was denatured by boiling for 5 mm, 
cooled immediately on ice and added to the hybridisation mix. 
2.5.2 End Labelling of DNA oligonucleotides 
Oligonucleotides were labelled by the transfer of the [y 32P]-ATP to the terminal 5'-
OH group of the oligonucleotide using polynucleotide kinase (PNK). To 50ng of 
oligonucleotide in 7.tl of dH20, 2l of PNK buffer (Boehringer Mannheim), lOj.il of 
(1 Op.CiJj.il) [y-32p]-ATP. The reaction was incubated at 37 °C for 40 mm. It was added 
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directly to the hybridisation mix without the need for further removal of incorporated 
nucleotides. 
2.6 Nucleic Acid Blotting and Hybridisation 
2.6.1 Southern blot analysis of DNA 
Southern blotting was used to transfer DNA from agarose gels to nylon membranes 
by capillary action (Southern, 1975). Following electrophoresis, agarose gels were 
soaked in 0.4M NaOH for 20 min and transferred to 3MM filter paper using 0.4M 
NaOH as blotting buffer. The gel was overlaid with a Hybond N+ nylon membrane 
(Amersham) and transfer of DNA was allowed to proceed overnight. Following 
transfer the filter was washed briefly in 5X SSC (20X SSC : 175.3g NaCl, 88.2g 
sodium citrate pH7.0 per litre) and pre-hybridised in Church-Gilbert buffer (0.5M 
sodium phosphate pH 7.2, 7% SDS, 1mM EDTA, 0.5% powdered skimmed milk) 
for at least one hour prior to hybridisation (Church and Gilbert, 1984). Random 
primed double stranded probes were denatured by boiling for 5 mm, added to 25ml 
of fresh Church Gilbert buffer and allowed to hybridise overnight. Membranes were 
washed following hybridisation three times with lOOml of 0.2X SSC, 0.1% SDS for 
30 min each. Membranes were sealed in plastic wrap and exposed to X-ray film 
(XAR5 Kodak). Hybridisations and subsequent washes were carried out at 65°C for 
random primed probes or at 5 0C below the Tin of end labelled oligonucleotide probes. 
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2.6.2 Northern Blot Analysis of RNA 
1 Ogg of total RNA was electrophoresed on denaturing formaldehyde gels and washed 
in dH20 to remove formaldehyde. RNA was transferred to nylon membranes as 
described for Southern blotting (see 2.6.1) except that the transfer buffer was 20X 
SSC. Following overnight transfer, the RNA was immobilised by baking the filter at 
800C and crosslinked with UV radiation (3 l2nm). Membranes were hybridised, 
washed and exposed exactly as described for DNA hybridisation. 
2.6.3 Bacteriophage plaque lifts 
Bacteriophage plaque lifts were carried out as duplicates using Hybond N nylon 
membranes (Amersham). Nylon membrane filters were placed on pre-chilled top 
agarose plates for 1 min and marked by puncturing the membrane asymmetrically to 
facilitate subsequent orientation. Recombinant X bacteriophage adsorbed on 
membranes were denatured by placing plaque side up on 3MM filters soaked in 
1.5M NaCl, 0.5M NaOH for seven mm, then neutralised by placing membranes on 
3MM filters soaked in 1.5M NaCl, 0.5M Tris-HC1 pH 7.5 for 2 min and this 
neutralisation step was repeated. Filters were then washed in 2X SSC to remove any 
top agarose, air dried and baked at 80 0C for 2 hours prior to hybridisation of 
radiolabelled probes. 
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2.6.4 Removal of Probe Following Hybridisation 
In order to hybridise the same membranes with alternative probes, hybridised probe 
was removed by pouring boiling 0.5% SDS over the membrane and allowing to cool 
to room temperature with shaking. This was performed twice and the membrane was 
exposed to X-ray film to confirm probe removal. 
2.7 Enzymatic Manipulation of DNA 
2.7.1 Restriction endonuclease digestion of DNA 
Restriction endonuclease digestion was carried out in the appropriate buffer at the 
temperature recommended by the manufacturer (New England Biolabs). Typically, a 
2-3 fold unit excess of enzyme was employed to restrict DNA substrates. 
2.7.2 Dephosphorylation of DNA 
In some cases to prevent self-ligation of digested vectors, the 5' phosphate group 
was removed by dephosphorylation with call intestinal phosphatase (CIP). 
Following cleavage of vector DNA and gel isolation, DNA was dephosphorylated by 
CIP (GIBCO BRL) in appropriate buffers as recommended by the manufacturer. 
2.7.3 Ligation of DNA 
DNA ligase catalyses the ligation of DNA ends by the formation of a phosphodiester 
bond between the 3' hydroxyl group of one end and the 5' phosphate of another. 
Ligation reactions were normally carried out in a 20.d reaction volume with a molar 
ratio of insert to vector of 3:1 in the presence of 50mM Tris-HC1, 10mM M902, 
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10mM DTT, 1mM ATP, 50g/BSA and 100 units of T4 DNA ligase (NEB) at 16 0C 
overnight. Ligation reactions were spotted onto filters (Millipore type VS. 0.025j.tm ) 
and desalted by microdialysis against dH20 for 30 min prior to 
electrotransformation. 
2.8 Polymerase Chain Reaction 
The polymerase chain reaction (PCR) (Saiki et al., 1988) was employed in order to 
amplify DNA fragments for a variety of applications. Reactions were carried out in a 
50il volume containing 10mM Tris-HC1 pH 8.2, 50mM KC1, 0.2mM dNTPs, 1 g 
of each primer with 1 OOng of template and 2 units of Taq polymerase (Qiagen) in a 
PCR cycler (Hybaid) with heated lids. The polymerase used was dependent on the 
nature of the downstream application so where fidelity was the primary criterion 
proof-reading enzymes, such as Pfu (Siratagene) containing 3'—*5'exonuclease 
activity were employed and where yield was most important reactions were cycled 
with conventional non-proof reading polymerases. DNA was amplified by initial 
denaturation for 2 min at 94 0C, then 30 cycles of 94 0C for 15 sec, 550C for 30 sec, 
then 720C for 1 min per kb of product size and a final extension of 72 0C for 10 mm. 
2.9 DNA Sequencing 
DNA sequencing was carried out by sequence cycling using fluorescent dye 
terminators (Perkin-Elmer). Sequencing reactions were carried out in 1 Oj.tl volume 
containing 0.5pg of template DNA, 3.2pmol of primer and 4il of terminator pre-mix 
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(A-dye terminator, T-dye terminator, C-dye terminator, G-dye terminator, dATP, 
dTTP, dCTP, dITP, Tris-HC1 pH 9.0, MgCl2,  thermostable pyrophosphatase and 
AmpliTaq DNA polymerase). Reactions were sequence cycled in a PCR machine 
(Normal : 96 0C for 30 sec, 50 0C for 20 sec, 60 0C for 4 min for 25 cycles; GC-rich: 
980C for 30 sec, 550C for 20 sec, 60 0C for 4 min for 25 cycles). Samples were 
precipitated by addition of lj.i.l of 3M sodium acetate and 25p1 of 95% ethanol on ice 
in the dark for 10 mm. Reactions were then centrifuged at 14000 RPM followed by 
washing of the pellet in 75% ethanol and drying. Samples were dissolved in 4il of 
loading buffer (25mM EDTAI50mgIm1 blue dextran and a 1:5 ratio of de-ionised 
formamide), heated to 90 0C for 2 min and loaded on polyacrylamide gels in a 373 
automated DNA sequencer (Applied Biosystems) operated by Vicky Clark. 
Sequence files were analysed using Seqman (DNA star) and GeneJockey (Biosoft) 
software. 
2.10 Screening of cDNA libraries 
2.10.1 Preparation of phage-competent cells and library titration 
Single colonies of XL1-Blue were inoculated into 10 ml of L-broth containing 0.2% 
maltose and 10mM MgSO4 and grown overnight at 37 0C to generate bacteriophage-
competent host bacterial cells. cDNA libraries were titred by serial dilution and for 
large screens 3 X 105  pfu of bacteriophage were incubated with 0.8m1 of 
bacteriophage-competent bacteria for 20 min and were plated onto pre-warmed 22.5 
X 22.5 cm plates in 40m1 top agarose and incubated overnight at 37 0C. Bacteriophage 
plaque lifts were carried out as in 2.6.3. Secondary screening were carried out on all 
positives at a density of approximately 100 pfu per 175 cm2 plate using 0.6ml of 
XL1 blue host bacterial cells and lOmi of top agarose. Following tertiary screening 
individual strongly hybridising plaques were picked and transferred to a sterile 
microfuge tube containing 500pJ SM buffer (Per litre : 5.8g NaCl, 2g MgSO4.7 H20, 
50m1 1M Tris.Cl pH 7.5, 5 ml 2% gelatin solution) and 20jil chloroform. The cored 
plaques of interest were vortexed briefly to release the ?ZAP II phage particles into 
the SM buffer and incubated at room temperature for 1-2 hrs or overnight at 4 °C. 
This phage stock is stable for one year at 4 0C (Stratagene). 
2.10.2 In vivo excision of cDNA inserts from AZAP II cDNA libraries 
In a 50 ml conical tube 200pJ  of 0D600 = 1.0 XL1 blue cells, 200il of phage stock 
(>1 X 105  pfu/ml) and ip.! of R408 helper phage (>1 X 10 6 pfu/ml) were incubated at 
370C for 15 min. 5 ml of 2X YT media was added and incubated at 37 0C for 3 hr. The 
tube was heated at 70 0C for 20 mm, centrifuged for 5 min at 4000 g and then 1 0il of 
the supernatant was added to 200.tl of 0D600 = 1.0 XL1 blue cells and incubated at 
370C for 15 mm. lj.tl to 100.d was spread on LB plates containing ampicillin and 
incubated overnight at 37 0C. Plasmid DNA from transformants was prepared as in 
2.3.1, restriction mapped and inserts sequenced using the T3 and T7 promoters in 
pBluescript SK. 
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2.11 Fluorescent In Situ Hybridisation (FISH) 
2.11.1 Labelling genomic probes with biotin-16-dUTP 
To incorporate biotin- 1 6-dUTP to genomic probes a nick translation reaction was set 
up containing 2il of lox nick translation buffer (0.5M Tris pH 7.5, 0.1M M9SO4, 
1mM DTT and 500p.g/ml BSA Fraction V), 2.5il of each of 0.5mM dATP, dCTP, 
dGTP and biotin-16-dUTP, 0.5p.g of genomic probe, ljtl of DNaseI (Boehringer 
Mannheim) freshly diluted 1:500 and 10 units of DNA polymerase I (GIBCO BRL) 
adjusted to a final 20.d volume with d1120. The reaction was incubated at 16 0C for 
90 min and then precipitated with 0.1 volume of 3M sodium acetate and 2 volumes 
of ethanol and resuspended in TE. 
2.11.2 Detection of biotin-16-dUTP incorporation 
Botin-16-dUTP labelled probes were serially diluted and spotted onto Hybond N 
filters (Amersham) with biotin labelled standards (1-20pg biotin; GIBCO BRL) and 
UV crosslinked at 250mJ. The filter was washed in Buffer I (0.1M Tris pH 7.5, 
0.1 5M NaC1) for 5 min at room temperature and subsequently incubated in Buffer II 
(0.1 M Tris pH 7.5, 0.15M NaCl, 3% BSA Fraction V) at 60 0C for 1 hr. The filter 
was incubated in 1 Oral of Buffer I containing 1 Ojil of a 1:1000 dilution of streptavidin 
alkaline phosphatase (Boebringer Mannheim) in 0.5M Tris pH 7.5, 0.15M NaCl for 
10 min at room temperature. The filter was washed twice with Buffer I for 15 mm 
and once in Buffer III for S min and finally incubated with 10 ml of Buffer III with 
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I ml of BCIP/NBT alkaline phosphatase substrate kit IV (Vector) for 3 hr and biotin-
1 6-dUTP incorporation was estimated. 
2.11.3 In situ hybridisation with biotin-labelled probes 
Approximately 1 00ng of biotin-labelled probe was precipitated with two volumes of 
ethanol and the pellet was resuspended in lOj.il of hybridisation mix (50% formamide, 
2X SSC, 1% Tween20, 10% dextran sulphate, Spg salmon sperm DNA, 2j.tg human 
CotI DNA) at 370C for 3-4 hr. Slides with human metaphase spreads were incubated 
with lOOj.tl of RNase A (100 pg/mi 2X SSC) per slide for 1 hr at 37 0C. Slides were 
subsequently dehydrated in an ethanol series (70%, 90%, 100%) for 2 min each and 
allowed to dry. Slides were denatured by incubating in 70% formamide, 2X SSC for 3 
min at 700C and then subsequently dehydrated through the ethanol series as before. 
Biotin-labelled probes were denatured at 70 0C for 5 min and then re-annealed for 15 
min at 370C. lOpi of probe were added to each slide, covered in parafilm and 
incubated at 37 0C overnight. Slides were then washed for 4 X 3 min in each of the 
following solutions: 50% formamide / 2X SSC at 45°C; 2X SSC at 45 0C; 0.1X SSC at 
600C to remove non-specifically bound probe. 50j.tl of blocking buffer (4X SSC, 5% 
skimmed milk) was then applied to each slide and left at room temperature for 5 mm. 
SOpl of avidin-FITC (Vector) was applied to each slide, covered in parafilm and 
incubated at 37 0C for 30 min. Slides were then washed three times in 4X SSC, 0.1% 
Tween 20 for 2 min at 45 0C. SOpl of biotinylated anti-avidin (Vector) was applied 
per slide and incubated at 37 0C for 30 min and washed as above. Finally 50pJ of 
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avidin-FITC was applied and incubated and treated as before and allowed to dry. 
Slides were counter-stained with 20p.l of DAPI (lOp.g/ml; Sigma) on coverslips and 
mounted in Vectashield (Vector) and images captured under an epifluorescence 
microscope (Zeiss). 
2.12 Expression and affinity purification of recombinant proteins 
2.12.1 Affinity purification of histidine tagged recombinant proteins 
Overnight LB cultures of transformed E. coli BL2 1 DE3 (pLysS) were diluted 1:100 
in 1 litre of fresh LB medium containing 50p.g/ml ampicillin and grown at 37 0C until 
the 0D600 reached 0.5. The cultures were induced by addition of 0.4mM IPTG and 
incubated at 37 °C for a further 3-4 hrs. The induced cells were pelleted and washed 
twice in cold 50mM HEPES pH 7.9, 0.1M NaCl. Bacterial pellets were resuspended 
in 20 mis of resuspension buffer (20mM HEPES p11 7.9, 10% glycerol, 0.3M NaCl, 
0.5mM PMSF, 10mM -mercaptoethanol and the protease inhibitors leupeptin, 
antipain, chymostatin, pepstatin A, aprotin were included at 5p.g/ml to minimise 
proteolysis). The cells were then lysed on ice by mild sonication and addition of 
Triton-X- 100 to a final concentration of 0.1%. Samples were centrifuged at 16000 
RPM at 0°C for 30 min and 20mM imidizole was added to minimise non-specific 
binding during the subsequent purification steps. A Ni 2 -NTA superflow column 
(Qiagen) was packed to 1 .5m1 and equilibrated with 1 Omls of resuspension buffer 
containing 0.1% Triton-X-100 and 20mM imidizole. The crude lysate was passed 
twice over the column, then washed with 20mls of resuspension buffer. Finally, the 
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bound proteins were eluted from the column in 6.Omls of resuspension buffer 
containing 0.4M imidazole, analysed by SDS-PAGE and stored at -80 0C. 
2.12.2 Affinity purification of glutathione-S-transferase (GST)-tagged 
recombinant proteins 
For expression of GST-fusion proteins, an overnight culture of transformed E. coli 
BL21 DE3 (pLysS) was diluted 1:100 in 1 litre of fresh LB medium containing 
50p.g/ml ampicillin and grown at 37 0C until the 0D600 reached 0.5. Protein expression 
was then induced by addition of 0.4mM IPTG for 3 hrs at 37 0C. The induced 
bacterial pellets were centrifuged at 4K X 15 min at 0 °C, washed twice in GST-lysis 
buffer (50mM Hepes Tris.HC1 pH 7.9, 0.15M NaCl, 10% glycerol, 1mM EDTA), 
repelleted and either immediately lysed or stored at -80 0C. Bacterial pellets were 
resuspended in 20 mls 50mM HEPES pH 7.9, 10% glycerol, 0.15M NaCl, 1mM 
EDTA, 1mM PMSF, 10mM 3-mercaptoethanol, 1% Triton-X-100 and the protease 
inhibitors leupeptin, antipain, chymostatin, pepstatin A and aprotin were included at 
5jxg/ml to minimise proteolysis. The cells were then lysed on ice by mild sonication 
in 0.1% Triton-X-100. Samples were centrifuged at 16 000 RPM at 0 °C for 30 mm. 
500p.l of GSH-Sepharose beads, (Sigma G-4510) were washed with lysis buffer and 
incubated with the extract for 2 hr at 4 0C. The GSH-Sepharose beads were washed 
three times with lysis buffer and finally the bound proteins were eluted by addition 
of 2mls lysis buffer containing 15mM reduced glutathione (rGSH). Aliquots from 
these fractions were analysed by SDS-PAGE and stored at -80 0C. 
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2.13 DNA binding assays 
2.13.1 Electrophoretic mobility shift assay 
Bandshift binding reactions were carried out in 20mM HEPES pH7.9, 1mM EDTA, 
10mM -mercaptoethanol, 0.1% Triton Xl00 and 4% glycerol. Methylated and 
unniethylated probes were end-labelled with [a- 32P]-dCTP using the Kienow 
fragment of DNA polymerase I. Aliquots of labelled probes were quantitated using a 
scintillation counter and 10000 cpm of each probe were incubated with recombinant 
proteins and poly (dl-dC) non-specific competitor on ice then loaded on a 5% 
polyacrylamide gel. Alternatively, samples were loaded on a 1.5% agarose gel in 0.5X 
TBE and DNA-complexes resolved by running at 1 OV/cm at 4 0C for 3 -5 hours. Gels 
were dried down onto DE8 1 filter paper and exposed to XAR5 film (Kodak). 
2.13.2 Southwestern assay 
Proteins were denatured in 1X SDS/sample buffer (2X: 62.5mM Tris.HC1 pH6.8, 2% 
(w/v) SDS, 0.04% -mercaptoethanol, 10% glycerol, 0.1% bromophenol blue) at 
100°C for 5 min then loaded onto a 10% polyacrylamide gel and subjected to SDS-
PAGE under constant amperage. Polyacrylamide gels, nitrocellulose filters (BA85, 
Schleicher and Schuell) and Whatman 3MM were then soaked in IX transfer buffer 
(lOX transfer buffer: 30.28g Tris base, 142.63g glycine per litre) for 30 mm. Gels 
were then transferred onto nitrocellulose between 3MM filter paper and proteins 
were transferred in 1X transfer buffer by electroblotting at 350inA for 4 hrs. 
Following transfer, the filter was denatured by washing with 6M guanidine 
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hydrochloride in lx transfer buffer for 30 min at room temperature. Proteins 
immobilised onto nitrocellulose were then renatured by washing with four successive 
two fold serial dilutions of the denaturation buffer using 1X transfer buffer. Filters 
were then washed in 1X binding buffer (I OX binding buffer: 200mM HEPES pH 7.9, 
30mM M902, 400mM KC1) and -mercaptoethano1 was added to a final 
concentration of 10mM. Membranes were blocked in 2% non-fat dried milk (Marvel) 
for 30 mins. Filters were then rinsed in 1X binding buffer to remove excess blocking 
buffer and the nitrocellulose was incubated in pre-incubation buffer (IX binding 
buffer, 0.1% Triton X 100, 10mM -mercaptoethano1 and E. coil non-specific 
competitor) for 10min before addition of 150 000 cpm of radiolabelled DNA probe 
per ml. Filters were then washed in wash buffer (1X binding buffer : 0.01% Triton 
Xl00, 10mM f3-mercaptoethanol) three times for five mins and filters air dried and 
exposed to XAR5 film (Kodak). 
2.14 Caenorhabditis elegans handling, culture and genetic methods 
2.14.1 Handling of Nematodes 
The observation and genetic manipulation of nematodes was carried out on NGM 
plates (NG agar: 3g NaCl, 2.5g Bactopeptone (Difco) and 17g Bacto-agar (Difco) in 
975 ml distilled water. Following autoclaving, 1 ml of cholesterol in ethanol (5 
mg/mi), lml of 1M CaC12, lml of 1M MgSO4 and 25m1 1M potassium phosphate 
buffer (pH 6.0) were added in order). Strains were maintained by transferring a single 
hermaphrodite using a 32-gauge platinum wire to 9cm NGM plates seeded with 
0P50, a uracil auxotroph of E. coli (Brenner, 1974), and were incubated at 15 0C with 
cultures requiring sub-culturing every 10 days. All worm strains were derived from 
wild type Bristol N2 unless otherwise stated. 
2.14.2 Isolation of C. elegans insertion and deletion mutants 
Thousands of worm cultures can be screened for either TO transposon insertion 
events or EMS/TPA induced deletions by employing nested genomic PCR to analyse 
tens of orderly pooled DNA lysates (Zwaal et al., 1993; Jansen et al., 1997). These 
DNA lysates have a corresponding collection of frozen mutants to allow subsequent 
retrieval of the mutant animal. Typical libraries consist of three sets of 960 cultures 
of (frozen) worms : 10 racks of 12 X 8 and a corresponding set of crude lysates. A 
detailed description of the mutant libraries screened in this study are provided in 
sections 6.2.1 and 6.2.2. 
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Tcl transposon insertion library screening The DNA lysates described were 
analysed by PCR to visualise insertions of TO transposons into a gene of interest. 
The PCR employed two sets of primers where one is specific for TO and the other 
was specific to the gene of interest where products were obtained only if the Tc 1 and 
gene-specific primers were properly juxtaposed. The reaction is made more specific 
and more sensitive by employing two rounds of PCR, using nested primers in the 
second round. The strain employed is MT3 126 (Finney, 1987), which contains the 
mut-2 mutation, as a result of which it is permissive for TO transposon excision. 
EMS/TPA library screening : The DNA lysates described above were analysed by 
PCR to visualise an EMS/TPA induced deletion within a gene of interest. The PCR 
employed two sets of nested oligonucleotide primers approximately 3.0kb apart 5' to 
pbm-1 to facilitate the isolation of loss-of-function or reduction-of-function alleles. 
The reaction was made more specific and more sensitive by employing two rounds of 
PCR, using nested primers in the second round. When an address was identified, 
frozen oligoclonal stocks were thawed and plated onto a seeded 10cm NGM plate. 
Three days after thawing the culture, -500 individual young adults were picked and 
transferred to 0P50 seeded 9cm NGM plates and at the same time oligoclonal 
cultures of rising complexity were seeded by establishing 10 plates of 10 worms, 5 of 
20 worms, 5 of 50 worms and a single plate of the remaining worms. Two to four 
days later, the parental worms that have laid viable eggs on plates and contain viable 
progeny were picked into 2.5Rl  of single-worm lysis buffer (50mM KC1, 10mM 
Tris-HC1 pH 8.3, 2.5 mM MgC12, 0.45% Nonidet P-40, 0.45% Tween 20, 0.01% 
gelatin, freshly added 60pg/ml proteinase K) and the lysis was carried out at 650C for 
60 min followed by a protease heat inactivation at 950C for 10 min. PCR genotyping 
was then performed using the outer PCR primers on these single worm DNA lysates 
and as a positive control a microliter of the original DNA sample was used. Nested 
PCR was performed on approximately 1 Sng of genomic DNA in a 9600 thermocycler 
(Perkin-Elmer) and Taq polymerase (BRL) with 0.5 J.LM of each primer, 0.2mM each 
dNTP for 35 cycles of 950C X 40s, 580C X 40s and 72 0C X 1 mm. Following 
identification of the mutant in this series, single progeny of the mutant line were PCR 
genotyped (with a negative neighbour as a control) to determine whether a mutant is 
homozygous. TA-cloning of the deletion mutant PCR product and subsequent DNA 
sequencing (section 2.8) was carried out to identify the nature of the deletion. Internal 
primers to the deletion were then designed to facilitate PCR genotyping to determine 
whether lines are heterozygous or homozygous for the deletion. 
2.14.3 Outcrossing of C. elegans deletion mutants 
Five adult hermaphrodites homozygous for dpy-] 7 (e164) and unc-32 (e169) III 
(SP471) were mated with 15 young adult males him-8 (e1489) N on a seeded N G M 
plates at 20 0C. 15 male cross-progeny i.e. from plates that contained phenotypically 
wild type worms as well as DpyUnc worms, were mated from the third outcross 
stage with adult hermaphrodites homozygous for the pbm-1 deletion. Twenty L4 
hermaphrodite progeny from this cross were transferred individually to NGM plates 
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and allowed to self-fertilise. F 2 progeny from lines heterozygous for the pbm-1 
deletion by PCR genotyping (as described in sections 2.14.4 using oligonucleotide 
primers presented in sections 6.2.1 and 6.2.3) were allowed to self, PCR genotyped 
and the lines that were positive for the deletion were identified. This scheme was 
repeated five times and a homozygous pbm-1 strain was established after three 
outcrosses suggesting the removal of a linked mutation that was recessive lethal. The 
five times outcrossed strain was deposited with the Caenorhabditis Genetics Center 
(CGC, University of Minnesota, USA) as pbm-1 (qal 700). 
Outcrosses one and two were performed by mating hermaphrodites heterozygous for 
the pbm-] deletion with dpy-17;unc-32 heterozygous males and following the 
segregation of the deletion allele by PCR genotyping of their progeny. 
2.14.4 PCR genotyping of nematodes 
Single animals were transferred to lOjil single-worm lysis buffer (see 2.14.2) and lysis 
was carried out at 65 0C for 60 mm, followed by a protease heat inactivation at 950C 
for 10 mm. PCR genotyping was then performed using the outer PCR primers on 
these single worm DNA lysates. Nested PCR was performed on approximately lSng 
of genomic DNA in a 9600 thermocycler (Perkin-Elmer) and Taq polymerase (BRL) 
with 0.51M of each primer, 0.2mM each dNTP for 35 cycles of 95 0C X 40s, 580C X 
40s and 720C X 1 mm. 
CHAPTER THREE: IDENTIFICATION OF A FAMILY OF PHD-
ZINC FINGER, BROMODOMAIN AND METHYL CpG—BINDING 
DOMAIN (PBM)—CONTAINING PROTEINS 
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3.1 Intoduction 
The sequencing of the genome of the small nematode, Caenorhabditis elegans is now 
complete (The C. elegans sequencing consortium, 1998). This represents the first 
example of the entire nucleotide sequence of a multicellular organism and 19 099 
genes are evident within the C. elegans genome. The nematode worm, C. elegans is 
also understood at an anatomical level in great detail with a complete description of 
the cell lineages that gives rise to the 959 somatic cells of the adult hermaphrodite 
nematode existing (Suiston et al., 1983) and an exhaustive description of the 302 
neurons elucidated down to the level of individual synapses (White et al., 1987). 
Simpson et al., (1986) were unable to detect 5-methylcytosine in the genome of 
Caenorhabditis elegans at any stage of development and as a result it was considered 
to be unlikely to identify any of the molecular machinery associated with a 
methylation system such as DNA methyltransferases and methyl-CpG binding 
proteins. 
3.2 Results 
3.2.1 Identification of the M1313-containing gene, pbm-1 in the nematode 
Caenorhabditis elegans 
Following the screening of protein databases with the MBD of MeCP2 to identify 
candidate methyl-CpG binding proteins, a MBD domain was identified within a 
putative Caenorhabditis elegans gene (B. Hendrich, unpublished observations). 
Cosmid ZK783 (Accession No. U13646) from C. elegans chromosome III was 
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predicted to contain a gene (ZK783. 4), using GENEFINDER exon-prediction 
software (Green and Hillier, unpublished) that potentially encoded a large protein 
containing an N-terminal MBD and an extreme C-terminal PHD-zinc finger region 
and adjacent bromodomain (see Figure 3.1). The gene was given the standard name 
pbm-1 for PHD-zinc finger, Bromodomain and MBD gene-1. The MBD of C. 
elegans PBM-1 was found to be highly homologous to a human EST (593380) from 
an ovarian cancer cell line suggesting evolutionary and functional conservation of this 
domain. A project was undertaken to isolate and characterise these genes using a 
cross-species approach exploiting the advantages particular to the nematode and 
mammalian systems. 
3.2.2 Characterisation of the genomic structure and cDNA encoding 
PBM-1 
A cluster of C. elegans ESTs derived from the pbm-1 locus was identified by 
searching dbEST (NCBI BLAST server: http://www.ncbi.nlm.nih.gov/BLAST)  and 
XREF (http://www.ncbi.nlm.nih.gov/XREFdb)  with the predicted full length PBM- 1 
protein. The largest clone, yke2 was sequenced entirely to confirm identity between 
this EST and the predicted eDNA from the pbm-1 locus determined by using the 
GENEFINDER exon-prediction software to anaylse the genomic sequence (Wilson et 
al., 1994; Green and Hillier, unpublished software). 
The yke2 clone however, did not extend far enough 5' to include all of the predicted 
pbm-1 exons 1 and 2. In order to derive a complete 5'-end cDNA, a spliced leader 
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Figure 3.1 : Schematic representation of the C. elegans PBM-1 protein 
The locations of the glutamine-alanine (QA)-rich region, methyl-CpG binding domain (MBD), 
Plant homeoomain (PHD)-zinc finger and bromodomain motifs within the PBM-1 protein are 
indicated. The scale bar at the top of the diagram corresponds to amino acid positions numbered 
from the N-terminus. 
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primer (SL1 : 5'-GGTTTAATTACCCAAGTTTGAG-3'; Krause et al., 1989; 
Spieth et al., 1993) and a gene-specific primer derived from pbm-1 exon 3 (zk783p1 
5'-CCATTGGATGTGGACGCCTG-3') were used in an RT-PCR reaction to 
amplify from total C. elegans cDNA the intervening sequence. This PCR product 
was TA-cloned, sequenced and the clone was termed Cepcml0 (S.Tweedie, 
unpublished results). This method takes advantage of the fact that approximately 
70% of all C. elegans mRNA messages are trans-spliced with either a SL1 or SL2 
derived spliced leader sequence (Spieth et al., 1993; Hengartner and Horvitz, 1994; 
Hope, 1994) and is a commonly used method to demonstrate that a message is in fact 
trans-spliced. Thus, the pbm-1 gene encodes a trans-spliced SL  mRNA. 
A eDNA contig for pbm-1 was then derived by aligning the CepcmlO and yke2 
clones and comparing this with the predicted cDNA product from the genomic 
sequence of cosmid ZK783. This procedure was applied to exclude the possibility of 
any errors arising from failure of the GENEFINDER exon-prediction software to 
accurately assign intron-exon boundaries within the pbm-1 gene. The original 
submission by the C. elegans sequencing consortium of the genomic structure of the 
pbm-1 gene suggested it had 12 exons on the basis of non-experimental computer 
analysis. The sequence of the complete PBM-1 cDNA (i.e. CepcmlO/yke2 described 
above) and alignment with the pbm-1 genomic locus demonstrated that the locus has 
in fact eight exons interspersed with small introns. The corrected genomic structure 
for pbm-1 and the intronlexon boundaries are presented in Figure 3.2. 
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Figure 3.2 : Genomic structure of the C. elegans pbm-1 gene 
Exons are numbered in Roman numerals and the sizes of exons and introns are drawn to scale. The 
positions of the MBD, the PHD-zinc finger and the bromodomain motifs within the pbm-1 genomic locus 
are indicated. 
Small introns are typical for most C. elegans genes that are, on average, smaller than 
other eukaryotic introns (Blumenthal and Thomas, 1988). The introns within pbm-1 
conform to the "GT/AG" rule in C. elegans, and other eukaryotes where the 5' splice 
donor sequences fit the consensus GTRART (R=purine) and the 3' splice acceptor 
sequences terminate with the pyrimidine rich consensus TTTCAG (see Table 3.1; 
Fields, 1990). 
No systematic study exists for defining an optimal consensus for translational 
initiation in the nematode system. Krause (1995) has presented a preliminary 
compilation of translational initiation sites for 48 C. elegans mRNAs and defined the 
degenerate consensus sequence ANNA/ cA/GAAAUGN. All of these 48 proteins in C. 
elegans are initiated at AUG and this initiator codon was frequently preceded by A 
residues but little similarity exists to the Kozak consensus sequence for translational 
initiation of vertebrate mRNAs. The PBM-1 cDNA sequence is 4173 nucleotides in 
length and contains a long open reading frame (ORF), initiated by the putative ATG 
at position 50 and terminated by the STOP codon (TAA) at position 4220 (see 
Figure 3.3 for cDNA and amino acid sequences). The ATG at position 50 was chosen 
as the initiator methionine for conceptual translation of the PBM- 1 cDNA because it 
resides within an excellent context for translational initiation when compared to the 
nematode consensus sequence and is preceded by numerous A residues as has been 
found for a number of C. elegans mRNAs (Krause, 1995; 10/11 matches: 
UCCAAAAATGA). Furthermore, an upstream 5'UTR stop codon defines the most 
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3 Splice Acceptor cDNA 
Exon Exon 




Number Length Exon 	Intron Number Length position (bp) (bp) 
NA 1-744 1 744 AAGGCG/gtaaga... 1 52 
K  
...tttcagIGATCAA 
744-1119 2 375 
GTTAGG/gtaagt... 2 175 
D Q V  
...tttcag/TACCTC 1120-1639 3 520 GGAATAG/gtaagt... 3 48 
Y 	L G 	I 
...tttcag/ATCTrGAA 1640-1778 4 139 GAGAAAAG/gtaatt... 4 47 
D L E E 	KR 
...tttcag/ATTTGGC 1779-2714 5 936 CAGAATAG/gtcagt... 5 131 
F Q 	KR 
...mcag/AGACTGT 6 676 TTTAGG/gtgagt... 6 269 
DC 2715-3390 FR 
...fficag/CCCCGA 3391-3992 7 602 AAACTFAT/gtaagt... 7 296 
PR K 	L  
...ttccag/ATACGAG 3993-4432 8 181 NA NA NA YE 
Table 3.1 : Exon-Intron boundaries in the C. elegans pbm-1 gene 
Exon sequences are shown in uppercase and written as codons with the translated amino acid 
below (single-letter code) . Intron sequences are shown in lower case. The conserved GT 5' splice 
donor and AG 3' splice acceptor sequences are written in bold. The cDNA nucleotide positions are 
numbered from the A of the ATG initiator methionine shown in Figure 3.3. NA, not applicable. 
5' limit of the C. elegans PBM-1 cDNA and the ATG at position 50 represents the 
first in-frame methionine codon. 
The maturation of the 3' end of a C. elegans primary mRNA transcript appears to 
use an analogous pathway to that in other eukaryotes involving cleavage and 
polyadenylation catalysed by an enzymatic complex that recognises the poly(A) 
signal sequence, AAUAAA and a second undefined downstream element (Irniger and 
Braus, 1994). An analysis of some 1300 C. elegans cDNA clones showed that 
polyadenylation usually begins normally 13 nucleotides downstream of a sequence 
matching the previously defined poly(A) signal sequence (T. Blumenthal, 0. White 
and C. Fields, unpublished observation). Variations on the poly(A) hexanucleotide 
signal sequence in C. elegans normally involve the first position (22% of transcripts 
have other bases than A) and the fourth position (13% had G) as is in the case for the 
PBM-1 poly(A) signal sequence. In the PBM-1 cDNA sequence 3'-UTR a 
AAUGAA poly(A) signal sequence is evident 14 nucleotides upstream of the 
poly(A) tail sequence (at cDNA positions 4467-4472). The C. elegans PBM-1 
eDNA sequence potentially encodes a large protein of 1390 amino acids with a 
predicted molecular weight of 156kDa. No paralogs of the C. elegans pbm-1 gene are 
evident within the worm genome and furthermore, no PHD-zinc finger, bromodomain 
and MBD-containing proteins were identified in the completely sequenced genome of 
Saccharomyces cerevisiae suggesting a relatively recent evolutionary origin in 
eukaryotes. 
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Figure 3.3: cDNA and amino acid sequence of C. elegans PBM-1 
The PBM-1 cDNA sequence is 4173 nucleotides in length and contains a 
long open reading frame (ORF), initiated by the putative ATG shown in bold at 
position 50 and terminated by the STOP codon (TAA) at position 4220. The 
22 nucleotide 5' trans-spliced leader (SLI) is shown in bold. A 
polyadenylation signal AATGAA 14 nucleotides upstream of the poly(A) tail is 
underlined. The deduced peptide sequence of PBM-1 is 1390 amino acids in 
length. 
1TGTACATGTAAATTCTTTCCAAAAATGAGTGATAACTCATCTAATCAGTTTCTACTTCTGCTAGCAGCTGCACAG 100 
M S D N S S N Q F L L L L A A A Q 
101 CAACAACAGCAACAACAACTTCTACAGCAACAACTTGCAAAGATCCAGAAGGCCACTGCATCATCTCCATCGAAATCAACTAATGGAACATCAGCATCAA 200 
Q Q Q Q Q Q L L Q Q Q L A K I Q K A T A S S P S K S T N G T S A S T 
201 CGTCGGCTGTCCCGTCAACTTCTGGGACATCGTCATCrCAAAATGAAGCAGCTCAGTTGCAAAATTTAGCAAAAATGCAGCAAATTCAGCAGCTGGCCCA 300 
S A V P S T S G T S S S Q N E A A Q L Q N L A K M Q Q I Q Q L A Q 
301 GTTTGGAGCACTCATGGCTGCGCAGAAGAAACAACAAGAAAAAGCGGCAGCTGATAAGG 	 CTGCAGCAGCA400 
F G A L M A A Q K K Q Q E K A A A D K A K E K E K E K Q K A A A A 
401 GCTGCCGCCGCCGCAGCAAAAGCCTCAGCGTCrACTTCCTCCGCATCAGCAATTCCTGGATTGTCTCCAGAAATGCTCGCAGCATGGCAACAAGCAATCC 500 
A A A A A A K A S A S T S S A S A I P G L S P E M L A A W Q Q A I Q 
501 AGATGCAAGCrCTCCAACAAATGATGATGACTCCACAGAAATCTCAAATGGAAGAAGCTATCAAGAAAATGATGGATATGGCAAAGAAGAAGCCAGCTGG 600 
M Q A L Q Q M M M T P Q K S Q M E E A I K K M M D M A K K K P A G 
601 AGTCGCCTCAACAAGTTCAGCATCTACAAGCTCATCCACACCATCCACATCATCAGCTTCAATTACATCATCTAATAACAATGCAGCGAACAACGCTGCG 700 
V A S T S S A S T S S S T P S T S S A S I T S S N N N A A N N A A 
701 AGCAATATGATGAACAATGTGPTGTGGCAATTGGTGGCAGCACAATGCPACAAAAACAGCAAcACAACPGAAGGPTACTCAGAAAAAGGCGGATCAAG 800 
S N M M N N V M W Q L V A A Q M Q Q K Q Q Q Q Q K D T Q K K A D Q A 
801 CGAAAAAAGCGAAAGAGCTTGCCAAACAACAACAGAAAGAGCAAGATGTGAAGAATAAGCAACAAGAGGAGATTTTGAAGTTTCTTATGGCTCAACATCA 900 
K K A K E L A K Q Q Q K E Q D V K N K Q Q E E I L K F L M A Q H Q 
901 GCTGAATCATCAGAAAAAGCATGAGAAGAAGCAAGCTGACGCAGCTGCACTCGCAGCAAAAGTGCTTGCAGCTCACCGAGCAGCACTCGAATCGGACAGT 1000 
LNHQKKHEKI<QADAAALAAKVLAAHRAALESDS 
1001 CCTGAAGAAGGGAAAAAGACTAATGAAGCAATGCTTCGATTGCCTCTTCAACTTGGATGGAGGCGTCAAACATGTGTCAGAAGTATTGCTTCCGCTGGAG 1100 
P E E G K K T N E A M L R L P L Q L G W R R Q T C V R S I A S A G V 
1101 TTAAAGGAGATGTTTCGTATTTTGCTCCGTGCGGAAAAAAGTTGAGCACATACTCGGAAGTTGTTAGGTACCTCACCAAAAATTCGATTCACTACATCAC 1200 
K G D V S Y F A P C G K K L S T Y S E V V R Y L T K N S I H Y I T 
1201 CCGTGACAATTTTCTCTTCAACACAAAATTGGTTATCGGGGAATTCATTGTTCCAAAGCAAACAGAAGCTGATGAGACTCAACAAGAACGCGAATTTGCA 1300 
R D N F L F N T K L V I G E F I V P K Q T E A D E T Q Q E R E F A 
1301 ATGTTTACTGAAGATGACATTAACAAGGAACTTACAAGATTAAATGTTCTGAAATTCGTTCCAAAGATCCAGGCGTCCACATCCAATGGTGTTCACGAGG 1400 
M F T E D D I N K E L T R L N V L K F V P K I Q A S T S N G V H E D 
1401 ATGATATCAAAATGTCCAAAATTGAAGAACCCGACGAGCCATTGGATCCATCGGAGCTTAACGATGAATTCACCGAAGAGTTAGTTCATAGTCAGATTAT 1500 
DI KM SKI E E PD E P L D P S EL ND E F TEE L 	H S 	I M 
1501 GTCAAATGGAGTTGATGAATGCAAGATTCGGGAGAGAGAAGCTGATGATCTACTAGTAAATATCAATGATGTTCGGCATCTCCCAGATTTTTCrAGAATT 1600 
S N G V D E C K I R E R E A D D L L V N I N D V R H L P D F S R I 
1601 GGTAATCAATGTCTGAGTTCACAAGGATTCGCTGATGCACTTATGGTTCACGAATTTGTACAAAACTTTGGTCATGTTTTAGGAATAGATCTTGAAATCG 1700 
G N Q C L S S Q G F A D A L M V H E F V Q N F G H V L G I D L E I A 
1701 CCCCAACTAGAGTCGTTATGCGCAGGATTAGTGGAGATGCTAATCACGCCGPGCAPCTCTTCAATTACTAGGCAACTATTAAGACTAGCACTTGA 1800 
P K L E S L C A G L D G D A N H A E Q T L Q L T R Q L L R L A L E 
1801 ATTTCCTGGAATGGGAAATGAGAAAAGATTTGGCCAAGGTGGAGGAGAAATGGGACTTGATCGTGAAAACTTCAGTGAAGTGATGCGTCTTTTTCTTATC 1900 
F P G M G N E K R F G Q G G G E M G L D R E N F S E V M R L F L I 
1901 GACAAAGGAAAGCGAGGAGAAGAATTATCACAGCCTCTGCTTACTTGCAACrTTTTATCGATTTCTCCAGAACAAAAAGCTTCGATTTTAGCATTTCTCT 2000 
D K G K R G E E L S Q P L L T C N F L S I S P E Q K A S I L A F L C 
2001 GCGATGAGCTAGTTTGTTCTCGAAATGTTGTCACTGAGATTGATAAGAACCTTGATGAAATTTCAAGATTAAAAGGAGAAAAATGGATGAGAGAGGGAAA 2100 
D E L V C S R N V V T E I D K N L D E I S R L K G E K W M R E G K 
2101 AGCTAGAGCTTTGAGATCAGCAAGAAGTAAAAAGAAGAATGACGAGAAAGTTGTAGTTGTGAAAGAAGAACAGAATCATGAGAGTGATTCrGAACCTCCA 2200 
A R A L R S A R S K K K N D E K V V V V K E E Q N H E S D S E P P 
2201 ACTAGACCGGATACTCCGAAGAAAGCCACGGTTGCACCTCCAACTGTAGTTTCTGTTTCACCTGTCTCGGCAGCTCAGCAGCAACAACGAAAGTTCACTC 2300 
T R P D T P K K A T V A P P T V V S V S P V S A A Q Q Q Q R K F T P 
2301 CAGGATTAGGCCAGTGCGAGGTTTTAACAGAACAAGAAGAATCAATGAGTCTTCAACAAATGGATTCTCTGATCGGAGATCTTCATCAAGAAGCTCAAAA 2400 
G L G Q C E V L T E Q E E S M S L Q Q M D S L I G D L H Q E A Q N 
2401 CATCAATCAGAAGATTCATGATACTGGTCTCAAGATCCGATCCTTCCCATTCGGAACTGACCGTTTTCATCGAAACrACTGGATGTTGGCTCACACTGAT 2500 
I N Q K I H D T G L K I R S F P F G T D R F H R N Y W M L A H T D 
2501 AAAGTTATCATTGAGTCACTAGCAACAACrTCAGTGAACAACCCAGCCTGCAATGCAAACGAATATGCATCAAAGGATCCACCAACTCrTGAACAGCGTG 2600 
K V I I E S L A T T S V N N P A C N A N E Y A S K D P P T L E Q R V 
2601 TTCCAGGAGCATGTGAGACGATTGACTTAGATGTTATTGCTTGTGTTGAGGATTTGGTTGATGATGTTGTTCTGCTAAGAGCCAAAGCTGATAAGAAAAC 2700 
P G A C E T I D L D V I A C V E D L V D D V V L L R A K A D K K T 
2701 TCGAAAAAGATACACAAGGATTGAAAATCATATGAAGAGAGGATGGTGGACAATGCAGAATAGAGACTGTGTAGAATCCCTTCGTTCTTGTATGCTCAGT 2800 
R KR Y 	RI EN H M K R G W W P M Q N RD C V 	S L R SC ML S 
2801 CGCGGATTCGTGACGTGCTCTTCATCGTCTACTCACTACCTGGTTTCThPATGAACTCAPATTCGGTACAATCACAATCCpACCAGTTCGTGAGA 2900 
R G I R E R A L H R L L T K P W F L N E L K F G T I T I E P V G E K 
2901 AATCCGACCTGGAACTGGTTCGAAGACAAGGATGGACTCGACTAAATACGGCTATCGACAAGCTTCAATGTCATTTGAAAATGTCAGATGTGTCTAAACC 3000 
S D L E L V R R Q G W T R L N T A I D K L Q C H L K M S D V S K P 
3001 ATTGCCTTCTATCACGCCTTTCGAGACCCAGAAGCCTATTGTGGTGCCTCCTACAATGGCATTGGCGCAAATTGTGAAGGACGATATGGCATGGAAGGTT 3100 
L P S IT P F E T Q K P I V V P P T M A L A Q I V K D D M A W K V 
3101 ATAGATGAGGAGGTTGATGGACAAGAACTCGATGAGACTATAATCCGACAAAAAATCATTGAAACAGCGGACATGGTGCAGCCAAAGTTTTGGAGACCCA 3200 
I D E E V D G Q E L D E T I I R Q K I I E T A D M V Q P K F W R P K 
3201 AATTTcAAArGGGGATcAAGATAcATGccAAcTATTTGAGGATTGGAAGTcTTATGTTTcAAcTGpGcAcAAAcAACGPGTcAGTTAATGGTAGC 3300 
F Q K L E D Q D T C Q L F E D W K S Y V S T E A Q T T S Q L M V A 
3301 TCTTCACTCTCGAAGGAATGATTATGTGGGAGATCTCTCGTGAAGCCTTTGTCAGTTTGTAAGAGTATGGATGGAGATGAATGTTGGTTTGT 3400 
L Q T L E G M I M W E R S S R E A L C Q I C K S M D G D E M L V C 
3401 GATGGATGTGAGAGTGGATGCCATATGGAATGTTTTAGGCCCCGAATGACAAAAGTACCTGAAGGTGATTGGTTCTGTCAGCGGTGCCGCGAGGAAAAAT 3500 
DGCEsGCHMEcFRpRMTKvpEGDWFCQRCREEKS 
3501 cTGGAGAccAATGTGcTGTTcTGTAGccGTGAGAcTGGMATcTTcATcGTGTcAAcGcrGTGcATAccATGTTcATcAAGAATGTTcAcAAGATGG 3600 
G R P M C M F C S R E T G N L H Q C Q R C A Y H V H Q E C S Q D G 
3601 CCCAAAAGAGGCrATAAACCCTGAAACATTTATCTGTGGGCATTGTCAAGAAATGAAGCAAATGCGTTTTGTGAAGCGACTCATTCTTCGAAGTGAATCG 3700 
P K E A I N P E T F I C G H C Q E M K Q M R F V K R L I L R S E S 
3701 GAAGAACGAGAATTGGAAGATGATAATCATGCAGAAAATGGAGAGAATACTAAAAATGGTCATATGAATGGAATGAATGGAGCAATTGCAATCGGCGTTC 3800 
E E R E L E D D N H A E N G E N T K N G H M N G M N G A I A I G V H 
3801 ATAATCAPCAAAACGGAGTCAAGGAAPTCTGAAGAGAAAATTGGAGGTTCCAAGTATTGGTGGTCTTCCAMAATATGAATAAGGAGTTGTGTCAACT 3900 
N Q Q N G V K G N L K R K L E V P S I G G L P K N M N K E L C Q L 
3901 CATGTTGGATGAACTCGTCGTCCAAGCAAATGCTTTGCCATTTTTGGAGCCTGTCAATCCAAAATTGGTTCCTGGATATAAAATGATTATTTCAAAACCA 4000 
M L D E L V V Q A N A L P F L E P V N P K L V P G Y K M I I S K P 
4001 ATGGACTTGAAGACAATTCGACAGAAGAATGAGAAACTTATATACGAGACTCCAGAAGATTTTGCTGAAGACATAGAGCTCATGTTCGCCAACTGTCGTC 4100 
M D L K TI R Q K NE K L 	YET P ED FA ED I ELM FAN C 	Q 
4101 AATTCAACATTGATCACTCAGAAATTGGACGTGCTGGAATCAGTTTGCACAAGTTTTTCCAAAAACGTTGGAAGCAGCTGAAATACAACTTTACAAAAAG 4200 
F N I D H S E I G R A G I S L H K F F Q K R W K Q L K Y N F T K R 
4201 ACTCAGACGCCTTCATCGTTAATTTCATGTTTTAATCAATTATCATCTCACCGTAACCGGTTAACrTTTTCTGTTCATAAATACAAAAATCATCCCATTG 4300 
L R R L H R * 
4301 ATGTTCGGGTAGTTATTTAATGTTTTTTATAATTTTGCATATTTGTGCCACATGTACAGTTGTACATTTTCTCTTTTTTAATTTATTTATCAATACCCCA 4400 
4401 TCACATTTCTTTCCGTGACGGATTTCTCATGCTTTGATCTGATTATTTATTGCAATCTTGAAGAAAa&T98LAAATTTTTCAAAACAAAAAAAAAAAAAA 4500 
4501 AAAAAW\AAPAA1A 4518 
3.2.3 Isolation of mPBMI - a mammalian ortholog of C. elegans PBM-1 
Caenorhabditis elegans represents a powerful model system for the elucidation of 
various biological phenomena by the means of molecular genetics (Wood, 1988; 
Epstein and Shakes, 1995). The nematode worm has proven to be particularly useful 
for the isolation of loss-of-function mutants or hypomorphic alleles to aid in the 
elucidation of gene function (Plasterk, 1995) and powerful forward and reverse 
genetics exists in this organism. However, a serious limitation of the worm system is 
that no tissue culture cell lines have been established and it is problematic to isolate 
any homogenous cell type (Krause, 1995). Thus in order to exploit the molecular 
approaches possible with mouse and human cell lines it was necessary to isolate a 
full length murine cDNA sequence encoding a protein homologous to C. elegans 
PBM-1. 
In order to isolate murine cDNAs homologous to C. elegans PBM- 1, the corrected 
full length PBM-1 protein was used to search the dbEST and XREF databases and a 
cluster of murine (and human) ESTs highly homologous to C. elegans PBM- 1 were 
identified. A 1.2kb Mus musculus kidney cDNA clone (519459) exhibited the highest 
probability score P(N) of homology (P< 10-24)  to a central region of the C. elegans 
PBM-1 cDNA and following sequencing and conceptual translation was found to 
contain a small uninterrupted ORF. 
RE 
A mouse brain (pituitary) ?ZAPII cDNA library (a kind gift from Michael Shipston, 
Physiology, University of Edinburgh) was screened with this 1.2kb Mus musculus 
kidney cDNA clone (519459) in order to isolate murine cDNAs homologous to the 
nematode PBM-1 sequence. From 500 000 plaques seven independent positive phage 
clones were identified, re-plated and the screening process repeated until finally five 
pure phage plaques were obtained. The cDNAs present within these phage were 
recovered by in vivo excision of the inserts in pBluescript following co-infection of 
XL 1-Blue E. coil cells with the AZAPII phage clones and a Fl helper phage (R408). 
Re-infection of bacterial cells with this phagemid generated double stranded DNA to 
produce bacterial colonies for plasmid amplification. This in vivo excision procedure 
possesses the distinct advantage that it circumvents the requirement for phage DNA 
purification and subcloning of cDNA inserts. The inserts from these five cDNA 
clones were released by restriction digestion with EcoRI/XhoI and size fractionated 
on agarose gels (see Figure 3.4A). From these five cDNA clones, 519459/B and 
519459/C were the largest spanning 3.6kb. The 519459/A clone was approximately 
2.9kb and clones 519459/D and 51 9459/G were 0.9kb and 0.7kb respectively. These 
clones were sequenced entirely from each end by a primer walking approach using 
sequence cycling using fluorescent dye terminators (Perkin-Elmer). BLAST and 
FASTA searches against peptide sequence databases revealed significant protein 
sequence identity to the C. eiegans PBM-1 protein (P<10-25). 
519459 A 	B 	C 	D 	G 
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Figure 3.4: Isolation and restriction mapping of the mPBMI cDNA clones 
A: Restriction mapping of the 519459 cDNA clones. 
cDNA clones isolated from a mouse brain cDNA library with the 519459 probe were restriction 
digested with EcoRl, Xhol and EcoRl/Xhol and size fractionated on 1% agarose gels. An alternative 
splicing event (+285bp) present within the 519459/C cDNA clone but absent in the 519459/A and 
519459/13 clones is indicated by arrows. 
Molecular weight standards are shown in kilobases. 
B. Restriction map of the mPBM1 cDNA sequence. 
The cDNA clones used to assemble the mPBM1 cDNA contig are presented as lines below the 
restriction map. The dashed lines at the ends of the mZKl 2 and 363697 cDNA clones represents 
the 5' and 3' UTR of the mPBM 1. The cDNA clones are drawn to scale. 
In particular, the largest of these cDNA clones (51 9459/13 and 519459/C) potentially 
encoded a methyl-CpG binding domain (MBD) motif homologous to the MBD motif 
of the C. elegans PBM- 1. However, this cDNA sequence was considered incomplete 
on the basis of a number of considerations. Firstly, conceptual translation of the 
largest of these cDNA clones generated an uninterrupted ORF containing no 
upstream, in-frame terminator codon to allow unambiguous demarcation of the 5' 
limit of the cDNA, raising the possibility that the initiator methionine had not yet 
been identified. Secondly, all the cDNA clones originated from an A-rich region which 
was likely the priming site bound by the oligo-dT primer employed in the 
construction of the cDNA library. Furthermore, these cDNA clones did not contain 
an upstream terminator codon or a downstream polyadenylation signal sequence, 
strongly suggesting that this A-rich region was not the true poly (A) tail. Finally, 
these clones were considered incomplete because no coding sequences for the 3' 
bipartite PHD-zinc finger/bromodomain characteristic of the C. elegans PBM- 1 
cDNA were present. 
In order to identify more 5' and 3' clones to complete this cDNA sequence, 700bp 
fragments from the largest of these cDNA clones (519459/C) were employed as 
probes to re-screen the mouse pituitary AZAPII cDNA library. From this screen, 22 
positive primary AZAPII clones were identified that hybridised strongly to the 5' 
and 3' fragments. These phage cDNA clones were re-plated and the screening process 
repeated until finally 14 ?ZAPII pure phage plaques were obtained. The 14 AZAPII 
clones were in vivo excised, their cDNA inserts released by restriction digestion with 
EcoRI/XhoI and these products size fractionated on agarose gels. These cDNA clones 
were sequenced from each end by sequence cycling using fluorescent dye terminators 
(Perkin-Elmer). Using the sequences from the ends of these cDNA clones and the 
largest of the 519459 clones (519459/13 and 519459/C) a cDNA contig was 
constructed employing DNA analysis software (DNAStar). Of these 14 A.ZAPII 
cDNA clones, seven were identical, six were unique but all were contained within the 
original 519459 clones identified in the original screen. All were derived from the 5' 
end of the cDNA contig with no 3' clones isolated by the 0.7kb 3' fragment of the 
519459 cDNA clone. A single cDNA clone however, XZK12 was found to contain a 
3.2kb cDNA insert that extended 600bp 5' of the 519459 clones. This upstream 
sequence allowed the assembly of a cDNA contig termed ?ZK12/5 19459 (see Figure 
3.413). The ?ZK12 clone was sequenced entirely and conceptual translation of this 
cDNA clone generated an interrupted ORF that contained numerous upstream 
translation terminator codons allowing the cDNA to be defined and the assignment of 
a putative initiator AUG codon to this cDNA. The criteria used to assess the 
completeness of the cDNA sequence and specifically the choice of the initiator 
methionine will be described in section 3.2.4. 
In order to isolate 3' cDNA clones to contig with the 3' end of the 519459 clones, the 
cDNA sequence encoding the C. elegans PBM- 1 PHD-zinc finger/bromodomain 
region was used as a search probe to screen the dbEST and XREF databases. A 
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human retinal EST (363697) was identified that potentially encoded a protein 
containing a bipartite PHD-zinc finger/bromodomain that was highly homologous to 
the extreme C-terminus of the C. elegans PBM- 1 protein (p<10-24).  A 2.2kb 
NotI/EcoRI restriction fragment from the 363697 human EST was employed as a 
heterologous probe to screen the mouse pituitary ?ZAPII cDNA library. From this 
screen, four positive primary murine ?ZAPII phage clones were identified that 
hybridised to the 363697 probe. These phage cDNA clones were re-plated and the 
screening process repeated until pure phage plaques were obtained. Finally, two 
7ZAPII clones (363697/A and 3636971D) were in vivo excised, restriction digested 
and the products sized on agarose gels. Of the clones isolated, 363697/A contained an 
insert of around 3.5kb and the 3636971D clone had a larger cDNA insert of 
approximately 5.0kb. Using the sequences from the ends of the 363697 clones and 
the AZK12/5 19459 cDNA sequence a cDNA contig was constructed. The large 
3636971D cDNA clone extended 4.0kb 3' of the 519459 clones (see Figure 3.4B). 
The 363697/D eDNA clone was partially sequenced by primer walking from the 5' 
end until a downstream TGA translation terminator codon was identified delineating 
the 3' end of the cDNA. The 3'UTR present within the 363697 cDNA clones was 
not sequenced. The XZK12/5 19459/363697 cDNA contig was conceptually 
translated and BLAST and FASTA searches against peptide sequence databases with 
the predicted protein sequence revealed a highly significant homology to the C. 
elegans PBM-1 protein (P<10 79). This murine cDNA was termed mPBM1 for 
murine PHD-zinc finger, Bromodomain and MBD1. 
The XZK12, 519459/A and 363697/D cDNA clones were ligated together to join the 
mPBM1 cDNA (the clones used are shown schematically in Figure 3.4B). A 3.5kb 
)(mal/XhoI 363697/D fragment comprising the 3' end of the mPBM1 cDNA was 
directionally sub-cloned into XmaIfXhoI linearised pBluescript generating a clone 
termed p363697/D. This p363697/D vector was XmaI linearised and a 2.1kb XmaJ 
fragment from the 519459/A cDNA clone, comprising essentially the central region of 
the mPBM1 cDNA was inserted generating a clone termed p519459/363697. Correct 
orientation of the 2.1kb 519459/A fragment in the p363697/D vector was confirmed 
by restriction mapping. Finally, a 2.2kb NotI fragment from AZK12 (corresponding 
to the 5' end of the mPBM1 cDNA) was subcloned into NotI digested 
p519459/363697 generating a construct, pmPBM1. This pmPBM1 construct was 
restriction mapped and sequenced entirely to ensure no mutations were present 
within the sequence. This pmPBM1 construct is the vector employed for PCR-
subcloning to expression constructs described in Chapter 4. 
Figure 3.5: cDNA and amino acid sequence of mPBMI 
The mPBM1 cDNA sequence is 7081 nucleotides in length and contains a 
long open reading frame (ORE), initiated by the putative ATG shown in bold at 
position 411 and terminated by the STOP codon (IGA) at position 6996. The 
presence of upstream terminator codons (*) within the 5' UTR of the mPBMI 
are indicated. 
As described in section 3.2.4, the mPBMI transcript is alternatively spliced 
and three major RNA isoforms of the mPBMI transcript were detected and 
are termed mPBMIa, mPBM1b and mPBMIc (see Figure 3.7). mPBMIa 
splices out a 6bp region at the extreme 5' end of the mPBMI cDNA (at 
nucleotide positions 792-798) and interestingly removes a 285bp region 
(positions 2360-2645) immediately 5' of the MBD. The mPBMIb isoform 
splices out the 6bp and 285bp sequences as in the mPBMIa transcript but 
also removes a 27bp region 3' of the MBD (at positions 3358-3385). Finally, 
the mPBMIc transcript alternatively splices a 66bp sequence adjacent to the 
MBD (cDNA nucleotide positions 3246-3312). The MBD of mPBMI is shown 
in bold. All splice variants are underlined. 
EEO 
1 CATGTTTTGTGPGGGAGAGGTTGTGTTAGGTAATTTTAGGTGTTTCTACACGPGCATTGCAATGCTTGCTTGGCTTGTGTTTTCATTATAGCGCT 100 
101 TGATAPAGAC1TATTGTGACCTcTGGGGTCAGCAGAGCTAGGTACAATAGTAAGTATTCTTTCMGCCTTTCACAGAAAACACCGTGGCTGGCTGTG 200 
201 CAGTGCTGCCTrGrCTGATCGAAGGATAATGGCTACTTCCTGATTAAGCCGGTCCACCGTAJkGCGAGCTCCGTGCTGATGTCTTTCrCCTGCT 300 
301 AACGAGCGAGCGCGTTGCCGCTTGCTTTATTGTGTGTCTGTTTTCATTGATTTTTCTAATAGGAGCTTCTTCAGAGAATAGAAAAGAATGAGTGTAAGTT 400 
* * 
401 ATACACTGATATGGAGTCTGGAGAACTGTTGCCATCCTCACCAGCCTCCrCCACTACACCAACATCATCTTCTGCTCCTTCCGTGGCTTCAGCAGTTTCA 500 
M E S G E L L P S S P A S S T T P T S S S A P S V A S A V S 
501 AAGAGCAGCCTTTCCACAGGAGCTGCTTCACTTAGTTCTACAGCCAGCCCATGTGTACTTGAAGCTGGGAAGTCCAAGATCAAGGTATCACCTGACTcAG 600 
K S S L S T G A A S L S S T A S P C V L E A G K S K I K V S P D S V 
601 TGTCTGGACATTTATTCAGAGCAGCTGGGGATCAGCCGTTTAACCTGTCCACAGTGCCGAGTGCCTTCCCAATGCTCAGCCACCCAGGCTTTGGTCTACA 700 
S G H L F R A A G D Q P F N L S T V P S A F P M L S H P G F G L H 
701 TTCAGCCAGCTCAGGGCATTCAGAATTTGGTGGTTTGGGGACACTTGGTACACCCACAGCCrTAGCCGCACATCCCCAGCTAACATCTTTTCCAGGTGCA 800 
SAS S G H S E F G G L G T L G T P T A L A A H P Q L T S F P G A 
801 GAGTGGTGGCGACCCAGPTGGCCACTCrCGTGCTGGACGCCCTTCTTTCCACCATTACTGGGAATTCCACCP.CTGTTTGCTCCTCCAGCCCAGATC 900 
E W W R T T D G H S R A G T P F F P P L L G I FPLFAPPAQNH 
901 ACGATTCGTCATTCCATTCGAGGACTTCTGGGAAGAGCAGTCGAAATGGTCCTGAGAAAGGTATAAATGGGTCGGTTAATGGAACCAGTGCAGCATCAGT 1000 
D S S F H S R T S G K S S R N G P E K G I N G S V N G T S A A S V 
1001 ACTTGGTGTCAATGCATCTGTAGTAGCCACTCCTGCTTCAAGTTCCATGGGACAGAACCAAAGCACAAGCTCAGGTGGAGGAACCCTAAAATGTCATCAG 1100 
L G V N A S V V A T P A S S S M G Q N Q S T S S G G G T L K C H Q 
1101 GAACAAACAAGCCAGCCTGTGGACGCCAGAGCCGACGAATCAAAGATAGAAACCAAGGPAGAAGGcTATGGAAAGTTCTAGCAACAGTGATAGTG 1200 
E Q N K S Q P V D A R A D R I K D K K P R K K A M E S S S N S D S D 
1201 ACTCAGGCACATCGTCAGACACCTCGAGTGAAGGCATTAGCAGCAGTGACTCAGACGATCTGGAAGAGGAAGAGGAAGAAGATCAAAGCGTGGAGGAGAG 1300 
S G T S S D T S S E G I S S S D S D D L E E E E E E D Q S V E E S 
1301 TGAAGATGACGATTCTGACTCAGAGACTGAAGCACAACACAAAAGTAACAACCAGGTGCTATTACATGGTATTTCAGACCCAAAAACAGATGGACAGAAA 1400 
E D D D S D S E T E A Q H K S N N Q V L L H G I S D P K T D G Q K 
1401 GCAACTGAAAAAGCCCAGGAAAGAAGAACACACCAGCCATTACCTCCTGTGTCTGAGTCCCAGACGCACCCACCATTCCAGTCCCAGCAGAAGCAGCCTC 1500 
A T E K A Q E R R T H Q P L P P V S E S Q T H P P F Q S Q Q K Q P Q 
1501 AGGTTCTCTCACAGCGcTTCCGTTTATTTTCCAGCTCTCAGGCAGGGGAGTCTGTGACCACACACC1GTGTAATACAGTCGACGGGAcTGGT 1600 
V L S Q Q L P F I F Q S S Q A K E E S V T K H T S V I Q S T G L V 
1601 GTCCAATGTGAAACCrTTGTCrTTGGTAAATCAAGCCAAAAAGGAAACTTACAGGAAACTCGTAGTTCCTTCTCCTGATGTACTTAAAGCAGGGAATAAA 1700 
S N V K P L S L V N Q A K K E T Y R K L V V P S P D V L K A G N K 
1701 AATACCTCTGAAGAGTCTAGTTCTTTGACCAGTGAATTGCGATCCAAACGGGAACAATATAAGCAGACATTCCCATCACAAGGAAAGAAACAGGAGATGG 1800 
N T S E E S SSLTSELRSKREQYI<QTFPSQGKKQEMG 
1801 GGAAGAGCCTGAAGAAGGTTATTGCAGCTTTGTCAAATACTAAAGCAACCTCTAGCTCACCAGCACATCCAAAACTACCACTAGATAACAACCACCCTAA 1900 
K S L K K V I A A L S N T K A T S S S PAHPKLFLDNNHPN 
1901 TCCATTTTTGACAAATGCACTTTTAGGGAATCACCAACCAAATGGAGTCATTCAAAGCGTCATTCAAGAAGCTCCGTTAGCACTAACTACCAAAACGAAA 2000 
P F L T N A L L G N H Q P N G V I Q S V I Q E A P L A L T T K T K 
2001 ATGCAGAGTAAGATTACGAAATGTCTCAGTAGCACCCCGTTCTCCTCACCTGTCAATCTGAGCACGAGTGGGAGGAGAGCCCCTGGCAGTCAGACTC 2100 
M Q S K I N E N V S S S T P F S S P V N L S T S G R R A P G S Q T P 
2101 CAGCGCTGCCCTCTGCCTCGCCCATCCTGCACAGCAGTGGGAAGGAAAAGCGGGTCAGCAATGACGCAACCCCGCTCAAAGCGCACCATCACCCCCATCC 2200 
A L P S A S P I L H S S G K E K R V S N D A T P L K A H H H P H P 
2201 GGCGGCAGCGGCCGCGGCCTTGGTGGAACAGTTTAGAGGGACAGATTCAGACGTTCCCAGTAGTAAAGACTCTGAGGACTCAAATGAGGATGAGGAGGAA 2300 
A A A A A A L V E Q F R G T D S D V P S S K D S E D S N E D E E E 
2301 	2400 
H D E E E D E E D D E D D E S D D S Q S E S D S N S Q S D S E G S E 
2401 	 2500 
D D E E K D Q E E S D S D T E G E K P A V N L T Q T S S S A K S P 
2501 	 2600 
PS S L T A H S A P H L H I G S P P G S A P A A L C S E S Q P P A 
2601 TTTCTTGGCATTCLCTTCCAACTCACTTCACTCcACACTcGGTACATCCAAACGAAGPAGAGTGGCAGACGATCAGGAGCTGCGCATCCCTCTGG 2700 
F L G T S S STLTSTPHSGTSKRRRVADDQELRIPLD 
2701 ACTATGGCTGGCGAGGGAGACAAGGGTGAGMACTTTGGTGGGCGCCTTCCAGGAGAAGTTGCATATTATGCCCCGTGTGGGAAGAAGCTGAGGCAGTG 2800 
Y G W 0 R E T RV RN F G G R L PG E V A Y YAP C G K K L R Q C 
2801 CCCTGACATGGTAAAGGGAATGCAGTGGTGTCTTTTGAAAGAAGAGGATGTCATTCCTCGTATCAGGGCAATGGACGGCCGGAGAGGAAGACCACCCAAT 2900 
PD MV K GM Q 	CL L K E ED VIP RI R A M D G RR G R P P N 
2901 CCAGATAGACCCAGAGCAAGAGAGGAATCCAGGATGAAACGCCGGAAGGGTCGCCCTCCCAATGTTGGCAGTGCAGAATTCCTAGATAACACAGATGCAA 3000 
P D R P R A R E E S R M K R R K G R P P N V G S A E F L D N T D A K 
3001 AATTACTAAGGAAACTGCAGGCTCAAGAAATAGCCAGACAAGCAGCACAAATAAAACTTTTGAGAAAACTTCAGAAGCAGGAACAGGCACGGGTTGCCAA 3100 
LLRKLQAQEIARQAAQIKLLRI<LQKQEQARVAK 
3101 AGAAGCTAAAAAACAGCAAGCGATAATGGCTGCGGAAGAGAAGCGCAAACAGAAAGAACAGATGAAGATTATAAAGCAGCAGGAAAAAATTAAGAGAATA 3200 
E A K K Q Q A I M A A E E K R K Q K E Q M K I I K Q Q E K I K R I 
3201 CAGCAAATCAGAATGGAGAAAGAACTGAGAGCTCAGCAGATTCTCGAGGCTAAAAAGAAAAAGAAGGAAGAAGCGGCAAATGCCAAATTATTGGAGGCCG 3300 
Q Q I R M E K E L R A Q Q I L E A K K K K K E E A A N A K L L E A E 
3301 	 3400 
K R T K E K E L R R Q Q A V L L K H Q E L E R H R L D M E R E R R 
3401 GCGGCAGCATGTGATGCTTATGAAAGCTATGGAAGCTCGTAAAAAAGCAGAAGAAAAAGAACGATTGAAGCAAGAGAAACGTGATGAGAAAAGATTGAAT 3500 
R Q H V M L M K A M E A R K K A E E K E R L K Q E K R D E K R L N 
3501 AAGGAACGCAAACTAGAGCAGCGGAGACTGGAGTTAGAAATGGCGAAGGAGCTAAAGAAACCTAAGGAAGACATGTGCTTAGCAGACCAAAAGCCCTTGC 3600 
K E R K L E Q R R L E L E M A K E L K K P K E D M C L A D Q K P L P 
3601 CAcAGTGGCCTCGCATCCCGGGACTTGTGCTCTCTGGAACCAATTTTCAGPICTGTCICATGGTGGTGCAGTTCI'TACGAAACTTTGGTAAAGTTTTGGG 3700 
E W P R I P G L V L S G T T F S D C L M V V Q F L R N F G K V L G 
3701 CTTTGATGTGAATATTGATGTTCCAAACCrCAGTGTTCTTCAAGAGGGATTGCTAAATATAGGGGACAGCATGGGTGAAGTACAAGACrTGCTTGTGAGG 3800 
F D V N I D V P N L S V L Q E G L L N I G D S M G E V Q D L L V R 
3801 CTCCTCTCAGCTGCTGTATGTGATCCAGGTCTAATTACAGGATACAAGGCAAAAACAGCTCTGGGAGAACATTTGCTGAACGTTGGTGTGAATCGAGACA 3900 
L L S A A V C D P G L I T G Y K A K T A L G E H L L N V G V N R D N 
3901 ATGTGTCCGAGGTTTTGCAGATTTTCATGGAGGCCCACTGTGGGCAGACTGAGCrGACTGAGAGCCTGAAGACTAAAGCrTTCCAGGCTCACACTCCAGC 4000 
VSEVLQITMEAHCGQTELTESLKTKAFQAHTPA 
4001 ACAGAAGCGTCCATCCTGGCCTTCCTCGTTACGAGCTGGCTGCAGCAGAGTGTGGTGAGTGAGATTGACAAGAACATTGPATACATGTCTAtCTTG 4100 
6 KAS I L A F L V N E L A C S K S V V S E I D K N I E Y M S N L 
4101 AGAAGAGATAAATGGATGGTGGAAGGTAAACTCCGCAAGCTTAGGATAATTCATGCTAAGAAAACAGGCAAGAGAGACGCCTCAGGGGGCATTGACCTCG 4200 
R R D K W M V E G K L R K L R I I H A K K T G K R D A S G G I D L G 
4201 GGGAAGAACAACACCCCTTGGGCACGCCCACGCCAGGACGCAAGCGGAGAAGGAAGGGAGGGGACAGTGATTATGACGATGATGACGATGATGACAGCGA 4300 
E E Q H P L G T P T P G R K R R R K G G D S D Y D D D D D D D S D 
4301 	 4400 
DOADE D E E D E E D K D D K K G K K T DICE DE DE G DOT 
4401 GCCAGCGTTGAGGAGCTAGAAAAACAGATTGAAAAACrGAGCAAACAACAGAGCCAGTACAGACGAAAGCTCTTTGATGCTTCTCACTCACTACGCTCGA 4500 
A S V E E L E K Q I E K L S K Q Q S Q Y R R K L F D A S H S L R S M 
4501 TGATGTTTGGTCAGGATCGGTACCGACGCAGATACTGGATTCTCCCTCAATGTGGAGGGATTTTTGTAGAAGGCATGGAAAGTGGTGAAGGCCTAGAAGA 4600 
M F G Q D R Y R R R Y W I L P Q C G G I F V E G M E S G E G L E E 
4601 AATTGCAAAAGAAAAAGAAAAGCTTAAAAAGGCAGAGAGTCTCCAGATCAAAGAAGAAGTATTTGAGACTTCTGCGGAGACATTAAACTGTTCCATTAGA 4700 
I A K E K E K L K K A E S L Q I K E E V F E T S A E T L N C S I  
4701 GATCACTGCGAGCAGAAAGACGACCCAAAAGAGAAAGATAACACAAATCTATTTCTTCAGAAACCAGGCTCTTTCTCCAAGTTAAGCAAGCTTTTAGAGG 4800 
D H C E Q K D D P K E K D N T N L F L Q K P G S F S K L S K L L E V 
4801 TAGCAAATGCCTCCTGGTCAGATGTTATGACCCCCCCAAAGTCAATGTTAGTACAAACGGGGGCCC1CTGTCTCATCAGAACAGCGGGAAGC.TCC 4900 
A K M P P E S D V M T P P K V N V S T N G G P L S H Q N S G K H P 
4901 ACTGGGGAGCGTTCCCTCAGCAACAACAGCACAAAGCCCCGTGGGAAAGACAGACGCCAGTCrCTTTAGCTCAGGCTCCGGCAGTTGTGGGAAGTTCTAC 5000 
L G S V P S A T T A Q S P V G K T D A S L F S S G S G S C G K F Y 
5001 AGTCCTCTCCCCAATGACCAGCTGTTAAAAACACTGACTGAAAAGAACAGACAGTGGTTTAGCCTTTTGCCAAAAACACCTTGCGATGACACGTCCCTGA 5100 
S P L P N D Q L L K T L T E K N R Q W F S L L P K T P C D D T S L T 
5101 CCCACGCTGACCTGTCCACCACTCrGGTGACTCCTCAGTCTCAGCCACCATCTAAGTCACCTTCGCCGGCCCCAGCTGCACTGCTCGGACCCTCTTCTGT 5200 
H A D L S T T L V T P Q S Q P P S K S P S P A P A A L L G P S S  
5201 TCGpGCCCCCCTGGCTGAACCCGTTTGCTcTGTCGCCTCTTCAGGTGMAGGTGGTGTGTCTATGATGGGACTTCAGTTCTGTGGGTGGCcrGCTGGA 5300 
OSPPGLNPFALSPLQVKGGVSMMGLQFCGWPAG 
5301 GTGCTCGCTTCCAACGTCCCATTTACATCACCrTTGCCTGCTCTCGGCTCAGGGTTGGGACTGCCAGAAGGAAATGGCAGTAGTTCATTCTTGACTTCCA 5400 
V L A S N V P F T S P L P A L G S G L G L P E G N G S S S F L T S S 
5401 GTGTTGCTTCAAGTAAAAGTGACTCTCCAGTCCCTCCAGCTGAAAGACCCTCCAGCGCTCAGCCAGTGGCTGTTGAAGTAGCAAAGCCAGTAGATTTTCC 5500 
VASSKSDSPVPPAERPSSAQPVAVEVAI<PVDFP 
5501 TAGTCCCACCTATCCCAGAAGAAATGCAGTTCGGATGGTGGAGAATCTTGACCCCGAGGACCTGAAGACATTGCTCAPAGTGCTGCACCTCCGCGGG 5600 
S P K P I P E E M Q F G W W R I I D P E D L K T L L K V L H L R G 
5601 ATCCGGGAAAAGGCATTGCAAAAGCAAATTCAGAAACACTTGGATTACATTACCCAAGCCTGTGTCAGGAACAAGGACGTCGCTATTATTGAATTAAACG 5700 
I R E K A L Q K Q I Q K H L D Y I T Q A C V R N K D V A I I E L N E 
5701 AAAATGAAGACAATCAGGTAACCCGCGATCTAGTGGAGAACTGGTCGGTCGAAAAGCAAGCAATGGAGCTGGACCTGAGCATACTCCAGCAGGTGGAGGA 5800 
N E D N Q V T R D L V E N W S V E K Q A M E L D L S I L Q Q V E D 
5801 CTTGGAACGGAGGGTTGCATCAGCGAGTTTGCAAGTGAAGGGTTGGATGTGTCCAGAGCCTGCATCGGAAAGGGAGGACrTGGTATATTTTGAACATAAG 5900 
L E R R V A S A S L Q V K G W M C P E P A S E R E D L V Y F E H K 
5901 TCACTTACTAAGTTGTTCAAGGAGCATGATGGAGAACTTACTGGTGACGAAGAAAACAGTGCGCATGCACTGGCTCGGAAGAGTGACAACCCCCTAGATA 6000 
S L T K L F K E H D G E L T G D E E N S A H A L A R K S D N P L D I 
6001 TAGCTGTAACCAGGCTGGCTGATTTGGAGCGGAACATTGAGAGAAGGTATCTGAAGAGCCCCTTAAGTACCACCATTCAGATCAAACTGGATAATGTGGG 6100 
A V T R L A D L E R N I E R R Y L K S P L S T T I Q I K L D N V G 
6101 CACAGTTACTGTCCCTGCTCCTGCACCATCCATTAGTGGTGATGGTGACGGAATTGAAGATATTGCTCCAGGGCTCAGGGTCrGGAG1AGGGCCTTA 6200 
T V T V P A P A P S I S G D G D G I E E D I A P G L R V W R R A L 
6201 GCAGAAGCTCGCAGTGCTGCGCAGGTAGCCCTGTGCATCCAGCAGTTACAGAGATCAATAGCATGGGAAAAATCAATTATGAAAGTTTACTGCCAGATCT 6300 
A E A R S A A Q V A L C I Q Q L Q R S I A W E K S I M K V Y C Q I C 
6301 GTCGGAAGGGCGACAATGAAGAGCTGCTTCTACTCTGCGACGGCTGTGACAAAGGCTGCCACACCTACrGCCACAGGCCCAAGATTACAACTATCCCCGA 6400 
R K G D N E E L L L L C D G C D K G C H T Y C H R P K I T T I PD 
6401 TGGGGACTGGTTTTGCCCAGCTTGCATCTCTAAAGCAAGCGGCCAGAGTATAAAAATTAAAAAAATTCATGTCAAAGGAAAAAAGACAAATGATTCCAAG 6500 
G D W F C P A C I S K A S G Q S I K I K K I H V K G K K T N D S K 
6501 AAAACCAAGAAAGGAAACGTCGCCGGGGACACAGAGGATGAAGACTCGGCTTCCACAAGCAGCTCCCTCAAGAGAGGAAGCAAAGAGCTCAAAAAGAGGA 6600 
K T K K G N V A G D T E D E D S A S T S S S L K R G S K E L K K R K 
6601 AAATGGAGGAAACCACTTCCCTCAACCTGTCAAAAGCAGAAAGCACCACCTCCATTAAGAAACCCAAAAAAGATGAGTCCAGGGACCTGGCTCTCTGCAG 6700 
M E E T T S L N L S K A E S T T S I K K P K K D E S R D L A L C S 
6701 TATGATCCTGACrGAAATGGAGACACATGAGGACTCCTGGCCTTTCCTGCTTCCrGTGAACTTGAAACrCGTACCCGGCTATAAGAAGGTTATCAAGAAA 6800 
MI L T E M E T H E D S W P F L L P V N L K L V P G Y K K V I K K 
6801 CCTATGGATTTTTCTACAATTAGAGAAAAACTAAATAATGGACAGTATCCCAACTTTGAGACCTTTGCrCTAGACGTCAGGCTTGTTTTTGACAAC7rGTG 6900 
P M D F S T I R E K L N N G Q Y P N F E T F A L D V R L V F D N C E 
6901 AAACATTTAATGAAGATGACTCGGACATAGGCAGAGCTGGCCACAGTATGCGAAAATACTTTGAAAAAAAGTGGACAGATACCTTCAAAGTGAGCTGAAG 7000 
T F N E DD SD I G R A G H S M R K Y FE K K W T DT F K V S 
7001 TTGTATCTCCTTTTTCTCCrTTTTCCTTTTAACAAGGACAAACAAGACCAGCGGTGTTGAACrGCATTCACACAGATGT 7081 
3.2.4 Structure and splice variants of the mPBMI cDNA 
The cDNA sequence derived by alignment of the XZK12, p5 19459 and 363697 
clones is 7081 nucleotides in length and contains a long open reading frame (see 
Figure 3.5 for mPBM1 cDNA and amino acid sequences). Kozak has defined the 
optimal initiator methionine consensus sequence for translation, in vertebrate 
mRNAs as GCCACCAUGG (Kozak, 1986, 1987) and it has been demonstrated that 
two positions are highly conserved : a purine (normally A) at position -3 and a G at 
+4 (where A of AUG is +1). The ATG at position 411 of the mPBM1 cDNA was 
chosen as the initiator methionine codon for the conceptual translation for a number 
of reasons. Firstly, the putative initiator methionine codon at position 411 of the 
mPBM1 cDNA sequence conforms to the R 3 (R=purine) and G 4 consensus for 
translational initiation described above. Secondly, numerous upstream terminator 
codon are evident within the 5'UTR of the mPBM1 eDNA and the ATG at position 
411 represents the first in-frame methionine codon. However, in order to determine 
whether a eDNA sequence is complete, a favourable context for initiation around a 
potential ATG start codon and the presence of an upstream, in-frame stop codon are 
insufficient grounds for the assignment of an initiator methionine. Kozak (1996) has 
pointed out the presence of these two positive indicators cannot represent the sole 
criteria for assessing the completeness of a new cDNA sequence and the absence of 
certain negative indicators is also required. For example, an upstream out of frame 
start codon that generates a reading frame that overlaps the major open reading frame, 
strongly suggests that an error in sequencing of the cDNA may have occurred. Within 
97 
the mPBM1 5'UTR, no open reading frames are evident upstream of the putative 
methionine at position 411 and furthermore the out of frame ATG codons are not in 
favourable contexts for translational initiaion. Whilst these indicators suggest the 
ATG codon at position 411 is the initiator methionine codon, to unambiguously map 
the 5' terminus of the mPBM1 message primer extension analysis would need to be 
carried out. 
RT-PCR analysis was carried out on cDNA generated from total RNA from a range 
of mouse tissues and cell lines to ascertain the expression pattern of the mPBM1 
transcript. Figure 3.6 shows the results of this expression analysis of mPBM1 
following Southern blotting and hybridisation with an internal labeled oligonucleotide 
specific to the mPBM1 transcript. mRNA transcripts of the correct size that 
hybridise to an internal oligomer were detectable in all tissues and cell lines analysed 
but were not present in preparations where no reverse transcriptase was added. 
These were confirmed to be mPBM1 transcripts by direct sequencing of DNA 
fragments. These results taken together with the widespread origin of ESTs derived 
from the mPBM1 cDNA suggest a ubiquitous pattern of expression for mPBM1. 
During the isolation, restriction mapping and sequencing of the mPBM1 cDNA 
clones, a series of alternatively spliced isoforms of the mPBM1 transcript were 
identified. Figure 3.5 shows the positions of the splice variants within the mPBM1 
cDNA and the amino acids encoded by these splicing events. The predicted structure 
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Figure 3.6 : Analysis of mPBM1 expression in murine tissues and cell lines 
Southern blot hybridisation following RT-PCR analysis from cDNA prepared from 
kidney, brain, liver, testis, L929 fibroblasts and undifferentiated embryonic stem 
(ES) cells. Results are presented as an autoradiograph following hybridisation with 
an internal labeled mPBM1-specific oligonucleotide. A 3-actin positive control was 
performed on the same cDNA samples and hybridised to an internal labeled -actin 
-specific oligonucleotide. 
zZKEXP/F 	 : 5'-CGTTAACGAGCTGGCATGCAGC-3' 
mZKEXPIR : 5'-ATCATCGTCATAATCACTGTCC-3' 
mZKEXP-INT 	 : 5'-AGCTrAGGATAATTCATGCT-3' 
MU SBETA-ACTI N/F 	: 5'-ACACCTTCTACAATGAGCTGCG-3' 
MUSBETA-ACTIN/R : 5'-AGAGCATAGCCCTCGTAGATGG-3' 
MUSBETAACTI N-I NT 	: 5'-AGCCATGTACGTAGCCATCC-3' 
- and + denotes no addition or addition of reverse transcriptase during preparation 
of the cDNA. 
of the proteins encoded by these alternative splicing events is diagrammed in Figure 
3.7. Three major RNA isoforms of the mPBM1 transcript were detected and are 
termed mPBM1a, mPBM1b and mPBM1c. mPBM1a splices out a 6bp region at the 
extreme 5' end of the mPBM1 cDNA (at nucleotide positions 792-798) and 
interestingly removes a 285bp region (positions 2360-2645) immediately 5' of the 
MBD. The mPBM1b isoform splices out the 6bp and 285bp sequences as in the 
mPBM1a transcript but also removes a 27bp region 3' of the MBD (nucleotide 
positions 3358-3385). Finally, the mPBM1c transcript alternatively splices a 66bp 
sequence adjacent to the MBD (cDNA nucleotide 3246-3312) (see Figure 3.5). 
It was of interest to determine whether spliced and unspliced mRNAs corresponding 
to the 285bp event adjacent to the MBD of mPBM1 are detectable in murine tissues 
or cultured cells given the proximity of the alternative splicing event to the MBD. 
RT-PCR analysis using primers flanking the predicted site of the 285bp splicing 
event were used to amplify transcripts from a range of somatic and mouse cell line 
cDNAs (see Figure 3.7C). Southern blot hybridisation with an internal labelled 
oligomer specific to the mPBM1 transcript, the amplification of products of the 
predicted size and the direct sequencing of these fragments confirmed the 285bp 
alternative splicing events in the mPBM1 isoforms. Furthermore, the identification of 
both spliced and unspliced versions of the mPBM1 transcripts from independent 
cDNA clones strongly suggests these represent genuine alternative splicing events 
and are not simply artefacts generated during construction of the cDNA library from 
100 
Figure 3.7: Structure and expression of alternative splicing events in mPBMI 
Alignment of the mPBMIa, mPBMIb and mPBMIc splice variants 
Alternative splicing events are indicated by diagonal lines below the protein 
isoforms. The scale bar at the top of the diagram corresponds to amino 
acid positions numbered from the N-terminus. 
Alternative splicing events within the mPBMI cDNA 
mPBMIa splices out a 6bp region at the extreme 5' end of the mPBMI 
cDNA (at cDNA nucleotide positions 792-798) and interestingly removes a 
285bp region (positions 2360-2645) immediately 5' of the MBD. The 
mPBMIb isoform contains the 6bp and 285bp alternative splicing events 
seen in the mPBMIa transcript and also removes a 27bp region 3' of the 
MBD (at positions 3358-3385). Finally, the mPBMIc transcript alternatively 
splices out a 66bp sequence adjacent to the MBD (positions 3246-3312). 
RT-PCR analysis of the mPBM1 285bp splice isoform in murine tissues 
and cell lines 
Southern blot hybridisation with a probe specific to mPBM1 following RT-
PCR analysis from cDNA prepared from kidney, brain, liver, testis, L929 
fibroblasts and undifferentiated embryonic stem (ES) cells using mPBMI 
primers flanking the predicted 285bp splice site (mPBM1 +285/F and 
mPBMI +285/R). Results are presented as an autoradiograph following 
hybridisation with an internal 32  P-labeled mPBM1-specific oligonucleotide 
(mPBMI-INT). Spliced and unspliced isoforms of mPBMI are detectable in 
all cases. 
- and + denotes no addition or addition of reverse transcriptase during 
preparation of the cDNA. 
mPBMI +285/F 	5'-TGAAGAGGATGATGAAGATGATGAG-3' 
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which they were isolated. In order to unambiguously demonstrate that these mPBM 1 
isoforms were attributable to alternative splicing events, genomic clones need to be 
isolated and the splice donor and splice acceptor consensus sequences identified. 
The functional significance of these alternative splice isoforms is unknown but 
interestingly three of these splicing events are located either immediately 5' or 3' of 
the MBD of mPBM1. Bickmore et al., (1992) have demonstrated that the DNA-
binding properties of the WTI transcription factor are modulated by alternative 
splicing events within a zinc finger region of this protein. The DNA binding domains 
encoded by these different RNA species of WTI were found to possess distinct 
affinities for DNA sequences in vitro and also conceivably for downstream 
physiologic targets in vivo. Simliar findings have been reported for the DNA-binding 
proteins E12 and E47, products of alternative splicing events of the E2A gene that 
possess distinct affinities for sequence elements in vitro (Sun and Baltimore, 1991). 
3.2.5 Identification of a family of mammalian PBM proteins 
As described in section 3.2.3 a human EST (363697) was successfully employed as a 
heterologous probe to isolate cDNA clones spanning the 3' end of the mPBM1 
cDNA. This human cDNA clone was employed as a cross-species probe because it 
encoded a PHD-zinc finger and bromodomain motif highly homologous to the C. 
elegans PBM-1 cDNA sequence (P<10 24). It is important to note that this human 
cDNA clone contained significant sequence identity outside these conserved regions 
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to the C. elegans PBM-1 sequence because as the PHD-zinc finger and bromodomain 
motifs are present in many other eukaryotic proteins the presence of a bipartite 
PHD-zinc finger/bromodomain motif per se in a EST would not be sufficient grounds 
for justifying relatedness to the nematode protein. Furthermore, a cluster of human 
ESTs that contig with the 363697 human cDNA clone were identified by searching 
dbEST, XREF and Unigene databases (http://www.ncbi.nlm.nih.gov/Schuler/Unigene)  
and a partial cDNA sequence was assembled and is referred to as hPBM1 for human 
PHD-zinc finger, Bromodomain and MBD1. 
A human cDNA sequence (KJAA03 14), that is importantly distinct from the 
hPBM1 cDNA described above, has been deposited in GenBank (Accession No. 
AB0023 12) that potentially encoded an additional PHD-zinc fmger/bromodomain-
containing protein with a highly significant sequence identity to the C. elegans PBM-
1 protein (P<10 37). This cDNA sequence was as a result termed hPBM2 to 
distinguish it from hPBM1 described above. 
To determine whether a hPBM2 homolog existed in the mouse, primers specific to 
the hPBM2 cDNA were employed to amplify a 780bp fragment corresponding to 
the PHD zinc fmger/bromodomain region from HeLa cDNA: 
KTAA03 1 4F: 5' -TTCGTGTCTGGCGCCAGACCC-3' 
KIAA03 1 4R: 5' -TTCCCTGATAAAACTCCTCCC-3' 
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This 0.7kb fragment was used to screen the mouse pituitary AZAPII cDNA library. 
From this screen seven pure phage plaques were identified, in vivo excised, restriction 
digested and the fragments sized on agarose gels. These cDNA clones were sequenced 
from each end by sequence cycling using fluorescent dye terminators (Perkin-Elmer). 
The largest of these clones (?105) contained a 2.5kb cDNA insert and was sequenced 
entirely. Conceptual translation of this partial 2105 eDNA and BLAST and PASTA 
searches against peptide sequence databases revealed a highly significant protein 
sequence identity to the predicted protein product from the hPBM2 (KIAA03 14) 
partial cDNA sequence and the C. elegans PBM-1 protein (P<10 -41 ). This ?105 
murine cDNA is termed mPBM2 for murine PHD-zinc finger, Bromodomain and 
MBD2 to distinguish it from the mPBM1 cDNA. 
An alignment of the predicted protein products from the complete cDNAs from C. 
elegans PBM-1 and mPBM1 and from the partial cDNA sequences for hPBM1, 
mPBM2 and hPBM2 cDNAs is shown in Figure 3.8. The PHD-zinc finger motifs of 
C. elegans PBM-1, mPBM1, mPBM2, hPBM1 and hPBM2 and related PHD-zinc 
finger proteins is presented in Figure 3.9. The bromodomains of C. elegans PBM-1, 
mPBM1, mPBM2, hPBM1 and hPBM2 and the related bromodomains of yeast 
GCN5 and the human PCAF proteins are presented in Figure 3.10. These findings 
suggest the possible existence of a gene family in vertebrates, with two human and 
mouse genes encoding proteins highly homologous to the C. elegans PBM- 1 protein, 
the product of a single gene extant in the sequenced genome of this invertebrate. 
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Figure 3.8 : Alignment of the PBM proteins from nematode and mammals 
The relative protein lengths are drawn to scale. Amino acid sequences were determined from either full or 
partial cDNA sequences. The percentage amino acid identities are indicated. The scale bar at the top of 
the diagram corresponds to amino acid positions numbered from the N-terminus. 
Figure 3.9: Sequence comparision of the PHD-zinc finger motifs (C4HC3) 
of the PBM proteins with PHD-zinc finger containing proteins 
Protein sequence homology was identified by BLASTp database searches. 
The shaded residues represent amino acid sequence identity or presence 
of similar amino acids in greater than 50% of cases. The PHD (plant 
homeodomain) zinc finger, also termed TTC (trithorax consensus) and LAP 
(leukaemia-associated-protein) is present in known or suspected 
chromatin-associated proteins and is thought to represent a protein-protein 
interaction motif (Aasland et al., 1995). The PHD-zinc finger proteins in the 
alignment are grouped according to the degree of sequence conservation 
of the non-zinc co-ordinating residues. 
hWTSF is a putative transcription factor deleted in Williams syndrome; 
hMOZ is the monocytic leukaemia zinc finger protein; hSMCX escapes X-
chromosome inactivation and hSMCY is the pseudoautosomal homolog; 
RBBP2 is a retinoblatoma-binding protein; AIRE is a putative transcriptional 
regulator mutated in the autoimmune disorder APECED; Mi-2 is a 
component of the NuRD nucleosome remodeling and histone deacetylase 
complex (Mi-2a and Mi2b are the two PHD fingers of the protein); 
KAP1(TlF1) is a transcriptional co-repressor which like TlFla can interact 
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Figure 3.10: Sequence comparision of the PBM bromodomains 
Homology alignment of the bromodomains from the C. elegans 
pbm-1 and mammalian proteins with the yeast GCN5 and human 
PCAF sequences. Shaded residues represent amino acid sequence 
identities or conservative substitutions in greater than 50% of cases. 
Figure 3.11 Sequence alignment of the mPBM1 and hPBMI proteins 
Shaded residues represent amino acid sequence identities or conservative 
substitutions events. The mPBM1 protein is derived from a complete cDNA 
whereas the hPBM1 sequence was obtained from a partial cDNA clone. 
The 35 amino acid insertion event between residues 1879 and 1914 in the 
mPBMI protein may correspond to an unidentified splice isoform. 
Interestingly, it is immediately adjacent to the PHD-zinc finger region 
(amino acids 1961-2004) and the bromodomain motifs (2098-2191). 
The PBM1 proteins are highly homologous to one another within their PHD-
zinc finger and bromodomain regions and also crucially contain high 
sequence identity outside these regions not present in the related PHD-
zinc finger, bromodomain and PHD-zinc finger/bromodomain-containing 
proteins. Database searches with mPBM1 and hPBM1 revealed highly 
significant sequence identity to the C. elegans PBM-1 protein and slightly 
more limited sequence identity to the mPBM2 and hPBM2 proteins. 
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Figure 3.12 Sequence alignment of the mPBM2 and hPBM2 proteins 
Shaded residues represent amino acid sequence identities or conservative 
substitution events. The mPBM2 and hPBM2 protein sequences are 
derived from partial cDNA clones. They are highly homologous within their 
PHD-zinc finger and bromodomain regions but also importantly contain 
sequence identity outwith these regions that are not conserved in related 
proteins. 
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3.2.6 Construction of bacterial expression vectors and the purification of 
PBM-1, mPBMI and MBD4 MBDs 
The N-terminal MBD of the C. elegans PBM-1 and murine PBM1 proteins are 
homologous to the MBDs of known methyl-CpG binding proteins (see Figure 3.13). 
In order to determine whether these motifs were capable of binding specifically to 
methylated template, a set of expression vectors were constructed encoding the 
MBDs of the C. elegans PBM-1 and mouse PBM1 proteins. These vectors were 
expressed in E. coil as recombinant proteins, affinity purified and tested for their 
ability to associate with methylated and unmethylated probes in a series of in vitro 
binding assays. Nan et al., (1993, 1996) have previously demonstrated that an 80 
amino acid N-terminal region of MeCP2, the MBD is required for the specific 
association with methylated sites in vitro and in vivo. Furthermore, this minimal 
domain expressed as a fusion protein can discriminate methylated and unmethylated 
templates in a directly analogous fashion to the full length protein. 
In order to express the MBD of C. elegans PBM-1 and mouse PBM1 as recombinant 
proteins, the cDNAs encoding these motifs were subcloned into a bacterial 
expression vector, pGEH. This expression construct contains the cDNA encoding 
glutathione-S-transferase (GST) upstream of a multiple cloning site and a 
downstream sequence coding for six histidine residues, allowing protein purification 
by either glutathione-Sephadex beads or by nickel ion affinity chromatography. A 
41 2bp cDNA product encoding the MBD of C. elegans PBM- 1 and a 543bp cDNA 
product encoding the MBD of the mPBM 1 protein were amplified by PCR so as to 
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incorporate 5' BamHI and 3' MfeI sites for subcloning to a BamHI/EcoRI linearised 
pGEH expression vector to generate the expression constructs, pGEH-PBM- 1 -MBD 
and pGEH-mPBM 1 -MBD respectively: 
BamHI-PBM- 1 MBD/F : 5' -GCACTCGGATCCAAAGTGCTTGCAGCTCACC-3' 
MfeI-PBM- 1 MBD/R 	: 5' -CGAATTCAATTGCATTTAATCTTGTAAGTTCC-3' 
BamHI-mPBM 1 MBD/F : 5' -AGTCTCGGATCCCACTCAGCACCTCAccTc-.3' 
MfeI-mPBM 1 MBDIR : 5' -TTGTGCAATTGGTCTGGCTATTTCTTGAGC-3' 
These expression constructs were sequenced to ensure that the PBM-1 and mPBM1 
cDNAs were subcloned in-frame and that no mutations were present. These vectors 
were electrotransformed into E. coli BL21 (DE3) pLysS, grown in LB media until 
0D600 was 0.4 and protein expression was induced with 0.4mM isopropylthio-3-D-
galactosidase (IPTG) at for 3 hrs. Upon induction, these pGEH expression 
constructs would generate a recombinant fusion protein with a glutathione S-
transferase (GST) tagged N-termini fused in-frame to the MBD and a C-terminal tag 
of six histidine residues. The induced bacterial pellets were resuspended in a high salt 
buffer (300mM NaCl) containing protease inhibitors and the cells were lysed by 
sonication. These extracts were then passed over a nickel agarose column (Qiagen) 
then washed extensively with a buffer containing Triton-X-100 (0.1%) and the 
histidine analog, imidazole (20mM) to minimise non-specific protein adsorption. The 
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Figure 3.13 Sequence comparision of the MBD protein family 
Amino acid sequence alignment of the MBD regions from C. elegans PBM-
1, mouse PBMI and a human EST (593380) highly homologous to 
mPBMI. The MBDs of mouse and human MeCP2, MBD 1, MBD2, MBD4 
and MBD4 and plant and invertebrate MBD-containing proteins are 
included. The numbering scheme above the diagram is according to the 
MBD of MeCP2. 
An NMR solution structure exists for the MBD of MeCP2 (Wakefield et al, 
1999). Tyr123 and the adjacent charged residues Argill, Asp121 and 
Arg133 nearby are thought to be involved in making contact with m 5CpG. 
The high proportion of basically charged amino acids (R, K) flanking the 
central tyrosine residue at position 123 is consistent with the MBD motif 
associating with m 5CpGs in a variety of sequence contexts where the 
flanking positively charged residues could potentially mediate electrostatic 
interactions with the negatively charged phosphodiester backbone of DNA. 
This Tyr 123 is absent in the C. e!egans PBM-1, mPBMI and the human 
EST 593380 strongly supporting the in vitro and in vivo findings that the 
MBDs from these proteins are non-functional. 
II represents the location of a conserved intron within the MBD of the 
mammalian MBDI-4 and MeCP2 genes. This intron position is not 
conserved within the MBD of the nematode pbm-1 gene which contains an 
intron situated at III location (see Table 3.1). Furthermore, during the 
mapping of the hPBMI gene primers specific to the 593380 human EST 
which encodes an MBD highly homologous to the mPBMI identified an 
intron at the position indicated by I (see Figure 5.2). 
Species are indicated in the domain names as : Hs, human; Mm, mouse; 
Ce, Caenorhabditis elegans; Zm, maize; Os, rice; At Arabidopsis thaliana; 
Am, snapdragon; Dr, Zebrafish; Bf, Amphioxus; Ad, cricket; Dv, Drosophila 













































C-terminal histidine tagged GST-PBM-1-MBD-6H and GST-mPBM1-MBD-6H 
domains were eluted from the resin with O.4M imidazole and aliquots from fractions 
were analysed by SDS-PAGE. The recombinant proteins were well expressed and 
readily detectable by Coomassie Blue dye staining. The size of the protein bands are 
in agreement with the predicted molecular weights of GST-PBM-l-MBD-6H 
(42.3kDa) (see Figure 3.14A) and GST-mPBM1-MBD-6H domains (46.9kDa). 
The 5' end of the MBD of mPBM1 is alternatively spliced in the mPBM1c isoform 
(see Figure 3.7). To test whether the presence or absence of this alternatively spliced 
region influences the MBD of mPBM 1 in the recognition of DNA this minimal MBD 
was expressed in bacteria as a GST-fusion either containing or not the 95 amino acids 
encoded by the 285bp mPBM1c splice isoform. A 286bp cDNA encoding the 
minimal MBD of mPBMI and a 616bp cDNA fragment encoding the MBD plus the 
285bp splice variant present in the mPBM1c isoform were PCR amplified with 
oligonucleotides containing 5' BamHI and 3' EcoRl sites. These fragments were 
restriction digested and ligated to Bami-il/EcoRI linearised pGEH expression vector 
to generate the expression constructs pGEH(-285)mPBM1-MBD and 
pGEH(+285)mPBM1 -MBD: 
m2Kl-2851F 	: 5'-c3GTACAGGATCCCGAAGAAGAGTGGCAGAC-3' 
m2K 1 -285/R 5' -TGGATTGAATTCTTGCTCTGGGTCTATCTG-3' 
+28 5BP-m2K 1MB : 5' -GATGAAGGATCCGATGAAGATGATGAGTC-3' 
ill 
Figure 3.14: Purification of recombinant proteins by affinity chromatography 
Purification of the GST-PBM-1-MBD-6H 
BL21 (DE3)pLysS bacteria containing the pGEH-PBM-1 -MBD construct were 
grown to OD600 of 0.4 and induced with 0.4mM IPTG for 3 hours. Extracts 
from these cells were passed over a nickel agarose column to adsorb the 
C-terminal histidine tagged-PBM-1 protein. T is total proteins loaded onto 
the column and FT is the flow through from the column during washing 
steps to remove non-specifically bound proteins. Fl, F2 and F3 are 
fractions one to three eluting from the column following addition of 0.4M 
imidazole. Aliquots were separated on 10% polyacrylamide gels. A band of 
the predicted size of GST-PBM-1-MBD-6H (42.3kDa) is indicated. 
Purification of 1. the GST-mMBD4-MBD-6H 2. GST-(+95)mPBM1-MBD-
6H and 3. GST-(-95)mPBM1-MBD-6H. 
Bacterial cells containing the pGEH-PBM4-MBD plasmid were grown 
until the OD600 was 0.4 and protein expression was induced with 0.4mM 
IPTG at 370C for 3 hrs. Bacterial extracts were incubated with GSH-
Sepharose beads to bind the GST-tagged mMBD4-MBD, washed 
extensively to remove non-specifically bound proteins and finally eluted by 
addition of 15 mM reduced glutathione (rGSH). Fl and F2 are fractions 1 
and 2 collected following final elution. Aliquots from these fractions were 
analysed by SDS-PAGE. A band in agreement with the expected size of 
37kDa for the GST-mMBD4-MBD-6H is indicated. 
Bacteria were transformed with pGEH(+285)mPBM1-MBD to overexpress 
the mPBMI-MBD containing the 95 amino acid N-terminal splice variant 
encoded by the mPBM1c isofrom (see section 3.2.4). Extracts from these 
cells were treated exactly as in Figure 3.15A. Fractions 1 and 2 contained a 
band of the predicted size for the GST-(+95)mPBMI-MBD-6H fusion protein, 
49.lkDa. 
Bacteria transformed with pGEH(-285)mPBMI-MBD were treated as in 
Figure 3.14 A above for purification of GST-(-95)mPBM1-MBD-6H. Fractions 
1 and 2 contained a band of the predicted size of 37.9kDa. 
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These constructs were electrotransformed into E. coli BL2I (DE3) pLysS, grown in 
LB media until 0D600 was 0.4 and protein expression was induced with 0.4mM 
IPTG at 370C for 3 hrs. The recombinant proteins were purified by nickel agarose 
(Qiagen) as described previously and were analysed by SDS-PAGE. The recombinant 
proteins were expressed well as judged by Coomassie blue staining and the size of the 
protein bands agree with the predicted molecular weights of the GST-(-95)mPBMI-
MBD-6H (37.9 kDa) and the GST-(+95)mPBM1-MBD-6H domains (49.1 kDa) 
(see Figure 3.1413). 
The MBD of MBD4 shows a reduced homology to the MBD of MeCP2 similar to 
the MBD of the C. elegans PBM- 1 and mouse PBM 1 proteins (see Figure 3.13). 
Hendrich et al., (1999) have demonstrated that the MBD of MBD4 is capable of 
binding to with greater affinity to m 5 CpG/TpG mismatches than to probes 
containing either symmetrically methylated DNA or CpG/TpG mismatches. In order 
to use the minimal MBD of the mouse MBD4 protein as a positive control in DNA 
binding studies, a 278bp fragment encoding the MBD was PCR amplified with 
primers containing 5' BamHI and 3' EcoRl sites. This fragment was subcloned to 
BamFil/EcoRl linearised pGEH expression vector to generate the expression 
construct pGEH-PBM4-MBD: 
mMBD4/F: 5'-CTGCTGGATCCCTGTCTAGTACCACAGCG-3' 
mMBD4/R: 5'-AGCTGGAATTCTTTGGTGTTTATAACCGGG -3' 
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The pGEH-PBM4-MBD construct was electrotransformed into E. coli BL21 (DE3) 
pLysS cells, grown in LB media until 0D600 was 0.4 and protein expression was 
induced with 0.4mM IPTG at 37 0C for 3 hrs. Following induction, the pGEH-
PBM4-MBD construct generates a fusion protein with an N-terminal tagged 
glutathione S-transferase (GST) fused in-frame to the MBD of MBD4 and a C-
terminal tag of six histidine residues. The MBD of MBD4 was purified on 
glutathione-Sephadex as follows. The induced bacteria were pelleted by centrifugation 
at 4K for 15 n-dn at 0°C and then washed twice in GST-lysis buffer (50mM Hepes 
Tris.HC1 pH 7.9, 0.15M NaCl, 10% glycerol, 1mM EDTA). The pellets were lysed 
in a buffer containing protease inhibitors to minimise proteolytic degradation and high 
salt (0.15M NaCl) to facilitate the solubilisation of the recombinant protein. The 
bacterial cells were lysed and the extract was incubated with GSH-Sepharose beads to 
bind the GST-tagged mMBD4-MBD, washed extensively to remove non-specifically 
bound proteins and finally eluted by addition of 15 mM reduced glutathione (rGSH). 
Aliquots from these fractions were analysed by SDS-PAGE and the recombinant 
MBD of mouse MBD4 was expressed well as shown by Coomassie Blue staining. 
The size of the protein band is in agreement with the predicted molecular weight of 
GST-mMBD4-MBD-6H (37.OkDa) (see Figure 3.14B). 
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3.2.7 Analysis of the methyl-CpG binding and DNA binding activity of the 
C. elegans PBM-1 MBD and mouse PBMI MBDs 
In order to characterise sequence specific DNA-binding proteins with affinity for the 
promoter of the transferrin receptor gene, Miskimins et al., (1985) developed the 
southwestern assay. In essence, a southwestern assay involves proteins (either 
cellular or recombinant) separated by SDS-PAGE being immobilised onto 
nitrocellulose membranes by electroblotting and then incubated with 32P-labelled 
DNA probes containing sequences of interest. 
To determine whether the GST-PBM-1-MBD-6H and GST-mPBM1-MBD-6H 
domains were capable of binding to symmetrically methylated DNA duplexes a 
southwestern analysis was performed. Increasing amounts of these recombinant 
proteins and a positive control, the MBD of MeCP2, were separated by SDS-PAGE, 
electroblotted onto nitrocellulose membranes and challenged with either unmethylated 
(GAC) or methylated (GAM 12) 32P-labelled DNA probes in the presence of E. coli 
competitor DNA. These southwestern assays showed that the 85 amino acid MBD 
of MeCP2 specifically bound to a multiply methylated DNA duplex but had no 
detectable affinity for unmethylated DNA probes as previously demonstrated by 
Nan et al., (1993). However, by Southwestern analysis the MBD of the C. elegans 
PBM-1 and mouse PBM1 proteins showed no demonstrable affinity for either the 
methylated (GAM 12) or unmethylated (GAC) probes in the presence of E. coil 



















Figure 3.15: Determination of the affinity of mPBM1-MBD and PBM-1-MBD for methylated DNA by 
Southwestern analysis 
Lane 1: 50ng of recombinant MeCP2 MBD, Lanes 2-5 : 50, 100 and 1 5Ong of recombinant mPBM1 -MBD 
immobilised on a nitrocellulose filter were assayed for binding to unmethylated (GAC)- 32 P labeled probe in the 
presence of E. co/i competitor DNA. Lane 6 : 50ng of recombinant MeCP2 MBD, Lanes 7-10: 50, 100 and 
150ng of recombinant mPBM1-MBD immobilised on a nitrocellulose filter was assayed for binding to methylated 
(GAM-1 2)32P labeled probe in the presence of E. co/i competitor DNA. 
Recombinant PBM-1-MBD was assayed for binding to methylated (GAM-12)- 32 P labeled probe exactly 
as described for mPBM1. 
An alternative assay to characterise the DNA-binding properties of proteins is the 
bandshift assay. A bandshift assay involves the incubation of recombinant proteins 
or nuclear extracts with radiolabelled nucleic acid probes containing sequences of 
interest and the subsequent electrophoretic separation of protein-DNA complexes 
(Strauss and Varshavsky, 1984). 
In order to test whether the MBD from C. elegans PBM-1 and mouse PBMI 
proteins have any discernible affinity for methylated template by an alternative 
method, a series of bandshift assays were performed. Recombinant GST-PBM- 1-
MBD-6H and GST-mPBM1-MBD-6H were incubated with end-labeled GAC 
(unmethylated) or GAMI2 (methylated) probes (see Figure 3.18), in the presence of 
E. coli competitor DNA and the mixes run on 1.5% agarose gels to resolve DNA-
protein complexes from free probe. Figure 3.16 shows that the MBD region of 
MBD1 preferentially binds to methylated DNA whereas no detectable affinity for 
unmethylated DNA was detected in this assay. In support of the southwestern 
analysis, intact recombinant proteins encompassing the MBD of C. elegans PBM-1 
and mouse PBM1 did not bind to either methylated or unmethylated probes by 
bandshift analysis. Thus, by two independent techniques the MBD of the C. elegans 
PBM-1 and mouse PBM1 proteins do not form specific complexes with methylated 
probes, strongly suggesting that symmetric m 5CpG sites are not the target for these 
domains. 
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Figure 3.16 : Determination of the affinity of mPBM1-MBD and PBM-1-MBD 
for methylated DNA by bandshift analysis 
Lane 1: 50ng of the MBD of human MBDI incubated with unmethylated 
(GAC)- 32P labelled probe in the presence of 2p.g E. co/i competitor DNA. 
Lanes 2-4 : bOng of recombinant mPBMI-MBD incubated with 
unmethylated (GAC)-32P labelled probe in the presence of 0, 1 and 2.tg E. 
coil competitor DNA. 
Lanes 5-7: bOng of recombinant mPBM1-MBD incubated with methylated 
(GAM-12)-32P labelled probe in the presence of 0, 1 and 2ig E. co/i 
competitor DNA. 
Lanes 8-10 : 50, 100 and 150ng of recombinant mPBM1-MBD incubated 
with unmethylated (GAC)-32P labelled probe in the presence of no 
competitor DNA. 
Lane 11: 50ng of the MBD of human MBDI incubated with methylated 
(GAM12)- 32 P labelled probe in the presence of 2j.tg E. co/i competitor DNA. 
Lanes 12-14 : 50, 100 and 150ng of recombinant mPBMI-MBD incubated 
with methylated (GAM-12)- 32P labelled probe in the presence of no E. coil 
competitor DNA. 
Mixes were electrophoresed through a 1.5% agarose gel, dried onto DE8I 
filter paper and exposed to X-ray film. 
Recombinant PBM-1-MBD was assayed for binding to methylated (GAM-
12) labeled probe exactly as described for mPBM1. 
126 
ul 
1 	2 	3 	45 	67 	89 	10 11 12 13 14 
Free Probe 
Free Probe 
GAC 	GAM-12 GAO 	GAM-12 
MBD4 binds with greater affinity to m5 CpG/TpG mismatches than to probes 
containing symmetrically methylated DNA (m 5CpG/m 5CpG) or CpG!TpG 
mismatches (Hendrich et al, 1999). Thus both the DNA-binding MBD regions of 
MeCP2 and MBD4 are capable of binding to target sequences with additional but 
differing specificities. This raised the possibility that the C. elegans PBM-1 and 
mPBM 1 proteins could bind to DNA target sequences other than symmetrically 
methylated DNA via their MBD. 
The 5' end of the MBD of mPBM1 is alternatively spliced in the mPBM1c isoform. 
To test whether the presence or absence of this alternatively spliced region influences 
the recognition of DNA, the MBD of mPBM1 was expressed in bacteria as a 
recombinant fusion either containing, (+95)mPBM 1 -MBD or not, (-95)mPBM 1-
MBD the 95 amino acids encoded by the 285bp mPBM1c splice isoform. Figure 
3.17 shows that the MBD of MBD4 binds preferentially to a DNA fragment 
containing m5C in a variety of sequence contexts (see probe in Figure 3.19). The 
MBD of MBD4 also weakly shifted an unmethylated DNA probe which is 
potentially attributable to the low affinity of this region of the MBD4 protein for 
target sequences other than symmetrically methylated DNAs or m 5pG/TpG 
(Hendrich et al., 1999). The isoforms of the MBD of mPBM1 were tested for 
binding to these methylated and unmethylated probes. No specific complexes 
between either isoforms of the mPBM1-MBD and the methylated probe was 
observed as addition of the competitor poly (dl-dc) abolished any weak complexes 
128 
Figure 3.17: Determination of the affinity of the (-95)-mPBM1-MBD and 
(+95)-mPBM1-MBD isoforms for methylated DNA by bandshift 
analysis 
Lanes 1-2 : bOng of recombinant MBD4-MBD incubated with the AtMBD-
32 P labelled probe unmethylated at C in the absence (-) or presence (+) of 
1ig of poly(dl-dC) competitor DNA. 
Lanes 3-4 : bOng of recombinant (-95)-mPBM1-MBD incubated with the 
AtMBD-32P labelled probe unmethylated at C (see Figure 3.19) in the 
absence (-) or presence (+) of 1g of poly(d I-dC) competitor DNA. 
Lanes 5-6 : bOng of recombinant (+95)-mPBM1-MBD incubated with the 
AtMBD-32P labelled probe unmethylated at C in the absence (-) or presence 
(+) of 1g of poly(dl-dC) competitor DNA. 
Lanes 7-8 lOOng of recombinant MBD4-MBD incubated with the AtMBD-
32 P labelled probe methylated at C in the absence (-) or presence (+) of 1g 
of poly(dl-dC) competitor DNA. 
Lanes 9-10 : bOng of recombinant (-95)-mPBM1-MBD incubated with the 
AtMBD-32P labelled probe methylated at C in the absence (-) or presence 
(+) of 1g of poly(dl-dC) competitor DNA. 
Lanes 11-12 : bOng of recombinant (+95)-mPBM1-MBD incubated with the 
AtMBD-32P labelled probe methylated at C in the absence (-) or presence 




Poly (dl-dC) - + - + - + - + - + - + 
GAM-12 	 CA/GM-1 	
T CAGAT T CGCGCCAGCTGCGATAAGCT 




CGTCGTCGTCGTCGTCGTCGTCGTCGTCGTCGTCGTTAG 	 AGTCTAGCGCGGTCGATGCTATTCGA 
MG/GT1 	TCAGATTCGCGCMGGCTGCGATAAGCT 	 CA/GCI 	
TCAGATTCGCGCCAGCTGCGATAAGCT 
AGTCTAAGCGCGGTCGATGCTATTCGA AGTCTAAGCGCGGCCGATGCTATTCGA 
MG/GC-1 	TCAGATTCGCGCMGGCTGCGATAAGCT 	 CG/GTI 	
TCAGATTCGCGCCGGCTGCGATAAGCT 
AGTCTAAGCGCGGCCGATGCTATTCGA AGTCTAAGCGCGGTCGATGCTATTCGA 
Figure 3.18: Probes used to test DNA-binding properties of the MBD5 of PBM-1 and mPBMI 
The letter M denotes m 5C incorporated at this position of the oligonucleotide. The GAM-12 probe 
is composed of a symmetrical repeat of 12 m 5CGA. The GAC probe is identical to GAM 12 except 
C is substituted for m 5C. The MG/GC-1 probe is a hemi-methylated DNA and the remaining probes 
contain internal mismatches (in bold). 
5'MGGGATMMATGGAAAAMAMAGAMGAGMTTGTMTMMATTGA  
GMTIGMT)*1AGMT TM1T GGAAGAAJ½NTGTT T TAT4GA 
m 5C-AtM BD AAGAGMMGGTAMTMMGAGAAAGAMGGAGATTGTGTTTGTGGM 
TbI&kAMGGGT GAAGAGAT TAGMTMGMGGAAGMAGT TGGAGMA 








Figure 3.19: The single stranded AtMBD fragment was used to generate a 
double stranded probe to test the affinity of the (-95)-.mPBMI-MBD and (+95)-
mPBM1-MBD isoforms for methylated DNA. 
The AtMBD probe is a 247bp DNA fragment containing 55 cytosines in a variety 
of sequence contexts. Incorporation of m 5C was carried out by PCR amplification 
of this 0.24kb using m5C substituted for C. The letter M denotes m 5C incorporated 
at this position of the fragment. This fragment was annealed together to generate 
a double stranded DNA fragment for in vitro binding studies. 
with these probes which were thus adjudged to be the result of non-specific 
interactions. Furthermore, in bandshift assays with probes containing hemi-
methylated DNA, CpG/TpG and m5pG/TpG mismatch probes no affinity for these 
sequences was observed with the MBD of either the C. elegans PBM-1 or mouse 
PBM1 proteins (data not shown). 
3.3 Conclusions 
A C. elegans gene pbm-1 has been identified on the basis of homology to the methyl-
CpG binding domain of the MBD protein family. The pbm-1 gene has 8 exons 
spanning 5191bp of genomic DNA on chromosome III. A 4173bp cDNA clone 
derived from this locus contained an open reading frame predicted to encode a large 
protein of 1390 amino acids. In addition, to the MBD homology BLASTp searches 
revealed the existence at the extreme C-terminus of a bipartite PHD-zinc (C4HC3) 
finger and an adjacent bromodomain. Intriguingly, these motifs have been found in a 
diverse array of chromatin-associated transcriptional regulators. 
A mammalian ortholog of the C. elegans PBM-1 protein was identified by screening 
a mouse brain cDNA library and potentially encoded a protein with an N-terminal 
MBD and a C-terminal PHD-zinc fmgerlbromodomain region. This murine eDNA 
was named mPBM 1. The mPBM 1 eDNA was the product of a complex series of 
alternative splicing events and RT-PCR analysis detected a 95 amino acid splicing 
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event immediately N-terminal of the MBD. Both spliced and unspliced forms of the 
message were detected in a range of somatic and tissue cultured cells. 
During the isolation of the mPBM I cDNA sequence a partial murine cDNA, distinct 
from mPBM1, was identified that was highly homologous to the C. elegans PBM-1 
PHD-zinc finger/bromodomain region. This cDNA was named mPBM2. In addition, 
corresponding paralogs hPBMI and hPBM2 were identified in humans. This 
suggests the possible existence of a family of PHD-zinc finger, bromodomain and 
MBD (PBM)-containing proteins in mammals. 
Recombinant proteins comprising the MBD of the C. elegans PBM-1 and mouse 
PBMI proteins were generated and their affinity for methylated DNA was tested. 
By two independent approaches, no detectable binding of the MED of the C. elegans 
PBM- 1 and mouse PBM I proteins to a methylated template was observed whereas 
the MBDs of MeCP2 and MBDI bound methylated probes specifically. In addition, 
the presence of a 95 amino acid region N-terminal to the MBD of mPBM1 derived 
from a predicted alternative splicing event was not found to target the MBD region to 
methylated DNA duplexes. 
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CHAPTER FOUR: LOCALISATION AND TRANSCRIPTIONAL 
REGULATORY PROPERTIES OF THE mPBMI PROTEIN 
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4.1 Introduction to mPBMI localisation 
Green Fluorescent Protein (GFP) has attracted enormous interest as a biological 
marker for protein localisation and gene expression studies since the initial reports 
that the transcription of the cloned gene generated strong visible fluorescence in a 
range of cell types (Chalfie et al., 1994; Inouye and Tsuji, 1994). GFP has greatly 
aided the analysis of localisation patterns in the absence of immunofluorescence, 
however it does suffer from the caveat that expression levels are often not reflective 
of endogenous promoter strength and interpretation of localisation patterns must 
reflect this (Cubitt et al., 1995). However, translational fusions between mammalian 
proteins and reporter molecules have been found to localise to sites where the 
endogenous protein is known to reside, strongly suggesting that the localisation 
pattern discerned with these translational fusions is biologically meaningful (Gossler 
et al., 1989). 
4.2 Results 
4.2.1 Nuclear localisation of a full length GFP-mPBMI fusion 
To investigate the subcellular distribution of mPBM1 and specifically determine 
whether the protein was nuclear or cytoplasmically localised, the entire mPBM1 
ORF was fused in-frame to the GFP cDNA sub-cloned downstream of the strong 
cytomegalovirus (CMV) promoter and transfected into mouse EFS2 fibroblast cells 
for transient expression. This expression construct was generated in two steps. The 
first manipulation involved the PCR amplification of an 1 876bp fragment, comprising 
the extreme 3' end of the mPBM I ORF. This fragment contained an internal BamHI 
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site (from the mPBM 1 eDNA) and incorporated a 3' NheI site for subcloning in-
frame into a BamHI / NheI linearised pCMX-GFP2 vector (Hendrich and Bird, 
1998). This clone is termed pCMX-GFP2-3'mPBMl. A 4986bp fragment 
comprising the 5' end of mPBM1 was amplified by PCR. This fragment contained 
the internal BamHI site from the mPBM1 eDNA and incorporated a 5' BamHI for 
subcloning into the BamI-il linearised pCMX-GFP2-3'mPBMI. This construct is 
termed pCMX-GFP2-mPBM1. These clones were restriction mapped to identify 
correctly oriented inserts and all clones in this study were sequenced to ensure no 
PCR-generated mutations were present. 
Bam2Kl/F 	: 5'-GGATGGTGGAGAATCATTGACC -3' 
NheI GFP2/R : 5'-GAGATTGCTAGCTCAGCTCACTTTGAAGG-3'; 
GFP Barn ATG/F 	: 5'-TTATACGGATCCATGGAGTCTGGAGAACTG-3' 
Bam2K1IR 	: 5'-CTTGTTCCTGACACAGGCTTGG-3' 
A range of concentrations (0.5j.ig - 10xg) of this full length mPBMI-GFP fusion were 
transfected into mouse EFS2 fibroblasts by overlaying 40% confluent cells with a 
DNA-liposome mix as described in section 2.2.5. Ectopically expressed pCMX-
GFP2-mPBM1 was nuclear localised in murine fibroblasts (see Figure 4.1). 
Expression in EFS2 cells of full length mPBMI-GFP fusion gave a prominent, 
uniformly distributed pattern of fluorescent foci throughout the nucleoplasm with the 
exception of the nucleoli from which it appeared to be absolutely excluded (Figure 
4.1A). Numerous localisation studies on MeCPs have taken advantage of the heavily 
methylated mouse major satellite repeat which contains some 50% of all m 5C in the 
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Figure 4.1 : Sub-cellular localisation of the full length mPBM1 protein 
mPBM1-GFP fusions are nuclear localised in murine fibroblasts 
Transient expression in EFS2 cells of a full length mPBM1-GFP fusion, 
pCMX-GFP2-mPBMI showed a granular pattern of fluorescent foci within 
the nucleus and absolute exclusion from the nucleoli. The DAR bright 
spots are know to contain a large fraction of m 5C in the mouse genome 
(Miller et al., 1974). No co-localisation of mPBM1-GFP fusions with DAR 
bright spots could be observed strongly suggesting that methylated regions 
are not the in viva target. 
Full length mPBMI-GFP does not associate with chromosomes on entry 
to mitosis 
No-coincidence of the GFP and DAR signals was observed in cells fixed at 
the prometaphase stage of the cell cycle. 
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mouse genome (Miller et al., 1974). These regions of mouse major satellite that are 
constitutively heterochromatic within the mouse nucleus bind strongly to the DNA 
dyes Hoescht 33258 and DAPI (Miller et at., 1974). This has allowed investigators 
to use the major satellite repeat as an in vivo assay for association between an MeCP 
and heavily methylated heterochromatin. Nan et al., (1996) for example, found that 
transiently expressed MeCP2-3geo fusions localised to pericentromeric 
heterochromatin and Hendrich and Bird (1998) found that MBD I also co-localised 
with brightly staining DAPI foci of the mouse major satellite. In support of the in 
vitro DNA-binding studies that did not detect binding of the MBD of mPBM 1 to a 
methylated template, no strong co-localisation of mPBM 1 -GFP fusions with DAPI 
bright spots could be observed strongly suggesting that methylated regions are not 
the in vivo target. Furthermore, full length mPBM 1 -GFP was not found to associate 
with chromosomes at the time of entry to mitosis, with no coincidence of the DAPI 
and GFP signals detectable in those cells fixed at this stage (Figure 4.1 B). 
4.2.2 Punctate localisation of a GFP-mPBMIAMBD 
Is the diffuse, punctate nuclear localisation pattern of full length mPBM 1 -GFP 
dependent on the N-terminal region containing the MBD ? To answer this question, a 
deletion construct was engineered that removed this region and was transfected 
ectopically into mouse ESF2s. This expression construct was generated by the PCR 
amplification of a 2826bp fragment comprising the mPBMI cDNA downstream of 
the MBD of mPBM 1, that incorporated a BamHI site and contained an internal 
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BamHI site (from the mPBMI cDNA). This fragment was BamHI digested and 
subcloned in-frame into the BamHI linearised pCMX-GFP2-3'mPBMl construct 
(the pCMX-GFP2 expression vector containing the 3' end of mPBM 1). This clone is 
termed GFP-mPBMI AMBD. 
-MBD GFP/F : 5'-GTCATTGGATCCATCAGGGCAATGGACGGC-3' 
BamPBM1/R : 5'-CTTGTTCCTGACACAGGCTTGG-3' 
The diffuse localisation pattern of fluorescent foci seen with the full length mPBM 1 
fusion was recapitulated following overexpression in mouse EFS2 fibroblasts of the 
GFP-mPBM 1 IMBD construct (Figures 4.2A and 4.2B). Transfection experiments 
carried out with 1.Op.g, 2.5 jig, 5.0 jig and lOj.tg of GFP-mPBMliMBD led to similar 
observations. Thus, no domains reside within the N-terminal region of mPBM 1 
responsible for conferring either the nuclear importing or for mediating the distinct, 
granular pattern of localisation of the mPBM1 protein in mouse nuclei. 
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Figure 4.2: Deletion of the MBD of mPBM1 does not alter the nuclear 
localisation pattern 
The full length mPBM1-GFP localisation pattern in murine fibroblasts 
Localisation of the mPBM1-GFP without the N-terminal MBD is not 
perturbed following expression of the deletion 
Following transfection of the GFP-mPBM1MBD expression construct the 
pattern of nuclear diffuse foci of signal observed with the full length mPBMI 
fusion was observed. The deleted N-terminal region of mPBM1 therefore 
does not contain the nuclear localisation domain of mPBM1 or elements 
required for conferring the wild type diffuse localisation seen with the full 
length mPBMI protein. 
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4.2.3 Perturbed localisation of a GFP-mPBMIAPHD/BrD 
To determine whether the bipartite C-terminal PHD-zinc finger/bromodomain was 
responsible for this distinct nuclear localisation pattern, an expression construct was 
engineered that removed this region. This expression construct was generated by the 
PCR amplification of a 4986bp fragment comprising the 5' end of the mPBMI 
cDNA including the putative initiator methionine and contained an internal BamHI 
site from the mPBM1 cDNA upstream of the bipartite PHD-zinc finger and 
bromodomain. This fragment was BamHI digested to delete the PHD-zinc finger 
bromodomain motifs and subcloned in-frame into the BamHI linearised pCMX-
GFP2. This construct was termed mPBM1i\PHD/BrD: 
GFP ATG/F : 5'-TTATACGGATCCATGGAGTCTGGAGAACTG-3' 
BamPBMI/R : 5' -CTTGTTCCTGACACAGGCTTGG-3' 
Strikingly, the diffuse, granular GFP signal seen within the nucleus with full length 
mPBM 1 was abolished following deletion of the C-terminal region of the protein 
(compare Figure 4.3A and Figure 4.313). The nuclear localisation pattern with this 
deletion construct consisted of intensely labelled foci that localised in discrete nuclear 
domains in marked contrast to the wild type protein and the fusion lacking the MBD. 
This clear difference in localisation patterns between the wild type and C-terminally 
truncated proteins was importantly observed in independent transfection 
experiments. The truncated proteins still retain the ability to localise to the nucleus, 
compatible with the fusions still retaining a functional nuclear localisation signal. 
Figure 43: Deletion of the PHD-zinc finger and bromodomain of mPBMI 
results in an altered sub-nuclear localisation pattern 
The full length mPBMI-GFP localisation pattern in murine fibroblasts 
Perturbed localisation of the mPBM1-GFP fusion lacking the C-terminal 
PHD-zinc finger and bromodomain regions 
Transient expression of the GFP-mPBM1APHD/BrD construct in mouse 
EFS2 cells abolished the wild type localisation pattern and the truncated 
fusion localised in large aggregates of intensely labelled foci. The 
mPBM1PHD/BrD is still nuclear localised, consistent with the fusions still 
retaining a functional nuclear localisation signal. Thus, mPBM1 requires a 










Thus, the deletion mutant lacking the C-terminus containing the PHD zinc finger and 
bromodomain lacks an element that is responsible for conferring the wild type 
localisation pattern. Site-directed mutagenesis or deletion mapping would determine 
the precise region responsible for the wild type nuclear localisation of the mPBM 1 
protein. 
4.3 Conclusions 
This section describes the localisation of an mPBM 1 -GFP fusion protein in mouse 
EFS2 cells. Using translational fusions with a GFP reporter molecule, the full length 
mPBM1 protein was found to be uniformly distributed in the nucleus of mouse 
fibroblasts. No co-localisation of the full length mPBM1 GFP signal with the heavily 
methylated mouse major satellite DAPI signal was observed. This strongly suggests 
that full length mPBM1 does not associate with methylated domains in vivo, 
consistent with in vitro binding studies with the MBD of mPBM 1, however these 
findings do not formally exclude the possibility that mPBM1 associates with a DNA 
target other than methyl-CpG rich domains. 
The full length mPBM1 protein was not found to associate with chromosomes at the 
time of entry to mitosis as no co-localisation of the GFP and DAPI signal was 
observed at this time. Deletion of the N-teminus of mPBM1 containing the MBD did 
not alter the sub-nuclear localisation pattern demonstrating that no elements reside 
within this region responsible for the wild type localisation of the protein. The 
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localisation in a uniformly distributed pattern in the nucleoplasm does however 
require the extreme C-terminus of mPBM1 which contains the PHD-zinc finger and 
bromodomain motifs. Deletion of these motifs results in a strikingly different 
distribution pattern with the GFP signal present in discrete foci of intensely labelled 
fluorescence. A C-terminal element in mPBM1 is thus responsible for the spatial 
organisation of the mPBM1 protein within the nucleus of mouse fibroblasts. 
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4.4 Transcriptional regulatory properties of the mPBMI protein 
The mPBM1 protein contains a bipartite PHD-zinc finger and bromodomain motif at 
its extreme C-terminus previously found in a large number of nuclear regulatory or 
chromatin-associated proteins (Aasland et al., 1995; Jeanmougin et al., 1997). The 
molecular mechanisms underlying the regulation of the clustered homeotic genes 
(HOM-C) in Drosophila is well studied (Paro, 1993). The finding that many of the 
proteins implicated in the regulation of HOM-C expression patterns possess PHD-
zinc fingers and/or bromodomains serves to illustrate the central role of these domains 
in gene regulation at the level of the chromatin template. Transiently expressed 
regulatory proteins of the trithorax (trx-G) and polycomb (Pc-G) classes, that 
operate to activate or silence homeotic gene expression respectively, mediate their 
effects by altering chromatin structure of target genes. The repressive Pc-G activities 
are thought to silence HOM-C activity by the propagation of a heterochromatin-like 
structure across these clustered homeotic genes (Paro, 1990). Brahma is required for 
the activation of numerous homeotic loci during Drosophila development and loss-of-
function Brahma mutations suppress mutations in Polycomb which functions to 
repress homeotic gene expression (Tamkun et al., 1992). Brahma possesses extensive 
homology, including a bromodomain to SWI2/SNF2 that operates as a transcriptional 
activator in Saccharomyces cerevisiae by modulating the chromatin structure of genes 
it regulates (Kruger et al., 1995). In addition to the bromodomain, the PHD-zinc 
finger motif has been found in several chromatin-associated proteins including the 
Trithorax and Polycomb-like proteins which exert antagonistic effects on expression 
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and chromatin structure during Drosophila development. That the PHJ)-zinc finger 
and bromodomain motifs are present in both transcriptional activators and repressors 
of the clustered homeotic genes suggests that both positive and negative chromatin-
mediated transcriptional regulation might utilise similar mechanisms. 
Further links between the possession of these motifs and gene regulation involving 
chromatin is suggested by their frequent occurance of PHD-zinc finger and/or 
bromodomains in many of the proteins that modulate the acetylation status of the 
nucleosomal core histones. The intrinsic histone acetyltransferase, p300/CBP like the 
mPBM1 protein contains a C-terminal bromodomain and an adjacent PHD-zinc 
finger region. The finding that numerous other acetyltransferases also contain these 
motifs suggests that these domains are essential for the operation of these proteins 
within the environment of chromatin. 
4.5 Results 
To investigate whether mPBM1 was capable of modulating a reporter gene in vivo, 
the MBD at the N-terminus of mPBM1 was replaced with the DNA-targeting 
domain of the yeast transcription factor GAL4 in the pCMV-GAL4 expression 
vector. The ability of this GAL4-mPBM1 fusion driven by a cytomegalovirus 
promoter to affect a reporter gene containing GAL4 binding sites was assayed in 
mouse L929 cells. This GAL4-mPBM1 construct was created by PCR amplification 
of a 4161 bp PCR product that incorporated 5' and 3' Bell sites for subcloning 
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directly into a BaniHI linearised pCMV-GAL4 expression construct, generating the 
construct, pCMV-GAL4-mPBM1. 
-MBDGAL4 mPBM 1/F 	: 5' -TCATTCTGATCATCAGGGCAATGGACGGCC-3' 
pCMV-GAL4-mPBM 1 JR : 5' -GAGATTGATCATTCAGCTCACTFTGAAGGT-3' 
mPBM1 transcripts are detectable in mouse L fibroblasts and thus putative 
mediators of any effect on transcription would reasonably be expected to be 
expressed within this cell line also (see Figure 3.6). The effect of a transiently 
expressed GAL4-mPBM1 fusion on the transcription of a 13-galactosidase (f3-gal) 
reporter gene driven by the human 3-actin promoter was quantified in vivo by co-
transfection of a range of increasing amounts of effector (25ng-500ng GAL4-
mPBM1) with 2tg of reporter constructs that contained five GAL4 DNA-binding 
elements (pI3G5 BgllI : G5) or did not (p3geoN/B : GO). Using reporter constructs 
that were identical, except for the possession of upstream GAL4 binding elements 
allowed the effect of the GAL4-mPBM1 effector on f3-gal activity to be determined 
following the specific tethering of the fusion protein at a promoter as opposed to any 
non-specific activity on the reporter gene. 
Mouse L929 fibroblasts were co-transfected when 30% confluent with the pCMV-
GAL4-mPBM1 fusion and either the pj3G5 BgllI or pf33geoN/B reporter constructs 
by the DEAE-dextran method (section 2.2.5). Figure 4.4 shows that the GAL4-
mPBM 1 effector was capable of a modest dose-dependent and specific repression of 
the p3G5 BgllI construct whereas no repressive effect on the p33geoN/B reporter 
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was observed. Transcription of the pl3G5 BgllI construct was reduced by >50% 
when co-transfected with 500ng of the pCMV-GAL4-mPBM1 fusion. In contrast, 
overexpression of the GAL4-mPBM1 fusion protein in L929 cells co-transfected 
with p133geoNfB, that does not contain upstream GAL4 binding sites, lead to a robust 
transcriptional activation of reporter gene transcription. One potential explanation for 
this observation is that following the overexpression of the GAL4-mPBM1 fusion, 
there would result a titration of putative ancillary proteins required for silencing that 
would manifest itself as increased reporter gene activity in this assay. However, this 
non-specific effect of GAL4-mPBM1 on reporter gene transcription of p33geoN/B 
does not result in a repression of transcription and thus the effect of GAL4-mPBM 1 
on pG5 BgllI is likely the consequence of the specific tethering at the upstream 
GAL4 binding sites. These findings suggest the mPBM1 protein can potentially 
operate as a transcriptional repressor in mouse L929 cells. Deletion mapping would 
allow a minimal domain responsible for this silencing effect to be delineated and aid in 
the isolation of mediators of this effect. 
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Figure 4.4: mPBMI can repress transcription when tethered to a reporter 
gene by a heterologous DNA-binding domain in mouse L cells 
A The reporter and effector constructs used to assay the effect of mPBMI 
on transcription 
The ppgeoN/B reporter gene construct contains the human -actin 
promoter driving expression of the 3-galactosidase reporter gene. The p3G5 
Bglll vector is identical except for five GAL4 DNA binding elements 
upstream of the human 13-actin promoter. The mPBMI MBD region was 
replaced with the yeast GAL4 DNA-binding domain in the pCMV-GAL4 
expression construct. 
B. mPBMI can exert a repressive effect on transcription when tethered to a 
promoter proximal position 
A range of concentrations (25ng-500ng) of the pCMV-GAL4-mPBMI effector 
construct were co-transfected into mouse L929 cells with 2 jig of either the 
pf3G5 BgllI or the p3j3geoN/B reporters. Expression levels of the reporter 
constructs are quantitated as a histogram relative to the expression of the 
reporter constructs in the absence of mPBMI which is normalised to 100% 
for both reporters. Transcription from the pj3G5 BgIll construct which 
contains GAL4-binding elements and is thus able to tether the GAL4-
mPBMI fusion was reduced by -52% in the presence of 500ng of the 
mPBMI fusion. In contrast no repression of transcription was observed 
from the pf3j3geoN/B vector that is unable to bind the GAL4-mPBMI fusion. 
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4.6 Conclusions 
This section describes an investigation of the influence of the mPBM1 protein on 
transcription. Transfection of mouse L929 fibroblasts with increasing amounts of a 
GAL4-mPBM1 fusion lead to a modest dose-dependent repression of the 
transcriptional activity of a reporter gene containing GAL4 DNA-binding elements. 
Conversely, a GAL4-mPBM1 fusion exerted no repressive effect on a reporter gene 
lacking GAL4 binding sites. A stimulation of transcription of a reporter gene not 
containing GAL4 binding sites was observed following the overexpression of the 
niPBM1 protein. These finding are consistent with mPBM1 acting as a 
transcriptional repressor in mouse L929 cells. 
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CHAPTER FIVE: PHYSICAL MAPPING OF THE hPBMI GENE 
Wfol 
5.1 Introduction to mapping of human PBMI 
5.1.1 Chromosomal translocations involving transcriptional regulators 
Chromosomal translocations are a consistent finding in various forms of leukaemia, 
lymphoma and a subset of tumours (Rabbitts, 1994). Recently it has become 
apparent that many of the genes that are deregulated in chromosomal translocations 
possess features of known transcription factors. The resultant cancers are thought to 
arise through the mis-expression of many downstream target genes by these gain-of-
function transcriptional regulators (Cleary et al., 1992; Nichols and Nimer, 1992). 
This type of event can occur following breakage within intronic sequences in each of 
the partner genes such that the exonic sequences on either side are in-frame, resulting 
in a chimaeric oncofusion product. These new proteins contain domains such as 
various zinc fingers, AT-hooks, homeodomains and leucine zippers that appear to be 
critical in the development of leukaemia and other cancers. 
5.1.2 Chromosomal translocations and acetylases!deacetylases 
Recently, Gelmetti et al., (1998) and Lutterbach et al., (1998) have reported that the 
leukaemia fusion partner ETO (eight-twenty-one) is fused to the acute myelogenous 
leukaemia 1 (AML1) transcription factor in t(8;21) AML chromosomal 
rearrangements. AML 1 is a DNA-binding protein that can have both positive and 
negative effects on transcription (Ogawa et al., 1993). The t(8;21) AML1/ETO 
fusion protein contains the N-terminal DNA-binding domain of AML 1 fused to ETO 
which is able to interact via a zinc finger region with the nuclear co-repressors N-CoR 
and SMRT and can recruit HDAC activity. Similar recruitment of N-CoR-HDAC 
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activity has been found in studies of retinoic acid receptor alpha (RARcz) oncofusion 
proteins in acute promyelocytic leukaemia (APL) (Grignani et al., 1998). Thus in two 
separate leukaemia-signalling pathways (AML and APL), the recruitment of histone 
deacetylase activity by AML1IETO and PML/RARa could conceivably lead to 
transcriptional repression and the differentiation block at the myeloblast stage that 
contributes to myeloid leukaemias (see Figure 5.1). 
Interestingly, the translocation t(8;16)(pll;p13) in AML involves the intrinsic 
histone acetyltransferase CREB-binding protein, CBP gene and a previously 
unidentified gene termed MOZ (Borrow et al., 1996). CBP and the closely related 
p300 transcriptional coactivator protein are histone acetyltransferases (Ogryzko et 
al., 1996) while MOZ possesses a putative acetyltransferase domain. The position of 
the translocation breakpoint within CBP maintains the CREB-binding domain and an 
N-terminal region necessary for transactivation (Chrivia et al., 1993) and fuses in-
frame to MOZ maintaining the putative acetyltransferase signature motif and nuclear 
localisation signals. These findings suggest that the CBP-MOZ oncofusion product 
would result in leukaemogenesis through aberrant chromatin acetylation at promoters 
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Figure 5.1 : The cell lineages of the haematopoietic system 
All haematopoietic lineages derive from a pluripotent stem cell through lineage-commited intermediates. 
Chromosomal translocations that perturb normal haematopoietic development lead to leukaemias which 
are uncontrollled proliferations of haematopoietic cells that do not retain the capacity to differentiate to 
mature blood cells. 
5.1.3 Chromosomal translocations at 11q23 - the ALLI locus 
Curiously, many fusion proteins arising from chromosomal translocations show a 
specificity between the target genes, however some loci appear to rearrange 
promiscuously with numerous partner loci. For example, the ALL  locus at 1 1q23 
rearranges with as many as 25 different chromosomal regions generating a wide range 
of abnormalities in approximately 5% of acute leukaemias (Rabbitts, 1994). 
Chromosomal translocations involving band 1 1q23 are the most common cytogenetic 
abnormality in children with acute leukaemia. The ALL 1 protein has numerous 
motifs homologous to proteins implicated in transcriptional regulation such as an N-
terminal AT-hook, a cysteine rich region homologous to the Dnmtl 
methyltransferase, an extreme C-terminal SET domain and a centrally located 
cysteine rich region homologous to Drosophila trithorax that has been variously 
called a plant homeodomain (PHD)-zinc finger, trithorax consensus (TTC) and the 
leukaemia-associated protein (LAP) zinc finger (Aasland et al., 1995; Koken et al., 
1995; Sahaetal., 1995). 
5.1.4 Chromosomal rearrangements of ALLI - the PHD-zinc finger 
When Djabali et al., (1992) identified the ALL! gene at 1 1q23, it was apparent that 
the zinc finger motifs did not correspond to the zinc binding domains found in genes 
previously implicated in chromosomal translocations, such as the LIM, RING and 
Kruppel zinc finger domains (Sanchez-Garcia and Rabbitts, 1994) and was in fact the 
widely conserved PHD-finger motif. Intringuingly this domain was found in tandem 
in 1 1q23 partner genes on chromosome 10 (AF 10) and chromosome 17 (AF 17) in the 
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translocation t(10;1 1)(p 12;23) (Chaplin et al., 1995) and t(1 1;17)(q23;q21) (Prasad et 
al., 1994) rearrangements respectively. The basic domain consists of a C4HC3 zinc 
finger motif (C-X2-C-Xn-C-X2-C-X4-H-X2-C-X n-C-X2-C) that has been proposed 
to fold into a single domain that is stabilised by two zinc atoms and is found in a 
diverse array of proteins conserved from yeast to humans. In all t( 10; 11) and t( 11; 17) 
translocations documented, the derivative ALL 1 -AF 10 and ALL 1 -AF 17 fusions 
encode proteins completely lacking PHD-zinc finger domains. 
The aberrant recruitment of either acetyltransferase or deacetylase activities following 
chromosomal rearrangements has been a frequent finding, suggesting that normal 
patterns of histone acetylation might be perturbed by the resultant oncofusion 
products leading to leukaemia. The PHD-zinc finger of Mi2f does associate with 
HDAC activity and requires an intact zinc finger domain to do so (Zhang et al., 1998) 
and the oncofusion products from 11 q23 rearrangements with various target loci are 
frequently found to lack this motif suggesting a critical role for this conserved zinc 
finger domain in myeloproliferation. 
Thus, a wealth of evidence exists suggesting the PHD-zinc finger domain may be 
involved in leukaemogenesis. It was of interest, given the presence of a PHD-zinc 
finger domain at the C-terminus of mPBM 1, to localise chromosomally the human 
PBM1 gene to determine if rearrangements or deletions were found in cytogenetic 
abnormalities leading to leukaemia. 
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5.2 Results 
5.2.1 Mapping of hPBMI using monochromosomal cell hybrids 
Using the UniGene public server (http:/www.ncbi.nlm.nih.gov/SchulerfUniGene),  a 
cluster of human ESTs (593380 and 561792) were identified that were highly 
homologous to mPBM1 and were importantly distinct from hPBM2 (KJAA03 14). 
Specific primers to the human EST 593380 that encodes an MBD highly homologous 
to mPBM1 (see Figure 3.13) were designed to amplify a lOObp product from cDNA. 
5933 80F: 5' -ATGAACGTGAACTGCGTATrCC-3' 
593380R: 5'-TTTATFACTTCAGGGTACTGCC-3' 
Figure 5.2 shows that these primers amplified a 142bp fragment from a cDNA clone 
but amplified a -0.8kb product from human genomic DNA. This fragment was sub-
cloned and sequenced and the position of an internal intron within the MBD assigned 
(see Figure 3.13). A monochromosomal human/rodent cell hybrid panel of DNAs 
(obtained from the UK-HGMP Resource Centre, Cambridge, UK) was screened with 
the 593380F and 593380R primers. To avoid cross hybridisation and non-specific 
PCR amplification from related genes, forward primer with template, reverse primer 
with template, both primers without template and mouse, hamster and human DNAs 
with both primers were amplified in parallel with the genomic DNAs from the 
monochromosomal cell hybrids. A product was amplified from human genomic DNA 
and DNA from a hybrid containing human chromsome 2 (see Figure 5.2). 
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Figure 5.2 : Mapping of the human PBMI gene to chromosome 2 
Chromosomal assignment of the hPBM1 gene was performed by PCR analysis of 
human/rodent somatic cell hybrids using primers 593380F and 593380R that amplify 
a 142bp product from cDNA and a 833bp fragmnent from genomic DNA. In panel 1, 
the 593380 primers amplified a —0.8kb product from human genomic DNA and DNA 
derived from a hybrid containing human chromosome 2. No product was amplified 
from mouse or hamster DNA or DNA from hybrids containing the remaining human 
autosome and sex chromosomes. 
5.2.2 Mapping of hPBMI using fluorescence in situ hybridisation (FISH) 
To confirm the chromosomal localisation of the hPBM1 gene on chromosome 2 and 
further refine the map position, a specific genomic clone was isolated for fluorescence 
in situ hybridisation (FISH). A human P1 artificial chromosome (PAC) genomic 
library (obtained from UK-HGMP and constructed by Pieter de Jong, Roswell Park 
Cancer Institute, Buffalo, USA) was screened with primer pairs 593380S / 593380AS 
and 561792F / 561792R. 
593380S 	: 5' -AGCTGGCAGAGAGAGACAAG-3' 
593380AS : 5 '-CTTTCCACATGGAGCATAAT-3' 
561792F 	: 5'-AcACTCTTGCTGCATGCCAGTTC-3' 
561 792R : 5'-ACTGAAAGTCTGAAGACCAAAG-3' 
A PAC clone, P22 was identified by screening the PAC library using the 561792 
primer pairs and the presence of the hPBM1 gene within the P22 PAC clone was 
confirmed by sub-cloning and sequencing. The hPBM1 P22 PAC clone was labelled 
for probing by incorporation of biotin-16-dUTP. Following incubation of the biotin 
labelled probe on human metaphase spreads, the PAC clone was detected by avidin-
FITC and the signal was amplified by using a biotinylated anti-avidin antibody and a 
second incubation with avidin-FITC. FISH clearly showed a unique hybridisation 
signal on numerous metaphase spreads corresponding to the human G-band at 
chromosome 2q23 (Figure 5.3). Thus by two independent mapping approaches the 
human PBM1 gene maps to chromosome 2. 
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Figure 5.3 : Fluorescence in situ hybridisation with PAC P22, containing the hPBM1 gene, on human 
metaphase spreads 
PAC P22 labeled with biotin-16-dUTP and detected by avidin-FITC. The signal was amplified by using a biotinylated 
anti-avidin antibody and a second incubation with avidin-FITC. Chromosomes are stained with DAPI. 
An inverted DAR banding pattern showing the G-banding pattern of the human karotype. Arrows show a signal on 
human chromosome 2q23. 

































Figure 5.4: The human PBM1 gene maps to chromosome 2q23 
Chromosomal placement of the human PBM1 gene in a 10cM genetic interval between the microsatellite 
markers D2S1 56 and D2S376. The approximate corresponding location of the hPBM1 gene within the 
q23 region is indicated relative to a cytogenetic ideogram of human chromosome 2. 
5.2.3 Mapping of hPBMI by radiation hybrid mapping 
Recently, the Whitehead Institute/MIT Centre for Genome Research radiation hybrid 
mapping project has independently confirmed the assignment of the ESTs 593380 
and 561792 derived from the bPBM1 locus to chromosome 2. Using a sequence 
tagged site (STS) approach utilising radiation hybrid mapping, ESTs 593380 and 
561792 were placed in a 10 cM interval between the microsatellite markers D2S 156 
(distal; 170.5 cM) and D2S376 (proximal; 180.6 cM) on chromosome 2 downstream 
of the human TRAF-interacting protein 1 (TRAP1) gene that is within a region co-
linear with 2q23 (see Figure 5.4). 
5.3 Conclusions 
The hPBM1 gene was mapped by monochromosomal hybrid PCR to human 
chromosome 2. The location of hPBM1 was refined by the isolation of a PAC clone 
and FISH analysis which placed the hPBM1 gene on the long arm of chromosome 2 
at 2q23. An STS approach by the Whitehead Institute/MIT Centre for Genome 
Research radiation hybrid mapping project has independently confirmed the 
assignment of ESTs 593380 and 561792 from hPBM1 to a 10 cM interval between 
the microsatellite markers D2S156 (distal; 170.5 cM) and D2S376 (proximal; 180.6 
cM) on chromosome 2 downstream of the human TRAF-interacting protein 1 
(TRAP1) gene in a region co-linear with 2q23. The mapping of bPBM1 to 2q23 
makes it a candidate for disruption in the cases of leukaemia involving rearrangements 
and deletions on the distal arm of chromosome 2 (See discussion in Chapter 7). 
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CHAPTER SIX: ISOLATION OF A pbm-1 NULL MUTANT 
Im 
6.1 Intoduction 
Caneorhabditis elegans is a small, free-living soil nematode that is distributed 
worldwide. The propagation of the animal does not require mating as C. elegans is a 
self-fertilising hermaphrodite producing both sperm and oocytes. Males do however 
arise spontaneously at a low frequency (<0.2% males from wild type 
hermaphrodites) as a result of meiotic non-disjunction (Hodgkin et al., 1979) and are 
particularly useful for genetic crosses. Hermaphrodites and males are approximately 
1mm long and males are readily distinguishable on the basis of behaviour and 
morphology, with males possessing a distinctive tail which has a fan-shaped 
structure as opposed to the elongated tail spike of the hermaphrodite. An adult 
hermaphrodite worm lays around 300 eggs during its reproductive life. Worm larvae 
hatch from eggs and proceed through a series of four larval stages, Li to L4 and the 
adult (L4) hermaphrodite worms are fertile (see Figure 6.1). 
C. elegans was chosen originally as a model system to completely describe the 
development of a simple metazoan (Brenner, 1974). That is to describe the molecular 
mechanisms that maintain the determined and differentiated states of cellular lineages 
from the incipient embryo to the adult animal. Suiston et al., (1983) subsequently 
presented a complete description of the entire embryonic lineage from the zygote to 
the hatched larva. Briefly, following fertilisation of an oocyte by a sperm, the zygote 
develops by a series of asymmetric divisions that establishes the division of somatic 
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Figure 6.1 : Eggs, larvae and adult Caenorhabditis elegans 
The larval stages, LI - L4 of the hermaphrodite C. elegans are depicted. 
An adult male is shown in the lower right panel with the characteristic 
copulatory ray on the tail. 
This Figure was taken from Wood (1988). 
large anterior founder cell, AB and a smaller posterior founder cell P1. This P1 cell 
gives rise ultimately to four somatic founder cells MS, E, C and D and the germline 
precursor P4 and with AB, these blastomeres give rise to all the adult tissues of the 
worm (see Figure 6.2). Thus, the cell types derived from these initial founder cells 
and a complete description of the cell lineages has been traced from the zygote to the 
959 somatic cells that comprise the adult hermaphrodite worm. In addition, a 
complete description of the wiring of the nematode nervous system of the 302 
neuronal cells exists down to the synaptic level ()White et al., 1987). 
C. elegans is the first multicellular organism for which an essentially complete 
genome sequence has been determined (The C. elegans sequencing consortium, 1998). 
The total 97-megabase genome is approximately one-thirtieth the size of the human 
genome and eight times the size of the genome of the budding yeast, Saccharomyces 
cerevisiae. The C. elegans genome contains 19 099 genes predicted to encode a 
functional protein product. Some 42% of these protein products contain distant 
matches outside the nematode lineage (The C. elegans sequencing consortium, 1998). 
More than 70 human disease genes have been positionally cloned and the majority 
contain statistically significant sequence identity to genes in model organisms 
(Mushegian et al., 1997). Thus, while many newly identified mammalian sequences 
possess homologous sequences in the model organisms it is necessary to distinguish 
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Figure 6.2: Early lineage pattern of cleavages in the C. elegans embryo 
A series of asymmetric cleavages of the developing embryo generates 
the six blastomeres : AB, MS, E, C, D and P4 from which the differentiated 
tissues of the adult animal derives (Sulston et al., 1983). 
This Figure was taken from Wood (1988). 
identity across the sequence and the same modular organisation of motifs (a true 
ortholog) or are the sequences simply homologous with the similarity restricted to 
certain isolated regions of the sequence and certain domains. Strikingly, it has been 
found that the nematode worm, C. elegans encoded true orthologs in 36% of cases 
(Mushegian et al., 1997) and it has been estimated that 50% of human genes have 
some homology to a C. elegans gene (Ahringer, 1997). The assignment of human 
disease genes with orthologous genes in model organisms thus represents a 
comparative genomic approach where function can be elucidated by exploiting the 
forward and reverse genetic strategies possible in C. elegans, Drosophila and the 
yeasts. As a result, a systematic multi-organismal approach has been initiated to 
cross-reference sequences in model organisms with mammalian cDNAs to accelerate 
functional analysis (Bassett et al., 1997). 
In order to study the function of pbm-1, a mutation in the gene was required. There 
are three main methods to analyse gene function in the nematode by inhibiting its 
activity : 1) RNA interference (RNAi), 2) identification of a transposon insertion 
mutant and the subsequent isolation of a strain harbouring a deletion and 3) isolation 
of a chemically induced deletion mutant directly. 
Fire and co-workers (1998) have demonstrated that microinjection of double-stranded 
(ds) RNA into the worm syncitial germline leads to a potent and specific interference 
of gene activity. This RNAi technique has been demonstrated to phenocopy 
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previously identified loss of function or hypomorphic alleles in the targeted gene. 
However, despite the usefulness of RNAi, particularly in the study of multigene 
families, the technique suffers from the caveat that only the injected animal and the 
F1 progeny exhibit the effects of RNAi whereas the F3 progeny typically revert to 
the wildtype phenotype (Fire et al., 1998). The RNAi technique appears to operate 
at a post-transcriptional level (Montgomery et al., 1998) and as a result the effect is 
non-heritable. For genetic and functional analysis of pbm-1 a mutant was required. 
To obtain a pbm-1 mutant, the reverse genetic strategy of target-selected gene 
mutagenesis was employed to 1) identify worm strains containing either transposon 
element (Tcl) insertions within the pbm-1 gene from which a deletion strain could be 
derived (Zwaal et al., 1993) and 2) the direct isolation of a worm strain containing a 
deletion within pbm-1 induced by chemical mutagens (Jansen et al., 1997). These 
reverse genetic procedures for target-selected gene inactivation take advantage of the 
fact that C. elegans can survive frozen storage (Wood et al., 1988). As a result large 
scale mutagenisation protocols can be devised where following the identification of 
mutants by PCR, the siblings of the animal from which the genomic template was 
derived can be recovered for propagation for functional analysis. 
Tcl transposon mutagenesis in C. elegans is derived from the use of P element 
insertion in Drosophila (Ballinger and Benzer, 1989). This method takes advantage of 
the genome of C. elegans containing numerous copies of the Tc 1 transposon which is 
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mobile in certain mutator strains. Screening the Tel insertion library is by PCR to 
detect TO insertions within a gene of interest. Isolation of a strain from which the 
DNA template used in the amplification reaction was derived and the subsequent 
mobilisation of the element with removal of flanking DNA generates a deletion within 
the gene of interest (Zwaal et al., 1993) (see Figure 6.3). 
6.2 Results 
6.2.1 Identification of TO transposon insertions in pbm-1 
The Tel insertion mutant library consists of three sets of 960 cultures of MT3 126 
(mut-2) worms and an equivalent set of genomic DNAs arranged as an ordered matrix 
of 10 racks containing 12 X 8 trays. An ordered pooling of aliquots of the above 
genomic DNAs reduced these 960 lysates to 8 pools of 120 (see Figure 6.4A). The 
screening strategy to identify Tel insertions within the pbm-1 gene employed PCR 
using a primer specific to the inverted repeats of the tranposon and a pbm-1 specfic 
primer. Nested internal primers specific to Tel and pbm-1 were used to improve the 
specificity and the sensitivity of the screen. Following the amplification of the 
intervening DNA, the reactions were loaded onto agarose gels to visualise Tel 
insertion events. Two sets of nested primers were designed to be 3.0kb apart at the 
5' and 3' ends of the pbm-1 locus, to 1) maximise coverage of the screen to detect 
Tel insertions and 2) such that following the identification of insertions, these 
primers could be used to detect any deletions arising from excision of the transpo son. 
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Figure 6.3: Reverse genetic strategy for target-selected gene 
inactivation using transposon mutagenesis 
Transposon insertion events within a gene of interest are identified by a 
nested PCR-based approach. Boxes represent exons, lines intervening 
introns in a hypothetical three exon gene and triangles a Tcl transposon 
insertion event. A Tcl insertion mutant library consists of sets of polyclonal 
cultures of MT3126 (mut-2) worms and equivalent pools of genomic DNA 
derived from these frozen stocks. 
Genomic DNA from a transposon mutant bank is screened with gene-
specific (A, B, C and D) and transposon (Tcl)-specific primers (1 and 2). 
Consistent amplification of 	a DNA product by PCR identifies a 
corresponding frozen stock of nematodes in an ordered matrix. This 
oligoclonal population of nematodes are thawed and seeded individually to 
NGM plates. These worms are screened by PCR and a strain harbouring a 
Tcl insertion within the gene of interest identified. 
F1 progeny from these animals are tested by PCR for transposon 
excision events and the removal of flanking DNA by amplification across the 
site of the transposon insertion such that the deletion product has a 
selective advantage in the reaction. Sibling selection is carried out to 
maintain strains identified. The mechanism of Tcl transposon-induced 
deletion is not known but is thought to arise as a result of repair of the 
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783.4-3 : 5'-TGATCAATGTTGAATFGACG-3' 
783.4-4 : 5 1-GTTGTATTTCAGCTGCTTCC-3' 
The screen was carried out in quadruplicate to distinguish Tcl insertions within pbm-
1 from spurious amplification products. A positive address shows four identically 
sized products and four positive addresses G I, G II, F III and H II are indicated in 
Figure 6.4C corresponding to Tcl insertion events within the pbm-1 gene. 
In this instance, "positive address" refers to the reproducible amplification in 
quadruplicate of a PCR fragment corresponding to DNA derived from the transposon 
and the pbm-1 gene from genomic DNAs that correspond to a frozen stock of 
polyclonal nematodes. This can be confirmed directly by sequencing and is a useful 
way to determine the nature of the TO insertion event (i.e. intronic or exonic). 
Following the identification of a positive address, DNA lysates of lower complexity 
are animals until eventually a frozen stock of oligoclonal nematodes are thawed. 
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Figure 6.4: Identification of Tcl insertion events within the pbm-1 gene 
The TcI insertion mutant library consists of three sets (I, II and Ill) of 960 
cultures of MT3126 (mut-2) worms and an equivalent set of genomic DNAs 
arranged as an ordered matrix of 10 racks containing 12 X 8 trays. An 
ordered pooling of aliquots of the above genomic DNAs reduced these 960 
lysates to 8 pools (A-H) of 120. 
A location within this matrix ("an address") is identified by PCR screening 
of these DNA pools using primers specific to the inverted repeats of the id 
transposon and to the gene of interest. 
These 8 pools of 120 were screened with the pbm-1 specific primers 
(ZK1 to 4 and 783.1-I to 4) and the TcI-specific primers (LI, L2 and RI, 
R2) in all possible combinations to identify transposon insertion events 
within pbm-1. 
The primers employed in the gel shown are pbm-1 specific primer 783.4-4 
and TO transposon specific primer RI then nested PCR with primer pairs 
783.4-3 and R2 (see p178 for primer sequences). The screen was carried 
out in quadruplicate to distinguish TO insertions within pbm-1 from 
spurious PCR products. A positive address shows three or four identically 
sized products. Four positive addresses G I, G II, F Ill and H II are indicated 
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Individual animals are picked to seeded NGM plates and the strain containing a Tcl 
insertion inpbm-1 is directly identified. The progeny from this TO insertion mutant 
should contain deletion derivatives in the MT3 126 (mut-2) strain arising from 
mobilisation of the element and removal of flanking DNA. These deletion events can 
be visualised by PCR across the site of insertion (Zwaal et al., 1993). 
Thus, isolation of a deletion in pbm-1 from the Tcl transposon insertion bank is a 
two step procedure requiring first, the identification of a strain containing a Tc 1 
insertion event within the gene and second, the isolation of a deletion derivative from 
this strain. Moreover, Tc 1 transposons are known to preferentially intergrate within 
the T + A-rich introns in C. elegans (Rosenzweig et al., 1983; Zwaal et al., 1993). 
This non-random insertion bias of Tcl transposons within intronic sequences 
therefore does not guarantee isolation of a loss-of function mutant. The identification 
of a pbm-1 loss-of-function insertion mutant was discontinued at this stage, for the 
above reasons, and because a chemical deletion mutant was identified in parallel with 
the screening of the transposon insertion library. 
The deletion mutant library possesses the distinct advantage that it allows the direct 
isolation of a deletion within the pbm-1 gene in a single step. Furthermore, the 
mutagenesis procedure is random generating deletions in a non-specific manner 
(Jansen et al., 1997). This deletion mutant approach was chosen to isolate a pbm-1 
loss of function mutant. 
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6.2.2 Identification and isolation of a pbm-1 deletion mutant 
Plasterk and co-workers (Jansen et al., 1997) have described an improved method for 
target-selected gene inactivation using chemical mutagens. This procedure involves 
the random mutagenesis of worms with ethyl methanesuiphonate (EMS) or 
trimethyipsoralen (TMP) both of which can generate deletion mutations (Anderson, 
1995; Yandell et al., 1994). Mutagenised populations of animals are propagated until 
the F3 generation, then divided for freezing as a stock and for the preparation of a 
corresponding DNA lysate. These genomic DNA lysates derived from the 
mutagenised worms are arranged in an ordered matrix and screened by PCR to detect 
deletions (see Figure 6.5). The term "positive address" here refers to the reproducible 
amplification of a deletion fragment smaller than the wild type from genomic DNAs 
derived from a frozen stock of polyclonal nematodes. Each address contains multiple 
independent mutagenised genomes (Jansen et al., 1997). The deletion fragments 
importantly possess a selective advantage in the PCR compared to the larger wild 
type fragments. As the screen is by PCR on genomic DNA a round of sibling 
selection is carried out to maintain corresponding worm stocks. These DNA lysates 
were screened with the pbm-1 primers presented in section 6.2.1. 
Figure 6.6A shows the PCR screening of the deletion mutant library in quadruplicate 
with nested pbm-1 specific primers (ZK1, ZK2, ZK3 and ZK4) that amplified a wild 
type fragment of 2961 bp from the 5' end of the gene. In most lanes the amplification 
of a wild type fragment of 2.9kb is seen. The failure of the ZK1-4 primers to amplify 
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Figure 6.5 : Reverse genetics by chemical mutagenesis 
Synchronized worms are treated with either 50mM EMS or 30pg/ml 
trimethyipsoralen and then transferred to NGM plates. F3 progeny are 
washed off these plates and divided in three, twice for freezing polyclonal 
nematode stocks and once for isolation of genomic DNA for library 
construction. These crude lysates are pooled in a ordered matrix for PCR 
screeing. 
Deletions in a hypothetical gene of interest are screened by nested PCR 
across the gene locus using primers that amplify a 3kb fragment. 
This figure was taken directly from Jansen et al., (1997). 
a wild type fragment in all cases is likely due to the quality of the genomic DNA 
template that degrades as the number of freeze-thaw cycles increases (Karen 
Thijssen, personal communication). The screen is carried out 4-fold to distinguish 
deletion fragments from artefacts of the PCR amplification procedure. In lanes 5H 
(3/4 positive deletion fragments), 8H (2/4) and lOB (2/4) the pbm-1 primers 
amplified a deletion fragment of approximately I.M. This suggested that the 
corresponding stock of frozen worms from which the genomic DNA was derived 
contained an animal(s) with a large (-2.0kb) 5' deletion in the pbm-1 gene. The pbm-1 
primers specific to the 3' end of the gene (783.4-1, 783.4-2, 783.4-3 and 783.4-4) 
amplified a wild type fragment of —3.0kb in the majority of cases but no deletion 
fragments corresponding to deletions at the 3' end of the gene were identified (data 
not shown). The addresses 5H and 1 OB were found to reproducibly amplify a —1.0kb 
deletion fragment and were analysed further. No additional deletion fragments that 
could conceivably represent further deletion alleles of pbm-1 were detected in this 
screen of the mutant bank. 
The corresponding stocks of worms in the ordered matrix were thawed and genomic 
DNA isolated by standard protocols for PCR amplification (i.e. 5H 1-12, lOB 1-12; 
see Figure 6.6). Figure 6.613 shows the PCR screening of DNA derived from 5H 1-12 
and lOB 1-12 with the pbm-1 specific primers ZK1 -4 and the robust amplification of 
a —3.0kb wild type fragment in the majority of cases. In lane 5H4 the —1.0kb deletion 
fragment is present in quadruplicate. Figure 6.6C shows the PCR amplification from 
Figure 6.6: Identification of an EMS deletion within a mutant library 
The term "positive address" refers to the reproducible amplification of a 
deletion fragment smaller than the wild type from genomic DNAs derived 
from a frozen stock of polyclonal nematodes. The "dimension" of this 
address refers to the location within a frozen ordered matrix. 
Identification of a first dimension positive address 
In most lanes the amplification of a wild type fragment of 2.9kb is seen. The 
failure of the ZK1-4 primers to amplify a wild type fragment in all cases is 
likely due to the quality of the genomic DNA template that diminishes as the 
number of freeze-thaw cycles increases (Karen Thijssen, personal 
communication). The screen is carried out in quadruplicate to distinguish 
deletion fragments from spurious PCR products. In lanes 5H (3/4 positive 
deletion fragments) and lOB (2/4) the pbm-1 primers amplified a deletion 
fragment of approximately 1.0kb (indicated by arrows and an asterisk). This 
suggested that the corresponding stock of frozen worms from which the 
genomic DNA was derived contained an animal(s) with a large (-2.0kb) 5' 
deletion in the pbm-1 gene. 
Identification of a second dimension positive address 
Genomic DNA was isolated by standard protocols for PCR amplification 
from the addresses 5H and lOB (i.e. 5H 1-12, lOB 1-12) and screened for 
deletions within the pbm-1 gene. The majority of lanes amplify a wild type 
3.0kb fragment from the pbm-1. In lane 5H4 the -1.0kb deletion fragment 
present in quadruplicate is indicated. 
Identification of a third dimension positive address 
Genomic DNA was isolated from the 51­14 addresses (i.e. 5H4 A-H) and 
5H4G amplified in quadruplicate the -1.0kb deletion band. 
+ is a positive control using genomic DNA from the 51­14 address and 




a 114h 	 IV I IWJ U. &I 
qT VI 
• 
aJ-.- Vill IUUUI1 
S 
AM 
I .s11!J 	•'; 	I 
* 	-. 
taw 
genomic DNA derived from the 5H4 addresses (i.e. 5H4 A-H) and the detection of 
the 1.0kb deletion band in quadruplicate in 5H4G. The frozen stock of worms at 
51140 in the ordered deletion library was thawed and transferred to a 10cm seeded 
NGM agar plate and grown for 2 days at 25 0C. These cultures are oligoclonal and 
thus it is unknown what percentage of the animals that survived the thawing 
procedure contain the —P2.0kb deletion within pbm-1 (Plasterk, 1995). To ensure the 
deletion mutation in pbm-1 was maintained, hermaphrodite worms were picked to 
500 X 2cm seeded NGM plates and cultures of increasing complexity were 
established, i.e. 10 plates of 10 worms, 5 of 20 worms, 5 of 50 worms and a plate 
with the remaining population of animals. The parental hermaphrodites from the 500 
individually seeded NGM plates, that importantly had progeny and would thus 
segregate the deletion, were transferred to worm lysis buffer and genomic DNA 
prepared for PCR amplification (as described in section 2.14.4). Figure 6.713 shows 
that a single founder hermaphrodite (line 58), contained the 5' deletion within the 
pbm-1 gene whereas the remaining lines amplified the wild type fragment. Following 
identification of the pbm-1 deletion mutant in this series, the small number of F 1 
progeny of the mutant line (11) were transferred to individual NGM plates. This 
reduced fertility of EMS mutagenised nematodes has been observed previously 
(Jansen et al., 1997). These worms were PCR genotyped when they had laid viable 
progeny to ensure the mutation had segregated to the small number number of 
animals. Figure 63C shows that from the 11 lines, three amplified a -3.0kb 
fragment and were thus homozy gous wild type for pbm-1 whereas the reamaining 
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Figure 6.7: Identification of an EMS deletion within the pbm-1 gene 
A The 5.1kb pbm-1 genomic locus and location of the ZK1-4 primers that 
amplify a wild type 2961 bp fragment from the 5' end of the gene. 
The frozen stock of worms at position 5H4G in the ordered deletion library 
identified by PCR screening were thawed and transferred to a 10cm 
seeded NGM agar plate and grown for 2 days. Hermaphrodite worms were 
then picked to 500 seeded NGM plates. When viable Fl progeny were 
visible on these plates, genomic DNA was prepared from the 500 parental 
hermaphrodites. 
A single founder hermaphrodite (line 58) marked by an asterisk, 
contained the 5' deletion of pbm-1 whereas the remaining lines amplified 
the wild type —3.0kb fragment. + is a positive control using genomic DNA 
from the 5H4G address. 
Following identification of the pbm-1 deletion mutant in this series, the 
small number of F 1 progeny (11) of the mutant line 58 were transferred to 
individual NGM plates. These worms were PCR genotyped when they had 
laid viable progeny to ensure the mutation had segregated to the small 
number of animals. From these 11 lines, three amplified the 3.0kb 
fragment and were thus homozygous wild type for pbm-1 whereas the 
remaining eight lines segregated the mutation. As the —1.0kb deletion band 
has a selective advantage in the PCR amplification it was not possible to 
say whether these lines were heterozygous or homozygous for the 
mutation. 
a. 
eight lines contained the mutation. As the deletion band has a selective advantage in 
the PCR amplification it was not possible to say whether these lines were 
heterozygous or homozygous for the mutation. Subsequently, internal primers to the 
deletion allowed discrimination of wild type and deletion mutant alleles to allow 
unambiguous genotyping of the worms and are described in section 6.2.3. 
To characterise the nature of the deletion at the 5' of the pbm-1 gene, the -1.0kb 
pbm-1 deletion fragment was TA-cloned and sequenced from both ends. Alignment of 
the sequenced 1 088bp deletion fragment with the wild type genomic locus (from 
cosmid ZK783, Accession No. U13646) revealed an 1873bp deletion at the 5' end of 
the pbm-1 gene. Figure 6.8A shows the eight exon gene and the location of the ZK1-4 
5' primers used to isolate the deletion mutant and the 1.8kb deletion in pbm-1. The 
deletion joins the 5' end of exon 1 to the extreme 3' end of exon 4, just upstream of 
the splice donor of this exon (see Figure 6.8A). Importantly, this deletion completely 
removed exons 2 and 3 that encode the MBD of PBM-1. The 1.8kb deletion 
generates a +1 frameshift mutation in the pbm-1 gene such that the resulting out of 
frame mRNA encodes a severely truncated protein not containing any of the 









Figure 6.8: Establishment of a strain homozygous for the EMS deletion 
within the pbm-1 gene 
Characterisation of the EMS deletion at the 5' end of the pbm-1 gene 
The pbm-1 genomic locus and location of the ZKI-4 primers that amplify a 
wild type 2961bp fragment from the 5' end of the gene and a 1088bp 
deletion allele. PCR with the ZKI and ZK6 primers then amplification with 
the nested primers ZK2 and ZK5 generates a 556bp fragment from the wild 
type locus but no fragment from the deletion allele. 
The deletion fragment was sequenced and found to delete an 1873bp 
fragment from the 5' end of the pbm-1 gene. This joins the 5' end of exon I 
to the extreme 3' end of exon 4, just upstream of the 5' splice donor of this 
exon shown in bold (see Table 3.1 for exon4-intron4 junction in pbm-1). 
This deletion completely removed exons 2 and 3 that encode the MBD of 
PBM-1. The 1.8kb deletion generates a +1 frameshift mutation such that the 
resulting mRNA encodes a severely truncated protein not containing any of 
the conserved motifs in PBM-1 and is therefore considered a null allele. 
A homozygous pbm-1 strain for the deletion could not be identified 
The pbm-1 deletion was isolated as a heterozygote from the deletion 
mutant library and a homozygous line could not be identified. The failure to 
isolate a worm strain homozygous for the pbm-1 deletion suggested the 
mutation might be a recessive lethal or alternatively was linked to a second 
site mutation that was recessive lethal. Shown in the figure are 12 worm 
lines either homozygous wild type (+1+) or heterozygous for the pbm-1 
deletion (+1-). The PCR genotyping scheme used primers ZKI-4 to 
determine if the strain was wild type (2961bp wt) or harboured the deletion 
(1088bp A). PCR amplification with primers ZKI/6 and then nested PCR 
with primers ZK2/5 that are internal to the 1.8kb EMS deletion determined 
whether the strain was heterozygous (presence of a 556bp product) or 
homozygous (absence of a 556bp product) for the deletion allele. 
Isolation of a strain homozygous for the pbm-1 deletion after outcrossing 
To remove second site mutations to stabilise the strain and facilitate 
phenotypic analysis, extensive outcrossing to an unmutagenised genetic 
background was carried out using chromosome specific markers (see 
section 6.2.3). At outcross three a strain homozygous for the -1.8kb 
deletion was identified. Outcrossing to the unmutagenised background 
was carried out five times in total and the strain was deposited at the CGC, 
University of Minnesota, USA as pbm-1 (qa 1700). The hermaphrodite 
gross phenotype in the pbm-1 (qa 1700) strain was wildtype. 
- is a negative control without added DNA. + is a positve control amplifying a 
wild type 2961bp and 566bp pbm-1 fragments from genomic DNA isolated 
from the standard Bristol N2 strain. Adjacent to this are five lines 
homozygous for the deletion in pbm-1. 
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6.2.3 Outcrossing of the C. elegans deletion mutant 
Internal primers to the 1.8kb deletion of pbm-1 were designed to facilitate PCR 
genotyping to distinguish wild type and deletion alleles (see Figure 6.8A). 
pbm-1 specific primers 
ZK5 : 5'-AATTGAAGCTGATGATGTGG-3' 
ZK6 : 5'-ATTGTTCATCATATTGCTCG-3' 
The pbm-1 deletion was isolated as a heterozygote from the mutant library and a 
homozygous line could not be identified (Figure 6.813). This suggested that there 
might be selective pressure against isolation of a homozygous pbm-1 strain. 
However, the EMS in vivo mutagenesis generates numerous, extraneous second site 
mutations that need to be removed before phenotypic analysis can be carried out. 
One straightforward explanation for the failure to isolate a pbm-1 homozygote could 
be the result of linkage to a gene heterozygous for an EMS-deletion that is lethal in 
homozygous gene dosage. 
To remove second site EMS mutations, extensive outcrossing to an unmutagenised 
genetic background was carried out using chromosome-specific markers. The pbm-1 
gene is located on C. elegans chromosome III so the chromosome 111-specific markers 
dpy-1 7 and unc-32 were chosen to ensure outcrossing had occurred and to improve 
the mating efficiency. Dpy-1 7;unc-32 (DpyUnc) homozygotes are short, severely 
coiled nematodes that move little as adult hermaphrodites and thus provide an easily 
distinguishable, recessive visible marker. The outcrossing scheme is shown in Figure 
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6.9. This procedure was repeated five times and a homozygous pbm-1 strain was 
established after three outcrosses (see Figure 6.8C) suggesting the removal of a linked 
recessive lethal mutation. The five times outcrossed strain was deposited with the 
Caenorhabditis Genetics Center (CGC, University of Minnesota, USA) as pbm-1 
(qal 700). 
Total RNA was isolated from the outcrossed pbm-1 (qal 700) strain, cDNA 
synthesised and RT-PCR analysis carried out to characterise the nature of the mature 
mRNA produced from the deletion mutant locus. This was accomplished by using 
primers specific to exons 1 and exons 5, that span the 1 873bp deletion in the pbm-1 
mutant and amplified a predicted 2346bp fragment from wild type (Bristol N2) 
cDNA. 
CEZKEXON 1 /F : 5' -ATGAGTGATAACTCATCTAATC-3' 
CEZKEXON5/R: 5'-AGCTTCTTGATGAAGATCTCCG-3' 
In contrast, using eDNA derived from total RNA isolated from the pbm-1 (qal 700) 
strain, a 748bp fragment was amplified. Sequencing of these fragment confirmed the 
prediction that the pbm-1 (qal 700) allele encoded an out of frame mRNA that is 
prematurely truncated removing the PHD-zinc finger and bromodomain motifs. The 
allele is thus considered a null. The establishment of a strain homozygous for a null 
allele demonstrates that the pbm-1 gene is therefore non-essential on the basis of not 
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Figure 6.9: Outcrossing scheme to remove second site mutations from the 
pbm-1 deletion strain 
The cis-linked (chromosome 111)-specific markers dpy-17;unc-32 were 
used in this outcrossing scheme to distinguish self and cross-progeny in 
the matings to ensure outcrossing to the unmutageneized background had 
occurred. 
Adult hermaphrodites homozygous for dpy-17 (e164) and unc-32 (e169) Ill 
(SP471) were mated with an excess of young adult males him-8 (e1489) IV. 
Male cross-progeny, i.e. from plates that contained phenotypically wild type 
worms as well as DpyUnc worms, were mated from the third outcross 
stage with adult hermaphrodites homozygous for the pbm-1 deletion. 
Twenty L4 hermaphrodite progeny from this cross were seeded individually 
and allowed to self-fertilise. F 2 progeny from lines heterozygous for the 
pbm-1 deletion by PCR genotyping were allowed to self, PCR genotyped 
and the lines that were positive for the deletion were identified. This 
scheme was repeated five times and a homozygous pbm-1 strain was 
established after three outcrosses suggesting the removal of a linked 
mutation that was recessive lethal. The five times outcrossed strain was 
deposited with the Caenorhabditis Genetics Center (CGC, University of 
Minnesota, USA) as pbm-1 (qa1700). 
Outcrosses one and two were performed by mating hermaphrodites 
heterozygous for the pbm-1 deletion with dpy-17;unc-32 heterozygous 
males and as outlined above following the segregation of the deletion 
allele by PCR genotyping of their progeny. 
195 
+ 	+ + 	him-8 	 dpy-17 + unc-32 	 + 
I I 	I I 	 I I 	I 	I I I 
I 
c?' 	x  
I 	I 	I 	 I 
+ 	+ + 	him-8 	 dpy-17 + unc-32 + 
1 
dpy-17 + unc-32 	 + pbm-1 + 
+ + 	+ 	 + pbm-1+ 
1 
dpy-17 + unc-32 	 + + 	+ 
I 	I 	I I 	I I 
F. 	 ____ + ____ 
I 	I 	I 	 I 	I 	I 
+ pbm-1 + + pbm-1 + 
0,4 
pbm-1 PCR Genotype Phenotype 
dpy-17 + unc-32 
I 	I 	I 
F l 2 
dpy-17 + unc-32 
dpy-17 + unc-32 
I 	I 	I 
1 
2 




+ pbm-1 + 








being mutable to a recessive lethal. Furthermore, the hermaphrodite gross phenotype 
in the homozygous pbm-1 mutant was indistinguishable from wild type. 
6.3 Conclusions 
This chapter describes a reverse genetic approach for target-selected gene inactivation 
of the pbm-1 gene on C. elegans chromosome III. A 1.8 kb EMS induced deletion at 
the 5' end of the pbm-1 gene was isolated from a mutant library. Using the 
chromosome 111-specific markers dpy-1 7 (e164) and unc-32 (e169), the pbm-1 
deletion strain was outcrossed extensively into an urimutagenised genetic background. 
A strain homozygous for the deletion, pbm-1 (qal 700) was established and RT-PCR 
analysis from this homozygous mutant strain confirmed that the deletion was a null 
allele. The establishment of a C. elegans strain that is homozygous for a severe 
deletion allele demonstrates that the pbm-1 gene is non-essential for viability. 
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CHAPTER SEVEN: DISCUSSION 
W. 
7.1 Summary of Results 
A C. elegans gene was identified that exhibited homology to the methyl-CpG 
binding domain of the MBD protein family. Intriguingly, a cDNA derived from this 
locus encoded a protein containing PHD-zinc finger and bromodomain motifs found 
in chromatin-associated transcriptional regulators. The C. elegans gene was termed 
PHD-zinc finger, bromodomain and methyl-CpG binding domain gene-i (pbm-1). 
A mammalian ortholog of the nematode pbm-1 gene was isolated. mPBM1 was 
found to be alternatively spliced with three major RNA isoforms detectable in a range 
of somatic and tissue cultured cell lines. 
During the identification of mPBM1 a partial cDNA, mPBM2 was identified that 
potentially encoded a protein highly homologous to the C-terminus of the C. elegans 
PBM-1 protein. Corresponding paralogous cDNAs (hPBM1 and hPBM2) were 
identified in human tissues suggesting the existence of a gene family in mammals. 
The MBD regions from C. elegans PBM-1 and mPBM1 were produced as 
recombinant proteins. No affinity of these domains for methylated DNA was 
detected in a series of in vitro binding studies. Furthermore, no binding of these MBD 
domains to hemi-methylated DNAs, CpG/TpG, m 5CpG/TpG mismatches and a 
probe containing multiple TpG sites was observed. 
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The full length mPBM1 protein fused to the GFP reporter was found to be nuclear 
localised in a diffuse, granular pattern in mouse cells. The mPBM1 GFP signal did 
not overlap foci derived from the methylated mouse major satellite, strongly 
suggesting that mPBM1 does not associate with methylated domains in vivo. 
Furthermore, the MBD domain is not responsible for the distinct sub-nuclear 
localisation pattern of mPBM1. Deletion of the PHD-zinc finger/bromodomain 
however abolishes the uniformly distributed pattern of fluorescent foci throughout 
the nucleoplasm implicating these regions in the wild type localisation of the 
niPBM1 protein in mouse nuclei. 
GAL4-mPBM1 tethered to the promoter of a reporter gene was found to exert a 
modest dose-dependent transcriptional repression in mouse L929 fibroblasts. 
Expression of a GAL4-mPBM1 fusion protein however was found to result in the 
activation of a reporter gene lacking GAL4 binding sites, suggesting that the silencing 
on the reporter containing upstream GAL4 binding elements was a specific effect 
arising from the recruitment of the mPBM1 protein. 
The hPBM1 gene has been mapped by a number of independent approaches to 
2q23. Disruption of genes encoding PHD-zinc finger proteins have been implicated in 
leukaemogenesis. The mapping of hPBM1 to 2q23 makes it a candidate for 
disruption in the cases of leukaemia involving rearrangements and deletions on the 
distal arm of human chromosome 2. 
8) An EMS mutant library was screened to identify deletion events within the pbm-1 
gene. The deletion allele was shown to be a null by RT-PCR analysis. A C. elegans 
strain pbm-1 (qal 700) was isolated that was homozygous mutant for this loss-of-
function deletion. The pbm-1 gene was not essential for viability. 
7.2 The PHD-zinc finger, Bromodomain and MBD (PBM) protein family 
The C. elegans pbm-1 gene was identified in a search of the sequence databases for 
proteins with homology to the methyl-CpG binding domain. An alignment of the 
MBD of MBD1 with the MBD of PBM-1 over 40 amino acids showed 30% 
identity and an overall similarity of 52% (see Figure 3.13). Inspection of the extreme 
C-terminus of PBM- 1 revealed the presence of a PHD-zinc finger and an immediately 
adjacent bromodomain strongly suggesting a relationship with gene regulation 
(Figures 3.11 and 3.12). The identification of an MBD-containing protein in an 
organism apparently devoid of genomic methylation is not without precedent as an 
EST has been identified in Drosophila melanogaster that is highly homologous to the 
mammalian MBD2/3 proteins (Susan Tweedie, personal communication). The MBD 
of Drosophila MBD2/3 contains a large insertion and does not form a complex with a 
methylated probe in vitro. Furthermore, a cDNA has been identified in Drosophila 
that shares sequence identity to the fission yeast methyltransferase homolog pmt] 
(Wilkinson et al., 1995) and the mammalian cytosine-5 methyltransferase family 
member, Dnmt2 (Okano et al., 1998a) (Susan Tweedie, personal communication). 
These findings demonstrate that Drosophila encodes proteins homologous to the 
mammalian DNA methylation machinery and yet like C. elegans no m5C has been 
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detected in the fly genome (Rae and Steele, 1979). In marked contrast, no additional 
MBD-containing genes or sequences with homology to the DNA (cytosine-5) 
methyltransferase family members were detected in the C. elegans genome. 
A full length mouse cDNA termed mPBM1 was identified that was highly 
homologous to the C. elegans PBM-1 protein and importantly had the same modular 
organisation of motifs, i.e. the N-terminal MBD and C-terminal PHD-zinc 
finger/bromodomain regions. During the identification of mPBM 1, a partial cDNA 
(mPBM2) was identified that potentially encoded a protein highly homologous to the 
C-terminus of the C. elegans PBM- 1 protein. Corresponding partial cDNAs 
(hPBM1 and hPBM2) were identified in human tissues suggesting the existence of a 
family of PHD-zinc finger, Bromodomain and MBD (PBM)-containing proteins in 
mammals. 
Two separate subclasses of gene homology : orthology and paralogy have been 
described by Fitch (1970). Orthologous genes (ortho = exact) have been defined as 
homologous genes in different  species that encode proteins with the same biochemical 
function that have diverged from their common ancestral gene as a result of speciation 
and separate evolution. Paralogous genes (para = in parallel) are homologous genes in 
the same species that arise through gene duplication encoding proteins with related 
but non-identical biochemical functions. In this scheme, the mPBM1 and mPBM2 
genes are paralogous to one another and paralogous genes comprise the many gene 
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families that have been identified. However, as pointed out by Chervitz et al., (1998) 
in comparing the entire protein complements of the completely sequenced C. elegans 
and Saccharomyces cerevisiae genomes, orthology is not a one-to-one relationship as 
a unique gene in one species (in this case the C. elegans pbm-1 gene) may be the 
ortholog of a gene family in another species (here the mouse PBM family). Chervitz 
et al., (1998) arbitrarily chose to cluster worm and yeast genes in groups that had 
BLASTp values of p< 10`0. On the basis of this criteria, the completely sequenced 
worm PBM-1 and mPBM1 cDNAs were considered orthologous pairs in this study 
(BLASTp value of p< 1O). However, the assignment of mPBM1 as the ortholog of 
the C. elegans PBM- 1 protein cannot be definitive in the absence of complete 
genome sequence information in the mouse, as a gene encoding a protein with a higher 
sequence identity to the ancestral pbm-1 gene could reside in the unsequenced portion 
of the mouse genome. 
7.3 The MBD regions of the PBM proteins do not bind methylated DNA 
Recombinant proteins comprising the MBD regions from the worm PBM- 1 and 
mouse PBM1 proteins were expressed in E. coil. Purified proteins were found to 
express well with minimal proteolytic degradation. In order to test whether these 
MBD regions were capable of binding to a methylated template, a series of bandshift 
and southwestern assays were performed. A positive control (MeCP2, MBD 1) 
could bind readily to a methylated template whereas no binding of the MBD domains 
from the worm PBM-1 and mouse PBM1 proteins could be detected. In further 
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experiments using probes containing multiple TpGs, hemi-methylated DNAs, 
CpG/TpG and m 5CpGITpG mismatch probes no binding was observed whereas 
positive controls where found to form specific complexes with these DNAs. The 
sequence similarity between the MBD region from the worm PBM- 1 and mouse 
PBM1 proteins is reduced when compared with the MED family members known to 
complex with methylated probes (MeCP2, MBD 1, MBD2 and MBD4; see Figure 
3.13). 
An NMR structure for the MBD of human MeCP2 in - solution has been deduced and 
a number of critical residues within a conserved hydrophobic pocket are proposed to 
mediate the contacts between the MBD and m 5C in DNA (Wakefield et al., 1999). 
The MBD of MeCP2 is proposed to form a wedge-shaped structure with four N-
terminal anti-parallel 13-sheets (A-D) forming one side of this wedge and a C-terminal 
a-helix forming the other. The authors suggest that Tyr123 is juxtaposed on the 
surface of the protein with the charged residues Argi 11, Asp 121 and Arg133 nearby 
critical for making contact with the m 5CpG dinucleotide (see Figure 3.13). The 
Asp 121 residue is known to be absolutely required for binding of the MBD of 
MeCP2 to methylated DNA as site-directed mutagenesis to a glutamate residue 
abolishes binding (Wakefield et al., 1999; Andrew Free, personal communication). Of 
these residues thought to be critical for binding to methylated DNA within the MBD 
of MeCP2, Argi 11 is present in the PBM-1 and mouse PBM1 MBDs while Asp 121 
is present in the PBM- 1 protein however a glutamate residue exists in this position in 
mPBM1. The conserved Arg133 is conserved in the mPBM1 MBD however is 
"mutated" to serine in the worm PBM- 1 sequence. Strikingly, the Tyrl 23 residue is 
not present in either the worm PBM-1 or mPBM1 MBDs. Interestingly the adjacent 
residues at positions 124 and 125 contain conserved aromatic residues (see Figure 
3.13). These findings considered with the inability to detect a complex between the 
recombinant MBDs of PBM-1 and the mouse PBM1 proteins and methylated DNA 
strongly suggests that the methyl-CpG binding domain in these proteins is non-
functional. However, the experiments carried out in this study do not exclude the 
possibility that the MBD regions mediate sequence specific DNA-binding in these 
proteins to other target sequences. Alternatively, on the basis of sequence 
conservation between the nematode PBM-1 and mammalian mPBM1 MBDs these 
motifs may serve as RNA-binding motifs or potentially as protein-protein interaction 
motifs within these proteins. 
The mPBM1 cDNA was the product of a complex series of alternative splicing 
events located adjacent to the MBD (see Figure 3.7). RT-PCR detected a 95 amino 
acid splicing event N-terminal of the MBD and spliced and unspliced RNAs were 
detected in somatic and tissue cultured cells. Interestingly, alternative splices adjacent 
to DNA-targeting domains have been found to modulate binding in different isoforms 
and the basic helix-loop-helix (bHLH) family of transcription factors provide good 
examples of this effect. The bHLH-ZIP transcription factor microphthalmia (Mi) 
binds DNA as a homodimer (Hemesath et al., 1994). Mi has two isoforms that differ 
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by an alternatively spliced insert of 6 amino acids N-terminal of the basic DNA 
binding region and the presence of the insert was found to enhance DNA binding 
(1-lemesath et al., 1994). By analogy with the bHLI-1 family of transcription factors, 
the PBM-1 and mPBM1 proteins may bind to DNA as homodimers and the 
expression of the MBD regions alone would not allow dimerisation to occur to 
facilitate binding. One possibility that should be tested is that the different splice 
variants encode proteins that either stimulate or inhibit DNA binding via the MBD 
region in mPBM1. A number of techniques exist to determine the consensus target 
sequence of a suspected DNA binding domain. A binding site selection approach 
with an oligonucleotide containing a randomised internal region (Oliphant and Struhi, 
1987) or whole genome PCR (Kinzler and Vogelstein, 1989) could be used to 
determine whether C. elegans PBM-1 and mouse PBM1 proteins have affinity for 
DNA. Bulyk et al., (1999) have reported a novel double stranded DNA array for 
investigating DNA-protein interactions and have shown that the immobilised DNA 
can be covalently modified by methylation allowing recognition sequences containing 
post-synthetic modifications to DNA to be screened for interactions. 
7.4 Localisation of the mPBMI protein 
The mPBM1 protein has been localised in mouse fibroblasts by fusing the full length 
protein to a green fluorescent protein marker. The protein gave a distinct granular 
localisation pattern throughout the nucleoplasm but appeared to be absolutely 
excluded from the nucleoli. The mouse major satellite has been reported to contain 
206 
some 50% of all m5C in the mouse genome. The mouse satellite is present in 
pericentromeric heterochromatic regions which stain strongly with the DNA dye 
DAPI (Miller et al., 1974). Importantly, no co-localisation of the mPBM1-GFP 
signal with the DAPI signal was observed. This finding in vivo that the mPBM1 does 
not target to heavily methylated foci is in agreement with the in vitro binding studies 
which failed to detect an affinity for a methylated template. Furthermore, deletion of 
the N-terminal MBD region did not perturb localisation of the mPBM1 protein in the 
nucleus however the removal of the entire C-terminus containing the PHD-zinc 
fmger and bromodomain regions resulted in a dramatically altered localisation pattern 
with foci of intensely labelled signal as opposed to the diffuse pattern of the wild 
type protein. 
Intriguingly, similar results were observed by Rinderle et al., (1999) studying 
localisation of another PHD-zinc finger protein, the putative autoimmune regulator, 
AIRE. APECED (autoinimune polyendocrinopathy-candidiasis-ectodermal 
dystrophy; OMIM 240300) is an autosomal recessive human genetic disorder and 
arises through production of autoantibodies leading to a potent autoimmune response 
directed at numerous organs and autoantigens (Campbell and Milner, 1993). 
Nagamine et al., (1997) reported the positional cloning of AIRE, a putative 
transcription factor by virtue of possessing two PHD-zinc fingers, homologous to 
the single C-terminal mPBM1 zinc finger (see Figure 3.9). Mutational analysis in 
Finnish and Swiss APECED families identified a predominant, nonsense mutation 
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(R257X) in AIRE which results in a Arg—STOP nonsense mutation leading to 
truncation of the C-terminal PHD-zinc fingers. This suggested that the molecular 
aetiology of the APECED disorder might arise through mislocalisation of AIRE due 
to the absence of the zinc-finger domains. The nuclear sub-localisation of AIRE was 
strikingly similar to that of mPBM 1, with immunofluorescence revealing the protein 
to be distributed in discrete, punctate speckles throughout the nucleoplasm (Rinderle 
et al., 1999), reminiscent of the localisation of full length mPBM1 fusions (Figure 
4.1A). However, mutational analysis of AIRE deleting the two PHD-zinc fingers 
(corresponding to the major Finnish R257X mutation) lead to a dramatically altered 
nuclear localisation where the mutant protein concentrated in discrete foci as opposed 
to its normally diffuse pattern. This mimicked the mPBM1 mutant protein that 
lacked the C-terminal PHD-zinc fmger/bromodomain that was also found to be 
present in intensely labelled foci following deletion of a domain containing this highly 
conserved zinc finger region. The perturbed nuclear localisation of 
mPBMhWHDIBrD and that of the AIRE R257X mutant protein may thus arise 
through a failure to associate with nuclear proteins that confer the wild type diffuse, 
granular pattern via PHD-zinc finger regions. 
Importantly, the work by Rinderle et al., (1999) on AIRE localisation did not test 
directly by site-directed mutagenesis of the zinc finger whether this domain mediates 
targeting to specific nuclear sub-domains. The diffuse dot-like distribution of full 
length mPBM1 is reminiscent of the pattern observed with other nuclear proteins, 
particularly the promyelocytic leukaemia (PIVIIL) protein (Dyck et al., 1994) and the 
acute lymphoblastic leukaemia (ALL1) protein (Yano et al., 1997). In order, to 
investigate the structures containing the mPBM1 polypeptide, double-
immunofluorescence experiments using antibodies specific to mPBM1 and PML or 
ALL 1 would determine whether these activities co-localise. 
These studies on mPBM1 localisation were carried out using a GFP marker and 
overexpressed levels of protein. For in vivo immunohistochemical detection of the 
mPBM1 protein a specific polyclonal antibody is required to determine whether the 
diffuse staining pattern seen in fibroblasts ectopically expressing a GFP-tagged fusion 
protein is reflective of the endogenous localisation pattern. A single mouse fibroblast 
cell line (EFS2) was used in this study to localise the mPBM1 activity and it is 
necessary to determine whether the requirement for an intact C-terminus to confer a 
diffuse granular localisation pattern is reflective in a range of transfected cell types. 
A growing number of human genetic diseases have been identified that arise through 
mutation of PHD-zinc finger genes thought to encode general transcriptional 
regulators. In addition to the PHD-zinc finger containing protein AIRE found 
mutated in the APECED autoimmune disorder described above, mutations in the 
PHD-like finger of hATRX, a SNF2 family member has been shown to cause the X-
linked developmental disorder ATR-X syndrome (Gibbons et al., 1997). Mutation 
and deletion of the PHD-zinc fmger/bromodomain-containing CREB-binding protein 
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(CBP) have been found to be responsible for another developmental defect, 
Rubinstein-Taybi syndrome (RTS) (Petrij et al., 1995). Williams syndrome (WS) is a 
complex developmental disorder with multiple developmental defects caused by 
deletion of chromosome 7q1 1.23 and a PHD-zinc finger/bromodomain gene WSTF 
has been mapped to this WS deletion interval (Peoples et al., 1998; Lu et al., 1998). 
The ATR-X, RTS and WS human disease syndromes are characterised by 
developmental abnormalities and are thought to arise through a generalised 
deregulation of normal gene expression. 
7.5 Mapping of the hPBMI gene to 2q23 
Chromosomal translocations are frequently identified in patients with various forms 
of leukaemia (see Chapter 5). Clinical cases with a single cytogenetic abnormality 
facilitates the cloning of the breakpoints of the translocations leading to gene(s) 
identification involved in the molecular aetiology of leukaemia. The human PBM 1 
gene has been mapped by a number of approaches to human chromosome 2q23. 
Interestingly, a number of deletions and translocations of human chromosome 2q23 
are known in human leukaemias. 
Columbano-Green et al., (1990) have reported a cytogenetic analysis of bone marrow 
cells from a patient with acute nonlymphocytic leukaemia (ANLL) that had as the 
sole detectable cytogenetic abnormality the rearrangement t(2;14)(q23;q32.3). The 
only other t(2;14) reported was in a case of chronic myeloid leukaemia (CML) 
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(Sessarego et al., 1979). The position of hPBM1 gene on chromosome 2 is of interest 
because a number of cases of ANLL have been reported following deletions at 2q23 
(Arthur et al., 1987) and like the study by Columbano-Green et al., (1990) the 
patients responded poorly to therapeutic intervention suggesting 
deletions/rearrangements of 2q23 are indicative of a poor clinical prognosis. 
Thus, translocations and deletions involving 2q23 have suggested the existence of 
oncogenes or genes involved in controlling haemopoiesis at this locus. Transcription 
and developmental regulation are key elements in tumourigenesis where 
transcriptional regulators that control many downstream targets are thought to be 
crucial to the development of cancer by virtue of aberrantly regulating numerous loci. 
The mapping of hPBM1 to 2q23 makes it a candidate for disruption in the cases of 
leukaemia involving rearrangements and deletions on the distal arm of human 
chromosome 2. 
The report of a deletion specifically at 2q23 is the most convincing evidence that 
disruption of gene(s) at this chromosomal location are responsible for transformation 
and not simply the result of mutation of genes on partner chromosomes that give rise 
to the neoplasia. However, the cytogenetic abnormality specifically at 2q23 is a 
contiguous gene deletion disorder where many loci that reside within this 
chromosomal interval could be responsible for the leukaemogenesis. In order to 
determine whether the hPBM1 gene was involved in the cases of leukaemia at 
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chromosome 2q23, genomic DNA from patients who are cytogenetically 
t(2;14)(q23;q32.3) could be analysed by Southern blot analysis to see if 
rearrangements existed within the gene. If rearrangements were detected then the 
breakpoint should be cloned to 1) characterise the nature of the deletion (intronic or 
exonic) within the hPBM 1 gene and 2) to identify partner genes on chromosome 14. 
The first step would be to make somatic cell hybrids to have a source of genomic 
DNA to generate t(2;14)-specific cosmid libraries. This could be carried out by fusing 
viable leukaemic cells from t(2;14) patients to HPR Chinese hamster cells under 
selection for resulting hybridoma events. These hybrids could then be screened for 
the derivative (der) fusion chromosome 14 segregating from the normal chromosome 
14 and the other derivative chromosome, der(2) by using Southern hybridisation and 
STS mapping. Screening of a cosmid library made with genomic DNA from the 
der(14) somatic cell hybrid with 5' and 3' hPBM1 probes would isolate cbimaeric 
clones spanning the breakpoint. This junction cosmid spanning the breakpoint could 
then be exon trapped and chromosome 14 cDNAs identified. Chromosome 14-
specific sequences that give an rearranged Southern pattern could then be used in RT-
PCR on RNA from t(2;14) patients to characterise the nature of the oncofusion 
mRNA in the t(2;14) patients. 
7.6 Transcriptional regulatory properties of the mPBMI protein 
The mPBM1 protein sequence contains several motifs present in established 
transcriptional regulators. In this study, a fragment of mPBM1 fused to the 
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heterologous DNA-binding domain of GAL4 was found to be capable of a modest 
dose-dependent repression when tethered to a reporter gene in vivo. Importantly, no 
reduction in the transcriptional competence of the reporter gene was observed 
without the specific binding of the mPBM1 fusion. However, the repressive effect of 
the mPBM1 fusion was weak, resulting in only a 50% reduction in activity of the 
reporter (see Figure 4.4). In order to better characterise the transcriptional regulatory 
properties of mPBM1, nested deletions are required and the assaying of the effects of 
these constructs on a reporter would allow the mapping of transcriptional regulatory 
domains within the protein. Furthermore, the silencing of the reporter gene may occur 
by mechanisms involving steric hindrance or via protein-protein interactions. To test 
the possibility that the binding of mPBM1 on the reporter gene is inhibiting 
transcription directly by promoter occlusion, the GAL4-binding elements could be 
removed to a more distal location and assayed for repression in a distance-
independent manner. Repression at a distance would exclude the possibility that 
sterically hindering the promoter is mediating the repressive effect. GAL4 fusions of 
the C. elegans PBM- 1 cDNA could be tested for the ability to modulate a reporter 
gene in mammalian cells as has been demonstrated for C. elegans proteins that target 
the highly conserved RNA pol II transcriptional machinery (Batchelder et al., 1999). 
Testing the mPBM1 protein in yeast and Drosophila SL2 cells for the ability to 
modulate transcription would further strengthen a mechanism operating through 
repression of the conserved transcriptional machinery (Pengue and Lania, 1996). 
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Mapping of a repression domain and two hybrid screens for interacting proteins with 
this region would better characterise mediators of the silencing. 
The mPBM1 cDNA was found to be alternatively spliced and functional 
diversification of transcriptional regulators is known to occur as a result of splicing 
events. For example, the AML1 gene encodes three isoforms (AML1 a-c) which 
possess distinct effects on transcription, differentiation and proliferation of myeloid 
cells (Tanaka et a!, 1995). The repressive effect on the reporter gene by mPBM1 was 
observed with the mPBM1a isoform and it would be interesting to see whether the 
alternatively spliced mPBM1b and mPBM1c proteins (diagrammed in Figure 3.7) 
mediate distinct effects on transcription. 
An interaction between the PHD-zinc fingers of Mi23 and the histone deacetylase, 
HDAC 1 has been reported (Zhang et al., 1998). Treating the cells transfected with 
the mPBM1 fusion with an inhibitor of histone deacetylases such as trichostatin A 
(Yoshida et al., 1995) would establish whether deacetylation plays a part in the 
mechanism of transcriptional repression by mPBM1. 
7.7 Potential protein interaction targets of the PBM proteins 
MBD-containing proteins have been implicated in the epigenetic control of gene 
transcription. CpG methylation can induce histone deacetylation, chromatin 
remodelling and gene silencing by assembly of a transcriptional repressor complex 
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containing the histone deacetylases, HDAC1/2 bound to the co-repressor, mSin3A 
(Nan et al., 1998; Jones et al., 1998; Eden et al., 1998). This silencing complex is 
assembled by the binding of MeCP2 to methylated DNA through its methyl-CpG 
binding domain (MBD) and the recruitment of the mSin3A/HDAC machinery via a 
separable transcriptional repression domain. These findings establish a link between 
the epigenetic phenomena of DNA methylation and histone deacetylation. 
Interestingly, together with the MBD domains found in C. elegans PBM- 1 and 
mouse PBM 1, these proteins possess additional motifs implicated in epigenetic 
mechanisms of gene regulation the PHD-zinc finger and bromodomain motifs. The 
presence of the PHD-zinc finger in the Drosophila trithorax and polycomb-like 
proteins which exert antagonistic effects on chromatin structure and gene expression 
has prompted the suggestion that this motif may be involved in the interaction 
between chromatinic proteins (Aasland et al., 1995). Subsequently, it has been 
demonstrated that the PHD-zinc fingers of Mi2p are required for interaction with the 
histone deacetylase HDAC 1 within a large multiprotein complex termed NuRD that 
possesses histone deacetylase and chromatin remodeling ability (Zhang et al., 1998). 
The bromodomain motif is also found in protein complexes involved in chromatin 
remodeling such as in the GCN5 and TAF 11250 intrinsic histone acetyltransferases 
(Brownell et al., 1996; Mizzen et al., 1996). Barley et al., (1998) have identified a 
functional interaction between the bromodomain of GCN5 and the Ku70 subunit of 
the DNA-dependent protein kinase (DNA-PK) both in vitro and in vivo. 
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Phosphorylation of GCN5 by the DNA-PK holoenzyme resulted in an attenuation 
of GCN5s acetyltransferase potential. 
To identify protein targets of the mPBM1 PHD and bromodomain motifs a yeast 
two-hybrid screen could be used to look for interacting proteins with this region in 
vivo. Barley et al., (1998) have reported that in addition to GCN5, the bromodomains 
of the CREB-binding protein (CBP) and TAF 11250 also interacted directly with the 
Ku70 component of the DNA-PK complex in vitro and in vivo. This would make the 
bromodomain of mPBM1 a strong candidate for interaction also, which could be 
tested for by a GST pull-down assay by immobilising a GST-Ku70 fusion on GSH-
Sepharose beads and incubating with in vitro translated S 35-labelled mPBM1. An in 
vivo interaction between mPBM1 and Ku70 could be tested for by transient co-
transfection of mouse L929 cells with Myc-tagged Ku70 and HA-tagged mPBM1. 
Proteins imniunoprecipitated with an anti-HA antibody could be probed for the 
presence of Ku70 with an anti-Ku70 antibody to see whether Ku70 can associate 
with mPBM1 in vivo. Similarly, an interaction between the mPBM1 PHD-zinc finger 
and histone deacetylases, as has been demonstrated for HDAC 1 and the PHD-zinc 
finger of Mi23 reported by Zhang et al., (1998), could be tested for by a GST pull 
down assay with GST-HDAC1 and in vitro translated mPBM1 and a co-
immunoprecipitation experiment of the type described above. 
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7.8 The C. elegans pbm-1 gene is not essential for viability 
In order to determine the function of a gene, an integration of information is required 
from a number of sources with respect to ortholog characterisation and the 
determination of a mutant phenotype. To obtain a C. elegans strain containing a loss-
of-function mutant in the pbm-1 gene, a deletion mutant bank was screened. An 
EMS-induced deletion allele was identified within the pbm-1 gene and a C. elegans 
strain pbm-1 (qal 700) was isolated that was homozygous mutant for this deletion. 
Sequencing of transcripts from this deletion locus confirmed that the allele was a null. 
The homozygous pbm-1 mutant was viable and the pbm-1 gene is therefore non-
essential on the straightforward basis of not being mutable to a recessive lethal. No 
related genes were present in the C. elegans genome to account for functional 
redundancy within a multigene family where a related gene product might compensate 
for the loss-of-function pbm-1 mutation. 
Histone acetylation and deacetylation are known to play key roles in major 
differentiation events in C. elegans embryogenesis. Shi and Mello (1998) have shown 
that inhibition of the cbp-1 gene which encodes a protein with significant sequence 
similarity to the mammalian CBP/p300 histone acetyltransferases resulted in 
differentiation defects in endoderm and mesoderm development. Interfering with the 
HDAC and RbAp48-related genes hda-1, rba-1 and rba-2 partially suppressed the 
differentiation defects seen in the cbp-1 mutants. HDAC1 and RbAp48 are subunits 
of a mammalian histone deacetylase complex (Taunton et al., 1996) and may serve to 
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antagonise the activation function of CBP/p300. The PBM-1 protein shares 
homology with factors such as trithorax and polycomb-like involved in the 
developmental silencing of the clustered homeotic genes in Drosophila. Similarities 
exist between the silencing of the homeotic genes in Drosophila and the phenomenon 
of position-effect variegation where juxtaposition of a gene relative to 
heterochromatin results in transcriptional repression. Despite the large number of 
chromosomal rearrangements generated in C. elegans, there are few reports of 
position-effects and it has been suggested that chromatin organisation in C. elegans is 
more uniform than the mouse and Drosophila (Hodgkin, 1994). 
Second-site modification of mutations is a powerful approach to identify proteins 
that either target a gene directly or interact with the protein product. In the absence 
of a discernible phenotype, the pathways in which the pbm-1 gene operates cannot 
be isolated by traditional approaches such as the identification of enhancer or 
suppressor mutants. Gonadal microinjection of translational fusions between the 
pbm-1 gene and GFP under the control of the endogenous promoter however would 
yield valuable information on the sites of expression which would aid in phenotype 
identification. Overexpression of PBM- 1 in wild type worms could also generate a 
phenotype from which function might be ascertained. Antisera specific to PBM- 1 
would determine at what stage of development the pbm-1 gene is expressed and in 
which cell types and to confirm that no protein expression is detectable in the pbm-1 
(qal 700) strain. As the lineage of every cell in the worm is known, the information 
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generated by localising the site of protein expression can be particularly informative 
and could be used to screen for mutations in other genes that affect the localisation of 
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